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GENERALLY USED TERMINOLOGY AND NOMENCLATURE 
 
Generally accepted gene names, symbols and genetic terminology were used in this thesis. Gene 
names are given in upper case letters and italicised e.g. PERIOD abbreviated to PER. The 
abbreviations are defined in text upon first use in each chapter.  
 





Background: Circadian rhythms are internally driven biological variations that fluctuate with a 
period of approximately 24 hours, even in the absence of external environmental time cues. 
These rhythms enable organisms to synchronise their internal clock time with external 
environmental time. This ensures appropriate timing of biological and metabolic processes, and 
allows anticipation of daily changes in the environment. Circadian rhythms also play an important 
role in sports in terms of optimising performance time-of-day and aiding adjustment to global 
time zone changes. Thus, performance, which is under the control of the athlete, may be 
impacted by event time-of-day scheduling in the new time zone. It has previously been shown 
that individual sport athletes in South Africa tend to be morning-types and carry the PERIOD3 
(PER3) Variable Number Tandem Repeat (VNTR) 5-repeat allele, which has been associated with 
a preference for mornings. The distribution of the PER3 VNTR polymorphism in combination with 
an individual’s preference for mornings or evenings has not yet been described in team sports. 
Differences in the PER3 VNTR genotype between team and individual sport athletes are expected, 
given that individual sport athletes may be free to choose the time-of-day at which they train. In 
contrast, team sport athletes usually train in groups, thus these individuals may not have the 
flexibility to choose their preferred training times.  
There are notable inter-individual differences in adjustment to jet-lag after time zone changes. A 
possible genetic candidate that may be responsible for some of this variation is the PER3 VNTR 
gene. This gene consist of two alleles corresponding in size to 4-repeats (PER34) or 5-repeats 
(PER35). Individuals are either homozygous for the 4-repeat allele (PER34/4) or the 5-repeat allele 
(PER35/5), while others are heterozygous for the PER3 gene (PER34/5). The PER3 VNTR genotype 
might explain individual sensitivity to bright light and has been reported to be associated with 
sleep pressure- an increase in the brain’s pressure and need for sleep, following an extended 
period of awakening. Individuals homozygous for the longer variant of the gene (i.e. PER35/5) 
experience a higher sleep pressure during extended wakefulness. The PER35/5 genotype has been 
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reported to be more sensitive to the alerting and melatonin suppression effects of blue enriched 
light than the PER34/4 genotype. 
 
Aims: Therefore, the aim of Study 1 was to compare the chronotype and PER3 VNTR genotype 
distribution of South African Super Rugby players to individuals of low physical activity (i.e. those 
who are physically active ≤2 times per week). The aim of Study 2 was to determine whether PER3 
VNTR genotype might contribute to inter-individual variation in the extent to which game 
involvement and quality of play are affected following trans-meridian travel. Further, the aim of 
Study 3 was to compare the impact of time zone travel during the 2012 Super Rugby competition 
in South African players genotyped as PER34/4, PER34/5 and PER35/5 on the incidence of illnesses 
and injuries. Lastly, the aim of Study 4 was to compare the extent to which individuals genotyped 
as PER34/4 or PER35/5 respond to appropriately-timed blue light exposure in order to 
resynchronise their circadian rhythm, following simulated eastward travel, based on changes in 
dim-light melatonin onset and cortisol circadian phases. 
 
Methods: The cohort for Study 1 consisted of male, South African rugby players (n=205) and a 
healthy, active, but non-competitive control population (n=191). Firstly, the distribution of 
morning-, neither- or evening-preferring individuals was measured using the Horne-Östberg 
morningness-eveningness personality questionnaire. The genotype and allele frequency of the 
PER3 VNTR polymorphism were determined from genomic DNA products extracted from human 
blood/buccal cell samples amplified and digested with NcoI.  
 
In Studies 2 and 3, the impact of time zone travel during the 2011 and 2012 Super 15 Rugby 
competitions on South African players categorised as PER34/4, PER34/5 and PER35/5 was compared. 
Specifically, effects on game activity rate and quality of play in players categorised as PER34/4 
(n=20), PER34/5 (n=20) and PER35/5 (n=20) and the incidence of illness and injury in the three PER3 
VNTR genotypes were measured.  
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Lastly, in Study 4, the extent to which untrained males genotyped as PER34/4 (n=8) or PER35/5 
(n=8) responded to appropriately-timed blue light exposure in order to resynchronise their 
circadian rhythm was examined. Jet-lag was artificially induced in the laboratory to simulate 
eastward travel crossing six time zones, and circadian resynchronisation was assessed by 
measuring changes in DLMO and cortisol circadian phases.  
 
Results and Discussion: Results from Study 1 showed that the PER3 VNTR genotype distribution 
was similar in the rugby (PER34/4: 41.5%, PER34/5: 45.4%, PER35/5: 13.1%) and control (PER34/4: 
36.6%, PER34/5: 51.7%, PER35/5: 11.7%, p=0.738) groups. The frequencies of the 4- and 5-repeat 
alleles in the rugby (PER34: 64.1%; PER35: 35.9%) and control (PER34: 62.5%; PER35: 37.2%, 
p=0.598) groups were similar to those previously reported in other populations. However, they 
were different from findings by Kunorozva et al. (2012) in individual sports’ athletes (PER34: 
41.7%, PER35: 58.3%). The chronotype distribution was significantly different between the rugby 
(MT: 48.9%, NT: 48.8%, ET: 3.3%) and control (MT: 24.6%, NT: 56.5%, ET: 18.9%, p<0.001) groups. 
An association between PER3 VNTR genotype and chronotype was only observed in the control 
group (r=0.293, p=0.008). 
 
In study 2, game involvement was similar in all players regardless of direction travelled (No time 
zone travel: 0.24 (0.78 events∙min-1), Westward travel: 0.00 (0.39 events∙min-1), Eastward travel: 
0.18 (0.45 events∙min-1), p=0.072) or number of time zones crossed (No time zone travel: 0.24 
(0.77 events∙min-1), 6-8 Time zones: 0.08 (0.49 events∙min-1), >10 Time zones: 0.13 (0.45 
events∙min-1), p=0.351). Similarly, no significant differences in game involvement were noted 
when the PER3 VNTR genotype was taken into account (PER35/5: 0.18 (1.08 events∙min-1), PER34/5: 
0.13 (0.41 events∙min-1), PER34/4: 0.26 (0.57 events∙min-1), p=0.216). In contrast, quality of play 
was significantly higher after westward (90.63 (12.4%)) compared to eastward (88.8 (12.3%), 
p=0.031) travel. Further, quality of play was significantly higher following westward travel (89.2 
(14.7%)) compared to eastward travel (86.9 (14.0%), p=0.040) only when more than ten time 
zones were crossed. Lastly, play quality was worse in the PER34/4 (85.1 (13.2%)) compared to the 
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PER34/5 (93.2 (16.5%), p=0.041) and PER35/5 (92.1 (13.1%), p=0.026) groups following westward 
travel across ten or more time zones. 
 
Results from study 3 indicated that significantly more of the players became ill after both 
eastward and westward travel compared to when there was no time zone travel (No time zone 
travel: 16.5/1000 player days, Eastward travel: 42.6/1000 player days, Westward travel: 
30.4/1000 player days, p<0.001). Likewise, significantly more players sustained injuries following 
time zone travel (No time zone travel: 36.3/1000 exposure hours, Westward travel: 48.1/1000 
exposure hours, Eastward travel: 66.4/1000 exposure hours, p=0.022). Specifically, high injury 
incidence rates were noted following eastward travel (66.4/1000 exposure hours) compared to 
no time zone travel (36.3/1000 exposure hours, p=0.010). 
 
Results from Study 4 indicated that, regardless of genotype, a phase advance was achieved for 
all individuals, suggesting that the protocol was effective. In the simulated jet-lag travel study, 
mean DLMO time for the PER35/5 group (17h31±0h21) occurred earlier than that of the PER34/4 
group (17h58±0h24) following appropriately-timed blue-enriched light exposure (p=0.032).  
 
Conclusions: Chronotype distribution in rugby players may have been affected by the 
conditioning effect of morning training sessions. The PER3 VNTR genotype may explain some of 
the variations in an individual’s match quality of play, injury and illness incidence rates in South 
African Super Rugby players, as well as re-entrainment in healthy, active, but non-competitive 
individuals following simulated jet-lag. These findings may further the understanding of possible 
cause/s of illnesses and injuries, and improve health and performance in rugby players who travel 
to participate in international competitions. The PER3 VNTR genotype results have improved our 
understanding of inter-individual differences in response to jet-lag. This has the potential to 
transform the way team physicians manage their players in order to maintain proper circadian 
alignment with the external 24h day in the new environment.  
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CHAPTER ONE: INTRODUCTION AND BACKGROUND 
 
1.1 Introduction 
Air travel across multiple meridians prior to or between competitions is a common feature of the 
lifestyle of many elite athletes, not only for international events such as the Olympic Games, but 
also in places such as the USA and Australia, where even domestic competitions can involve 
significant travel across time zones. Such travel often results in “jet-lag”, the misalignment 
between the internal body clock, also known as the circadian clock, and the external 
environmental time in the new time zone (Reilly et al., 2007). The impact that circadian disruption 
as a consequent of trans-meridian travel can have on injury and illness is of fundamental 
importance for regular travellers (Waterhouse and Reilly, 2009, Baron and Reid, 2014). More 
importantly, in professional athletes whose livelihoods depend on their ability to train and 
compete.  
 
In addition, different systems (e.g. psychological) resynchronise into the new time zone at 
different rates, which might affect the rate at which optimal performance is restored. Specifically, 
the effects of psychological risk factors (e.g. mood) on injury are mediated by the cumulative 
effect of acute and/or chronic physiological responses (Vandekerckhove and Cluydts, 2010). 
Cumulative influences of both physical and psychological factors deplete perceptual and sensor 
motor reserves potentially exacerbating the risk of injury (Vandekerckhove and Cluydts, 2010, 
Evans et al., 2007). Thus, athletes who undergo time zone travel are more likely to have a higher 
compound allostatic load (i.e. stressor) and an even more diminished threshold for mounting 
situational appropriate responses. Likewise, disruption of a system physiologically affects its 
function, for example, disruption of the respiratory and cardiovascular systems may limit 
endurance performance (Walsh, 2000, Kottke, 1966). 
 
Under synchronised conditions, aspects of performance such as reaction time (Reilly et al., 2007), 
leg strength (Coldwells et al., 1994) and neuromuscular coordination (Ilmarinen et al., 1980) all 
peak in the late afternoon to early evening. The variation in the peak of the above-mentioned 
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variables may also be related to changes in the environment (i.e. light-dark cycles, ambient 
temperature), body temperature, time since awake, chronotype and sleep-wake cycles, just to 
mention a few (Lee and Galvez, 2012, Youngstedt and O'Connor, 1999).  
 
Super Rugby athletes engage in frequent trans-meridian travel prior to and between matches 
played in South Africa, Australia and New Zealand. This results in recurrent desynchronisation of 
circadian rhythms in the new time zone which leads to the undesirable symptoms of jet-lag 
including, altered sleep patterns, changes in mood state, impaired reaction time and 
gastrointestinal disturbances (Reilly et al., 2005, Waterhouse and Reilly, 2009). The extent to 
which an individual is affected by jet-lag symptoms varies and depends on several factors chief 
among them being number of time zones crossed, direction of travel, age, genetics and 
chronotype (Choy et al., 2011, Reilly et al., 2007, Wesentsten et al., 2003). The key to alleviating 
jet-lag symptoms in the new time zone lies in proper resynchronisation strategies. This is 
important particularly in the Super Rugby competition considering that athletes may cross up to 
ten time zones with very little time to recover before a match. Ideally a recovery time of one day 
per time zone crossed would be allowed (Manfredini et al., 1998), highlighting the importance of 
the amount of lead time desirable for body clock adjustment when scheduling international 
travel itineraries. However, because of budget and time constraints this is not usually the case in 
many sports including the Super Rugby competition.  
 
Strategies such as appropriately-timed light exposure (Forbes-Robertson et al., 2012) and 
external melatonin administration (Burke et al., 2013) may be used to aid resynchronisation into 
the new time zone. However, their effectiveness is complicated by the inter-individual variability 
in response to the same entraining stimuli. Therefore, effective jet-lag alleviation strategies 
following time zone travel will have to understand the basis for the inter-individual variabilities 
in addition to number of time zones crossed and direction of travel in order to be useful and 
reduce the impact of time zone travel on health and performance.  
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1.2 The circadian system  
Living organisms possess an intricately precise, internal molecular circadian system that times 
daily events ranging from sleep and wakefulness in humans to photosynthesis in plants (Shea et 
al., 2011, Morris et al., 2012, Takahashi et al., 2008, Crowley et al., 2014). This system represents 
an evolutionarily conserved adaptation to the temporal environment that dates back to the 
earliest life forms (Kleitman, 1949). The circadian clock generates rhythms, which are 
endogenously (internally) driven fluctuations in biological, physiological and behavioural 
variables that have a period of about 24h (Ebisawa, 2013, Mohawk et al., 2012). These rhythms 
often take the form of sinusoidal waves (Figure 1.1) that can be described in terms of period, 
phase and amplitude. The circadian phase is the time at which the circadian rhythm of a variable 
reaches a particular state relative to a marker (Roenneberg et al., 2003a, Korczak et al., 2008). 
An individual’s free-running (non-entrained) period determines the phase angle between 
endogenous and exogenous phase and subsequently this has an impact on the timing of 
entrainment to a zeitgeber (Aschoff, 1979, Roenneberg and Merrow, 2000).  
 
 
Figure 1.1: Sinusoidal waves showing key terms used to describe circadian rhythms. Period: 
the time during which a physiological process completes one circadian cycle, Phase: a stage 
(time-of-day) in the circadian cycle relative to a marker, Amplitude: one-half the distances from 
peak to trough during one period of an oscillation, Peak: the maximum point reached, Trough: 
the lowest point reached. Modified from Hsuchou (2013). 
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The circadian system consists of three parts: (1) the input pathways, which transmit 
environmental signals to entrain or synchronise (2) the “clocks”, which in turn generate rhythms 
that are relayed as (3) outputs (Figure 1.2). The outputs can also feedback to the clocks via 
fluctuations in endocrine rhythms or through changes in body temperature. Each cell in the body 
possesses the molecular mechanisms to generate rhythms, but mammals possess a central 




Figure 1.2: A simplified conceptual framework of the mammalian circadian system.  
The central clock is entrained mainly through light signals. The peripheral clocks (indicated by ~) can be 
affected by food, feeding time and temperature signals independent of the light entrainment pathway of 
the SCN. Peripheral clocks may receive direct signals from the SCN via the sympathetic and 
parasympathetic nervous systems. Sleep-wake cycle, locomotor activity and endocrine output rhythms 
feedback to the master clock and peripheral clocks regulating their function. In the diagram SCN: 
Suprachiasmatic nuclei, PACAP: Pituitary adenylate cyclase-activating peptide; TGFα: Tumour growth 
factor alpha; EGF: Epidermal growth factor. Reproduced from Garaulet et al. (2010). 
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Peripheral clocks are time keeping systems found in tissues which rhythmically express clock 
genes, are entrained by daily feeding and may receive input from the SCN (Giebultowicz, 2001). 
For example, cellular peripheral clocks in the heart, kidney, pancreas and the liver are entrained 
(synchronised) by signals from the SCN as well as food, social contact, physical exercise and 
temperature cues (Garaulet et al., 2010, Ebisawa, 2007, Schibler et al., 2015). Likewise, Schibler 
and co-workers (2003) observed that when nocturnal rodents were fed during daytime for one 
week, the phase of circadian gene expression in the liver, heart, kidney and pancreas were all 
inverted. This was not seen in the SCN. In addition, Hara et al. (2001) reported that restricted 
feeding was able to reactivate and phase entrain circadian liver gene expression in SCN-lesioned 
mice which were completely arrhythmic. 
 
In mammals, the circadian clock exerts its effects throughout the body by producing daily 
rhythms in all aspects of physiology such as core body temperature (Dijk et al., 2012), metabolism 
(Huang et al., 2011), DNA synthesis (Champier et al., 2012), brain wave activity (Dijk and Czeisler, 
1995, Marshall et al., 2011) and the regulation of plasma hormone levels such as melatonin (Dijk 
et al., 2012, Pevet and Challet, 2011), adrenalin (Vieira et al., 2013) and cortisol (Kudielka et al., 
2006). The rhythmic fluctuations of the aforementioned variables govern several of our habits 
and influence the activities that we perform during the 24h day (Roenneberg et al., 2013, 
Takahashi, 2015, Albrecht, 2012). Furthermore, these rhythms are self-sustaining, persisting in 
conditions where there are no external time cues, with an intrinsic period length close to 24h, 
indicating the presence of an internal time keeping mechanism (Hirota and Fukada, 2004, Saini 
et al., 2011).  
 
Aschoff’s work in the 1960’s was pioneering in elucidating the endogenous nature of mammalian 
circadian rhythms. In his experiments, one person was kept in a self-contained underground 
chamber (i.e. living room with a bed, kitchen, and bathroom) for several weeks. Day length was 
altered to be either longer than 24h, shorter than 24h or exactly 24h; while body temperature, 
urinary cortisol, wake-up and bed-times were measured throughout the experiment (Aschoff, 
1965). A normal 24h rhythm was maintained for the first seven days of the experiment when the 
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day length was exactly 24h, as evidenced by the rhythms in wakefulness and sleep, rectal 
temperature and urinary cortisol excretion. However, when external time cues were removed 
the rhythm was reported to free-run, with the circadian period measured between successive 
awakenings lengthening to 26.1h. When the day was shorter than 24h the circadian period 
measured between successive awakenings was shortened to 22.7h. The circadian period can 
adjust by lengthening or shortening to reset to the correct phase. In Aschoff’s experiment, the 
mean rhythmicity for the individual under free running conditions was 25.5h, implying that 
circadian rhythmicity persists, but with a period deviating slightly from 24h. 
 
The endogenous nature of mammalian circadian rhythms has also been demonstrated in-vitro, 
using cultured rat SCN cells which continued to generate 24h rhythms seven weeks post removal 
from the rat’s brain (Welsh et al., 1995). In a separate experiment using circadian gene reporter 
methods, it was demonstrated that nearly all peripheral organs and tissues can express circadian 
oscillations in isolation yet still receive, and may require, input from the SCN in-vivo (Yoo et al., 
2004). Furthermore, Akhtar et al. (2002) reported loss of circadian rhythms in the liver following 
SCN ablation in mice.  
 
The function of the SCN in setting time was demonstrated in an experiment were neural grafts 
from the SCN region were used to restore circadian rhythmicity to arrhythmic mutant hamsters 
whose own nucleus had been ablated (Ralph et al., 1990, Lehman et al., 1987). Furthermore, 
recent experiments in mammals have indicated that genetic mutations or knockout of essential 
clock genes result in either the loss of circadian rhythmicity or gross deficits in circadian timing 
of the SCN (Partch et al., 2014, Hastings et al., 2014). This indicates that the SCN is the 
endogenous timekeeper, with an important role in circadian timing. 
 
1.2.1 Molecular components of the circadian clock 
The basis of the circadian system is the presence of a molecular mechanism in each cell of the 
body. This mechanism consists of a network of transcriptional and translational feedback loops, 
which are similar at the molecular level in both the SCN and peripheral clocks (Balsalobre, 2002, 
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Yoo et al., 2004, Schibler and Sassone-Corsi, 2002). Protein products from core clock genes are 
important for generating and regulating circadian rhythms within each cell throughout an 
organism (Lowrey and Takahashi, 2004). The underlying molecular mechanisms of the circadian 
clock exhibit an exceptional amount of evolutionary conservation in diverse organisms ranging 
from cyanobacteria, fungi and plants to mammals (Muller et al., 2013, Tarrant and Reitzel, 2013, 
Chang and Guarente, 2013). However, the individual clock components for these organisms vary 
between species. In mammals, the molecular clockwork of rhythm generation consists of a 
network of interacting positive and negative auto-regulatory transcription-translation feedback 
loops involving central clock genes and proteins (Figure 1.3) (Partch et al., 2014, Robinson and 
Reddy, 2014, Beckwith and Yanovsky, 2014). The mammalian circadian behaviour can be viewed 
as an integrated system, beginning with transcription of clock genes and leading ultimately to 
behavioural outputs. Furthermore, the mammalian circadian clock model is based mostly on 
what has been discovered in mice.  
 
At the core of the circadian clock network are transcriptional activators, circadian locomotor 
output cycles kaput (CLOCK) and brain and muscle aryl hydrocarbon receptor nuclear 
translocator (ARNT)-like 1 (BMAL1) which, as heterodimers, positively regulate the expression of 
a number of genes, including the PERIOD (PER), CRYPTOCHROME (CRY) and Rev-erb alpha/beta 
(REV-ERBα/β) genes at the start of each cycle. PER and CRY gene products accumulate, dimerise, 
and form a multimeric complex that translocates into the nucleus where they interact with CLOCK 
and BMAL1, inhibiting their own transcription (Kucera et al., 2012, Yoo et al., 2013, Okamura et 
al., 2010). The enzymes casein kinase 1ε (CK1ε) and the mitogen activated protein kinase (MAPK) 
phosphorylate the PER, CRY, CLOCK and BMAL1 proteins regulating their stability and/or 
function, nuclear localisation, and degradation (Yoo et al., 2013, Lefta et al., 2011).  
 
An abundance of BMAL1 protein promotes CLOCK-BMAL1 heterodimerisation necessary to 
restart the PER/CRY transcriptional cycles. The positive-feedback loop in this manner augments 
regulation of the negative-feedback loop, perpetuating the clock cycle. The negative feedback 
loop includes the regulation of three PER genes (in humans, designated hPER1-3) and two CRY 
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genes (hCRY1-2). The rhythmic transcription of the PER and CRY genes is driven by the basic helix 
loop-helix (bHLH)-PER-ARNT-SIM (PAS) domain, consisting of CLOCK and BMAL1 transcription 
factors (Partch et al., 2014, Kucera et al., 2012). It takes approximately 24h for a single cycle to 
be completed; however, the exact stoichiometry and kinetics involved in this transcription-




Figure 1.3: A schematic outline of the transcription/translation feedback loops modulating 
circadian rhythms in mammals. CLOCK and BMAL1 heterodimerise and bind to the E-box 
promoter elements to activate the transcription of PER1 -3, CRY1-2, ROR, REV-ERBα and other 
genes in output pathways, forming the positive loop of the molecular clockwork of rhythm 
generation. Phosphorylated PER and CRY proteins heterodimerise and negatively regulate their 
own transcription and that of REV-ERBα. ROR and REV-ERBα also regulate the activity of the 
loops by increasing and repressing the transcription of BMAL1 expression, respectively. Post-
translational modification of clock factors, for example, phosphorylation, sequestration and 
sub-cellular localisation influence the regulation of the feedback loop. Reproduced from Wang 
et al. (2014). 
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There are numerous other feedback loops interlocked with the core CLOCK-BMAL/PER-CRY loop, 
including the REV-ERBα (Vieira et al., 2013, Kojetin and Burris, 2014) and the retinoic acid-related 
orphan receptor (ROR) loops (Ko and Takahashi, 2006). REV-ERBα is a component in the 
secondary auto-regulatory feedback loop that represses BMAL1 transcription and competes with 
a ROR to bind ROR response elements (RREs) in the BMAL1 promoter (Kojetin and Burris, 2014).  
 
1.2.2 Entrainment of the circadian clock 
Entrainment is the process by which the circadian clock synchronises to a time cue (Roenneberg 
et al., 2013, Buhr and Van Gelder, 2014, Husse et al., 2015). This happens to ensure that 
physiological and behavioural rhythmic events match the period and phase of the immediate 
external environmental oscillation. This is achieved by altering the concentration or activity of 
clock components through altered gene expression and protein stability (Sotak et al., 2013, 
McClung, 2013) in response to an entraining agent. The circadian clock keeps time accurately and 
adjusts to environmental time cues in order to ensure the efficacy of entrainment. Circadian 
rhythms are synchronised to the 24h day and exhibit specific phase relationships with the 
external light-dark cycles and internally with each other. For example, melatonin peaks during 
the dark period, in the middle of the habitual sleep episode, approximately 2h before the nadir 
of core body temperature rhythm and approximately 5h before the peak of the cortisol rhythm 
(Dijk et al., 2012, Morris et al., 2012).  
 
Several endogenous and exogenous time cues that entrain the circadian system in mammals 
exist. Chief amongst them are the light and temperature cues (Forbes-Robertson et al., 2012), 
with light being the primary entrainer of the SCN. Other factors also play a role in entrainment. 
For example, sound and feeding time (Ware et al., 2012, Escobar et al., 2011, Carneiro and 
Araujo, 2012), hormone levels (Bookout et al., 2013, Morris et al., 2012) and physical activity 
(Schroder and Esser, 2013). The rate and extent to which the circadian clock entrains to any 
zeitgeber depends on: (1) the free-running period of the clock (Tau or τ); (2) photoperiod; (3) the 
strength of the zeitgeber; (4) the amplitude of the zeitgeber, and (5) the clock’s sensitivity and 
responsiveness to a zeitgeber at the time of application/perception (Roenneberg et al., 2013, 
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Golombek and Rosenstein, 2010). The SCN is only found in mammals and is involved in the light 
entrainment pathway. Output rhythms from the SCN are fundamental to the signalling of other 
molecules and hormones. As the site of light input in mammals, the retina is vital for image-
forming and non-image-forming tasks (Dijk and Archer, 2009). It is the non-image forming tasks 
of the retina, which are important for circadian entrainment. The SCN receives light input from 
both classical photoreceptors (rods and cones), as well as from intrinsically-photosensitive retinal 
ganglion cells (LeGates et al., 2014). Melanopsin is found in intrinsically photosensitive retinal 
ganglion cells (iPRGC) (Schmidt et al., 2011). These cells play a pivotal role in relaying light 
information in the blue-light wavelength spectrum (450-495 nm) to the SCN via the retina 
(LeGates et al., 2014, Chellappa et al., 2014). The SCN uses information from the retino-
hypothalamic pathway and is able to coordinate daily 24h rhythms including hormonal secretion, 
temperature fluctuation and neural activation in line with solar time and the sleep-wake cycles 
(Buijs et al., 2003, Waterhouse et al., 2005a). 
 
The visual system for entrainment in humans functions optimally under light in the blue portion 
of the spectrum (Duffy and Wright, 2005, Wright et al., 2013, Lockley et al., 2003). The pathway 
relevant to light-entrainment relies mainly on information regarding the intensity and length of 
exposure of the light signal. Thus, a weak light signal leads to a smaller change in phase 
positioning than a stronger light signal; and an extended light exposure leads to a stronger change 
than a short exposure. Depending on when during the 24h cycle the light signal is presented to 
the eye, it will phase advance, phase delay or result in no shift at all in circadian rhythms (Figure 
1.4). For example, light exposure during late subjective night accelerates (phase advances) the 
clock into the next day and exposure to light during early subjective night decelerates (phase 
delays) the clock (Vosko et al., 2010, Kaur et al., 2009, Schwartz et al., 2011). Exposure during the 
middle of the subjective day causes no change in phase. Processes such as chromatin remodelling 
(Nakahata et al., 2008, Bunney and Potkin, 2008) are responsible for re-entrainment, which result 
in the repression or transcription of central clock genes. Since the same clock genes are expressed 
in the SCN and retina as in the cells of the rest of the body, it is thus possible to use other cells 
(e.g. hair follicle, cheek cells) to investigate the change in, for example, chromatin methylation.  




Figure 1.4: Shift (change) in melatonin midpoint as the circadian phase marker with  time of 
day of bright light stimulus. Phase advances (positive values) and delays (negative values) are 
plotted against the timing of the centre of the light exposure (alternating 6 min fixed gaze: ∼10 
000 lux; free gaze: ∼5000-9000 lux for 6.7h) relative to the melatonin midpoint on the pre -
stimulus constant routine in 21 healthy, entrained individuals. The filled circles represent data 
from plasma melatonin of 20 healthy, entrained individuals, and the open circle represen ts data 
from salivary melatonin in one individual from whom blood samples were not collected. The 
horizontal dashed line represents the 0.54h average delay drift of the body clock between the 
pre- and post-stimulus phase assessments. Reproduced from (Khalsa et al., 2003) 
 
1.3 Diurnal preference or chronotype 
The phase relationship between the external zeitgeber and the internal body clock varies 
between individuals resulting in circadian phenotypes that reflect one’s subjective preference for 
morning or evening activity (also known as ‘chronotype’). Such a concept has long been 
recognised with Kleitman (1949) documenting that some individuals have a consistent 
preference for daytime activities whilst others have a preference for evening- or nighttime 
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activities. Specifically, individuals are characterised along a continuum of preference for 
mornings or evenings. On one end are extreme morning-types (also called ‘larks’), who wake up 
early and are most alert in the first part of the day (Taillard et al., 2004). On the other end are 
extreme evening-types (also called ‘owls’), who wake up later and are most alert in the second 
part of the day (Zencirci and Arslan, 2011, Loureiro and Garcia-Marques, 2015). In the middle are 
neither-types, who have no particular preference for mornings or evenings, but can function 
optimally either in the mornings or evenings. The majority of people fall into this category.  
 
Chronotype differences may arise as a result of (1) tau length differences and (2) timing of the 
circadian rhythms of particular aspects of physiology such as sleep timing, body temperature, 
and hormone release (Archer et al., 2008, Baehr et al., 2000, Groeger et al., 2008). For example, 
the daily rhythms of core body temperature and melatonin secretion have been used to 
distinguish the timing of circadian rhythms between individuals preferring mornings compared 
to those preferring evenings (Scheer and Czeisler, 2005, Weinert and Waterhouse, 2007). 
Specifically, the rise in core body temperature in morning-types takes place at about ±04h00 
which is typically two hours ahead of evening-types as illustrated in Figure 1.5 (Baehr et al., 2000, 
Horne and Ostberg, 1976, Kerkhof and Van Dongen, 1996).  
 




Figure 1.5: Change in rectal body temperature (°C) as a function of time of day in seven 
morning- and seven evening-types during a constant routine laboratory experiment . E-types: 
evening-types (bold line), M-types: morning-types (thin line). Reproduced from (Kerkhof and 
Van Dongen, 1996). 
 
It has been illustrated that while the peak in urinary adrenalin occurs earlier in evening-types, 
the amplitude is higher in morning-types (Kerkhof, 1985). In addition, subjective alertness, 
fatigue, heart rate and vigilance performance have been shown to occur earlier in morning-types 
than in evening-types. While there were no amplitude differences, the onset, peak, and offset of 
melatonin were reported to occur about 3h earlier in morning-types than in evening-types 
(Mongrain et al., 2005). These combined data indicate that chronotype may be seen as a 
psychological preference for early or late rising, but it is influenced by the internal time keeping 
mechanism.  
 
Both genetics and the environment play an important role in determining chronotype, with 
estimates of heritability of about 50% (Barclay et al., 2010). In addition to polymorphisms in the 
circadian clock genes playing a part in the genetic determination, differences in resetting of the 
body clock, brought about by differences in conditioning or differences in exposure to phase-
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resetting stimuli, such as the light-dark cycle also play a role (Archer et al., 2008). For example, 
chronotype studies from various researchers tend to report more morning-types in 
temperate/warmer climates than in cooler ones (BaHammam et al., 2011, Henst et al., 2015, 
Kunorozva et al., 2012, Paine et al., 2006, Rae et al., 2015). 
 
1.3.1 Measuring chronotype 
While there are numerous validated questionnaires available to determine chronotype, including 
the Munich Chronotype Questionnaire (Roenneberg et al., 2003b), Composite Scale of 
Morningness (Smith et al., 1989) and the Circadian Energy Scale (Ottoni et al., 2011), the Horne-
Östberg (HÖ) questionnaire remains the most commonly used subjective tool (Adan and Natale, 
2002, Zavada et al., 2005, Randler, 2008, Punduk et al., 2005). Moreover, besides being translated 
into different languages, psychometric evaluation of this questionnaire confirms that it is made 
up of a fairly homogenous set of items with reputable internal consistency (Taillard et al., 2004, 
Randler, 2008, Urban et al., 2011, Rhee et al., 2012). In addition to being validated in a number 
of settings, the HÖ-questionnaire has also been shown to correlate well with several mechanisms 
involved in the regulation and timing of the natural sleep-wake cycle (Randler, 2008, Horne and 
Ostberg, 1976, Lehnkering and Siegmund, 2007) and the secretion of melatonin (Taillard et al., 
2003), providing further validation of its use. 
 
The HÖ-questionnaire is a 19-item questionnaire used to categorise individuals into one of five 
different chronotype groups (Horne and Ostberg, 1976). The scoring scale ranges from 16-86 with 
lower scores indicating a greater preference for evenings, and higher scores indicating a greater 
preference for mornings. Scores in the intermediate area indicate neither morning- nor evening-
type preference. The HÖ-questionnaire evaluates behavioural aspirations rather than actual 
behavioural patterns subject to circadian differences, based primarily on preferences for 
morning- and evening-orientation of activity (Juda et al., 2013, Roenneberg, 2012, Zavada et al., 
2005). Questions about the timing of actual sleep-wake behaviour on the HÖ-questionnaire are 
ideally fit for quantification of the circadian phase, as sleep-wake behaviour is easily observable 
and can be reported with no difficulties. The proportion of morning-, neither- and evening-type 
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individuals within various populations around the world has been reported in the literature, and 
is shown to vary considerably. The bulk of studies conducted thus far report more individuals in 
the neither- and evening-type categories and very few in the morning-type category in American, 
European, and Asian male and female general and student populations (Tonetti et al., 2010, 
Zavada et al., 2005, Osland et al., 2011, Chelminski et al., 1997). However, Paine et al. (2006) and 
Kunorozva et al. (2012) reported low proportions of evening-types (6% and 7%, respectively), and 
roughly equal proportions of neither-types (45% and 49%), and morning-types (49% and 41%) in 
Caucasian populations in temperate climates. 
 
1.3.2 Factors influencing chronotype 
Chronotype is influenced by developmental changes and ageing (Adan and Natale, 2002, Bliwise 
et al., 2005, Edelstein et al., 2012). For example, Horne and Östberg (1976) reported that a bed 
time of 23h30 may be indicative of a morning-type individual within a student population, but 
might be more related to an evening-type in the 40-60 years age group. Several other studies 
have reported age-related chronotype differences between young, middle-aged and older adults 
(Adan, 1992, Paine et al., 2006, Tonetti et al., 2010, Borisenkov et al., 2010, Reilly et al., 1997b, 
Kerkhof, 1988, Monk, 1989, Reilly et al., 1993, Waterhouse and Minors, 1995, Koskenvuo et al., 
2007b). For example, Tonetti et al. (2010) reported a chronotype distribution of morning (11.3%) 
and evening (23.4%) types in 1 041 young adults aged between 18-30 years. In another study, 
Koskenvuo and colleagues (2007a) reported that evening-type individuals were more prevalent 
in adolescents and young adults, while morning-types were more common in adolescents and 
older adults. Reilly et al. (1997b) illustrated that chronotype changes with age in 31 participants 
between the ages of 25-74. Specifically, they reported a reduced circadian amplitude and phase 
relation between systolic blood pressure and heart rate in older adults, implying an internal 
dissociation of rhythms with aging. This suggests an increase towards morningness with aging.  
 
In contrast, a study which assessed chronotype based on midpoints of sleep on free days (MSF) 
in people aged 8-to-94 years old indicated that males between 8-20 years show a later MSF, 
which is indicative of an evening chronotype (Roenneberg et al., 2004). In the same study, it was 
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noted that MSF displayed a reversed pattern in individuals above 21 years, changing to morning 
chronotype. The change to morning preference in the older generation becomes more apparent 
around the age of 50 years (Bliwise et al., 2005, Taillard et al., 2004). However, confounding this 
association is the strong synchronising effect of societal demands, particularly work habits, 
academic and family commitments in altering the natural chronotype of adolescents and young 
adults (Adan and Natale, 2002, Roepke and Duffy, 2010, Harb et al., 2012). In addition, when 
older people retire they do not have to wake early for work, thus they may become more 
evening-types through conditioning. Work-type is another factor, which may influence 
chronotype, for example, nighttime shift work may perturb the normal sleep-wake cycle, 
potentially altering an individual’s chronotype. This is conceivable given that in one study, only 
32% of healthy daytime shift workers were categorised as evening-types, while 75% of nighttime 
shift workers were categorised as evening-types (Burch et al., 2009).  
 
An individual’s sex may influence chronotype; however, there is no consensus as to which gender 
is more prone to being more morning- or evening-oriented. For example, Paine et al. (2006) 
reported no sex effect in 2 526 New Zealand participants between the ages of 30-49 years. 
Similarly, Lazar et al. (2012) illustrated no sex effect in 413 males and 262 females aged between 
20-35 years. In another study sex was not associated with chronotype using the reduced version 
of the HÖ-questionnaire in 330 males and 578 females (Adan, 1992). However, Adan and Natale 
(2002) reported that females scored highly on the HÖ-questionnaire compared to males in a 2 
135 University student population. In another study, Cavalera et al. (2011) reported that males 
were more evening-oriented compared to females.  
 
1.4 Relationship between clock genes and chronotype 
There are differences in circadian rhythm generation mainly due to genetic polymorphisms in 
clock genes, which lead to phenotypic differences in individuals. Several studies have 
demonstrated that mutations and polymorphisms in clock genes are associated with particular 
circadian abnormalities in humans, as well as with more subtle non-pathological phenotypes and 
chronotype. For instance, polymorphisms in a number of clock genes are associated with 
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increased or decreased risk of cancer (Kelleher et al., 2014, Gery et al., 2006, Winter et al., 2007) 
and sleep disorders, such as familial advanced sleep phase syndrome (ASPS) and delayed sleep 
phase syndrome (DSPS) (Reid et al., 2012, Archer et al., 2003, Ebisawa, 2007, Jones et al., 1999, 
Pereira et al., 2005), while others are associated with chronotype (Archer et al., 2003, Carpen et 
al., 2006, Katzenberg et al., 1998, Pedrazzoli et al., 2007). 
 
For the purpose of this thesis, the focus is on polymorphisms in clock genes associated with 
chronotype, focusing specifically on the PER3 gene. PER3 is a core clock gene, which is one of the 
transcriptional repressors that form the negative limb of the transcriptional-translational 
feedback loop. It has a redundant role with other PER proteins (PER1 and PER2) and is not 
essential for circadian rhythm maintenance. However, it plays an important role in the sleep-
wake timing and sleep homeostasis, without influencing circadian parameters (Dijk and Archer, 
2010, Viola et al., 2007, Maire et al., 2014, Hasan et al., 2014). It is highly expressed on the skin, 
in blood, epithelium of mammary- and salivary secreting-glands, just to mention a few. Several 
methods such as affymetrics, RNA sequencing and in-situ hybridisation can be used to measure 
PER3 expression levels (Hamada et al., 2001, Akashi et al., 2010, Li et al., 2013).  
 
Variations in PER3 including variable number tandem repeat (VNTR) and promoter have been 
associated with chronotype. The PER3 gene consist of two alleles, the longer version of the allele 
(PER35) is associated with morningness while the shorter variant (PER34, GeneBank AB047536) is 
associated with eveningness (Archer et al., 2003, Ebisawa et al., 2001). The functional roles of 
PER1 and PER2 the other two PER genes are well documented and have been shown to directly 
influence circadian rhythm maintenance (Jenkins et al., 2005, Zheng et al., 2001). Polymorphisms 
in these two genes have also been correlated with morning-evening preference (Carpen et al., 
2005, Lee et al., 2011, Toh et al., 2001, Carpen et al., 2006, Matsuo et al., 2007). For example, 
Lee et al. (2011) demonstrated an association between the PER2 3853G allele with morningness 
in 299 Korean college students (108 females and 191 males; mean age 22.1±2.1).  
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In another study, Carpen et al. (2005) illustrated an association between PER2 and diurnal 
preference in 105 British individuals (mean age: 40.1±14.1). Specifically, they reported a higher 
percentage of the PER2 111G in individuals with extreme morning preference. In addition, PER2 
2114A allele was shown to be associated with eveningness in 71 healthy Japanese individuals (50 
females and 21 males; mean age 23.5±7.6; Matsuo et al., 2007). There have been a few studies, 
which found no association in the other PER2 polymorphisms and chronotype (Carpen et al., 
2005, Lee et al., 2011, Choub et al., 2011). In two of these studies, no association was found 
between chronotype and either the C or G alleles of the PER2 gene in 156 healthy volunteers of 
Italian origin (104 females and 52 males; mean age 33.1±12.0; Choub et al., 2011) and 299 Korean 
college students (108 females and 191 males; mean age 22.1±2.1; Lee et al., 2011).  
 
The CLOCK 3111C (rs1080126) polymorphism has been associated with evening preference 
(Katzenberg et al., 1998, Mishima et al., 2005), while the PER2 3853G (rs934945) and 111G 
(rs2304672) polymorphisms have been associated with morning preference (Lee et al., 2011, 
Choub et al., 2011). Robillard et al. (2002) and Pedrazzoli et al. (2007) failed to reproduce the 
CLOCK 3111C in British and Brazilian samples, respectively, and Rae et al. (2015) and Henst et al. 
(2015) have found no association between the PER3 VNTR and chronotype in South African and 
Dutch marathon and professional swimming populations. Possible reasons for the contradictory 
findings in these studies vary and range from, the use of different ethnicities, differences in 
sample sizes and differences in latitude. 
 
1.4.1 The PER3 variable number tandem repeat (VNTR) and chronotype 
To date, there have been conflicting findings with respect to whether the VNTR polymorphism 
within the coding region of the PER3 gene is associated with diurnal preference or not. 
Specifically, just as many studies have reported an association between PER3 and diurnal 
preference (Henst et al., 2015, Archer et al., 2003, Groeger et al., 2008, Pereira et al., 2005, Ellis 
et al., 2009, Jones et al., 2007, Archer et al., 2010, Kunorozva et al., 2012) compared to those 
studies which have failed to find an association (Henst et al., 2015, Rae et al., 2015, Osland et al., 
2011, Voinescu and Coogan, 2012). This polymorphism comprises a 54 base pair repeat sequence 
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on exon 18 of the PER3 gene encoding eighteen amino acids in positions 966-1055, which is 
repeated four (PER34) or five (PER35) times (Figure 1.6), resulting in two forms of the protein 
(Ebisawa et al., 2001). A minority (10%) of people in most populations are homozygous for the 
PER35 allele, while approximately 50% are homozygous for the PER34 allele (Ciarleglio et al., 2008, 
Henst et al., 2015, Archer et al., 2003). In some populations, for example, the Papua New Guinea, 
the prevalence of these alleles is reversed (Ciarleglio et al., 2008).  
 
The 5-repeat allele has more serine or threonine residue phosphorylation sites; therefore it’s 
believed to be turned-over more rapidly than the 4-repeat allele which has fewer 
phosphorylation residues (Archer et al., 2003). The PER34 allele was reported to be associated 
with the evening chronotype in a British population (Archer et al., 2003), a finding that was 
reproduced in a Caucasian South African population (Kunorozva et al., 2012). Kunorozva et al. 
(2012) investigated the distribution of chronotype and PER3 VNTR genotype in South African, 
male, individual sport athletes and a control population of active, but non-competitive individuals 
(exercised more than three times per week). They reported a higher proportion of individuals 
carrying the PER3 5-repeat allele in the athletic population compared to the control group.  
 
One of the studies that found no association between chronotype and PER3 genotypes cite level 
of physical activity as a confounding factor (Henst et al., 2015). Specifically, they reported a higher 
percentage of morning-types in marathon runners regardless of PER3 VNTR genotype. The 
mismatch between PER3 genotype and chronotype in the Henst et al. (2015) study may also be 
attributed to the time of competition event. Specifically, that taking part in an endurance event 
with an earlier start time (i.e. between 06h00-08h00 for South African runners and 10h00-12h00 
for the Dutch runners) may affect chronotype. This is plausible given that while the majority of 
the runners trained in the evening, they were more morning-oriented than the control 
population. Therefore, biological effects (e.g. PER3 genotype) may be masked by environmental 
and social pressures subsequently affecting the chronotype and genotype association. Increased 
exercise frequency per se may influence the distribution of chronotype, but has no influence on  
 




Figure 1.6: A graphic representation of the hPER3 VNTR polymorphism located on exon 18.  
Grey boxes indicate the flanking regions. White boxes indicate the 54 base pair (bp) repeats, which are 
repeated four (PER34) or five (PER35) times, encoding proteins of different sizes. VNTR: Variable number 
tandem repeat polymorphism and PER3: PERIOD3. 
 
the PER3 gene expression, thus this may only affect the association between chronotype and 
genotype. There are noticeable differences in the distribution of the PER3 VNTR polymorphism 
worldwide, as demonstrated by the varying allele frequency in the African American, European 
American, Han Chinese, Ghanaians and Papua New Guinea populations (Ciarleglio et al., 2008, 
Nadkarni et al., 2005). In particular, the 4-repeat allele frequency in the European American 
(59%), Han Chinese (81%) and Papua New Guinea (41%) populations differed immensely 
(Ciarleglio et al., 2008). This is interesting because unlike the other clock genes, the PER3 VNTR 
allele frequency was reported not to be affected by environmental parameters such as seasonal 
fluctuations, photoperiod and temperature, which vary as a function of latitude (Ciarleglio et al., 
2008, Nadkarni et al., 2005).  
 
1.5 Sleep and circadian rhythms 
The sleep-wake cycle is the most obvious circadian output of the circadian system. Sleep is part 
of a daily biological rhythm that is necessary for survival, enhancing well-being, energy 
conservation and optimal bodily function (Siegel, 2005, Leproult and Van Cauter, 2010, Wang et 
al., 2011). Its widespread presence in nature highly suggests that it somehow serves an important 
evolutionary function. During the sleep period, humans are less aware of their surroundings and 
less able to respond immediately to danger, a situation that one would normally consider as being 
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highly disadvantageous to an organism’s chances of survival, yet sleep remains. Sleep is 
influenced by both the homeostatic (need based) and circadian (i.e. time-of-day) processes (Dijk 
and Archer, 2010, Caldwell and Redeker, 2005, Van Dongen et al., 2012, Daan et al., 1984, 
Borbely, 1982). The homeostatic process relates to the sleep-wake history of an individual, with 
a drive for sleep (sleep pressure) mounting during episodes of wakefulness (Dijk and Czeisler, 
1994, Kerkhof and Van Dongen, 2010, Cohen et al., 2010). The circadian process relates to the 
variation in the timing of preferred sleep and wake-up times over the course of 24 hours (Van 
Dongen et al., 2012, Wulff et al., 2010). These two processes combined influence sleep 
propensity and duration as well as the quality of wakefulness including cognitive function and 
physical performance (Morris et al., 2012, Dijk, 2010, Banks et al., 2010).  
 
Under suitable entraining conditions, the homeostatic and circadian systems interact to 
consolidate wakefulness during the biological day and sleep during the biological night. 
Importantly, sleep is not a single homogenous state; it has been reported to consist of four 
different sleep stages (Chellappa et al., 2012b, Viola et al., 2007, Dijk and Czeisler, 1995). It is 
broadly divided into two states namely; rapid eye movement (REM) sleep and non-rapid eye 
movement sleep (n-REM). REM sleep is mostly characterised by higher levels of 
electroencephalogram (EEG) activation, and episodic bursts of rapid eye movement under closed 
eye lids (Viola et al., 2007, Horovitz et al., 2008). In contrast, n-REM sleep is characterised by a 
reduction in electrical output from the brain cortex relative to waking as well as a reduction in 
muscle tone in the voluntary muscles.  
 
In addition, n-REM is sub-divided into four stages, with stage 1 sleep being the closest to 
wakefulness and having a much lower threshold for arousal. In contrast, stage 4 sleep is marked 
by a reduction in cortical activity along with a high arousal threshold. Being awoken from this 
stage of sleep is often accompanied by feelings of sleepiness. More often than not, sleep stages 
3 and 4 are combined to form the deep or slow wave sleep (SWS). This is because they are both 
characterised by a marked decrease in the frequency of electrical activity in the cortex 
(Diekelmann and Born, 2010, Crunelli and Hughes, 2010). REM sleep is believed to play a 
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fundamental role in sleep consolidation, perhaps due in some part to the fact that the brain is 
usually active during this phase of sleep (Goldstein and Walker, 2014). Sleep timing varies greatly 
in individuals and has been recognised as an interesting aspect of chronotype (Randler, 2014, 
Adan et al., 2012). Furthermore, it is a variable trait in humans, with some individuals retiring to 
bed at a time when others are waking up. This variability allows one to distinguish individuals 
that have a great sleep need and retire to bed earlier (morning-types) from those that retire to 
bed later (evening-types) (Roenneberg et al., 2004).  
Higher sleep need has also been reported in individuals homozygous for the PER3 5-repeat allele 
during sleep restriction/deprivation studies (Viola et al., 2007, Chellappa et al., 2014). Specifically, 
the PER35/5 genotype has been shown to be associated with a shorter sleep latency, more theta 
and alpha activity in wake and rapid eye movement (REM) sleep, and more slow wave activity in 
non-REM sleep compared to the PER34/4 genotype; which is indicative of an increased sleep 
pressure in the PER35/5 genotype (Chellappa et al., 2012b, Goel et al., 2009, Maire et al., 2014). 
Therefore, it is likely that PER35/5 individuals or those individuals with earlier sleep timing will be 
greatly affected by extended wakefulness or disruption of the sleep-wake cycle compared to the 
PER34/4 individuals or those with later sleep timing. 
1.5.1 Sleep and its effects on individual and team sport athletes 
Sleep is fundamental for athlete recovery due to its physiological and restorative effects (Lastella 
et al., 2014a). At present, a number of studies have explored the effects of sleep extension, 
deprivation and restriction on the sleep-wake behaviour of elite athletes (Lastella et al., 2015, 
Mah et al., 2011, Halson, 2014, Juliff et al., 2015, Robey et al., 2014, Richmond et al., 2007, Kline 
et al., 2007, Oliver et al., 2009, Mougin et al., 1991, Leeder et al., 2012). Several of these studies 
have reported sleep effects under partial or total sleep deprivation conditions (Blumert et al., 
2007, Oliver et al., 2009, Kline et al., 2007, Mougin et al., 1991), which makes their application 
on elite athletes during competition difficult. In addition, the amount of sleep athletes obtain 
varies and may depend on the type of sport (Lastella et al., 2015). For example, current evidence 
in the literature indicate that individual sport athletes may obtain less sleep at night than team 
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sport athletes (Leeder et al., 2012, Richmond et al., 2007, Sargent et al., 2014a). These differences 
may be attributed to training time-of-day, which has been reported to influence total sleep time 
(Sargent et al., 2014b). Sargent et al. (2014b) suggest that individual sport athletes may sleep less 
at night because they are able to nap during the afternoon to compensate for shorter nighttime 
sleep, given that they are flexible to plan their days. 
 
It has been reported that individual sport athletes from swimming, rowing and canoeing obtain 
between 5-7h of sleep per night (Sargent et al., 2014a, Leeder et al., 2012). In contrast, team 
sport athletes, for example, the Australian Rules Football athletes have been reported to obtain 
between 8-9h nighttime sleep (Richmond et al., 2004, Richmond et al., 2007). This is higher than 
the 5-7h obtained by individual sport athletes; suggesting that any sleep deficit may alter the 
rhythm of performance, particularly in team sport athletes, consequently reducing both the 
average level of performance and peak-to-peak amplitude (Souissi et al., 2003, Bougard et al., 
2008). Caution must however be exercised when interpreting total sleep time findings between 
individual and team sport athletes, given that there may be methodological and cultural 
differences between studies (Lastella et al., 2015). Small decrements in performance due to sleep 
deficit might separate a winning team or individual from another, whose performance is only 
slightly below peak values (Leger et al., 2005).  
 
In summary, it is difficult to apply findings on effects of sleep following partial and total sleep 
deprivation in elite athletes, given that the extent of disturbed sleep before and during a 
competition or after time zone travel is different to total or partial sleep deprivation.  
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Table 1.1: Sleep amount and its effects on various parameters in athletes  
Hours of 
sleep 
Population Parameters References 
≥10h Basketball players ↓Sprint time, ↑Shoot accuracy (Mah et al., 2011) 
10h Active individuals ↑ Leucocyte production (Faraut et al., 2011) 
10h Swimmers ↓15m sprint time, reaction time, 
turn time, improved mood 
(Mah et al., 2008) 
9h Speed skaters ↓Sleep efficiency  (Leeder et al., 2012) 
<8h Adolescent 
athletes 
↑1.7 increased risk of injury than 
athletes sleeping >8h 
(Milewski et al., 2014) 
8h Olympic athletes ↓Sleep quality  (Leeder et al., 2012) 
<7h Healthy individuals ↑T-cell function 
↓Natural killer cell activity 
(Fondell et al., 2011) 
5h Endurance athletes ↑Heart rate and lactate 
accumulation 
(Mougin et al., 1991) 
3h Swimmers ↓Swim performance (Kline et al., 2007) 
3h Weightlifters ↓Maximal bench press, leg press 
and deadlifts 
(Reilly and Piercy, 1994) 
2.5h Swimmers ↓ Mood state (Sinnerton and Reilly, 
1992) 
2.5h Endurance athletes ↓Psychomotor performance (Reilly and Deykin, 1983) 
24h SD Weightlifters ↓Mood state (Blumert et al., 2007) 
24h SD Marathon runners  ↓Running performance (Oliver et al., 2009) 
30 SD Elite male  ↓ Mean and total sleep time,  
↓ Muscle glycogen content 
(Skein et al., 2011) 
36 SD Cyclists ↓anaerobic power (Souissi et al., 2003) 
↑↓ represent an increase and decrease respectively, SD- sleep deprivation  
 
1.6 Disruption of the circadian clock 
  
1.6.1 Circadian disruption  
One of the primary ways in which the circadian clock can be disrupted is through circadian 
misalignment, which may be transient or chronic. Both transient and chronic rhythm disruption 
lead to the misalignment of the sleep-wake cycle and the internal body clock with geophysical 
time resulting in physiological activation and hormone secretion at unusual times during the 24h 
day (Morris et al., 2012, Turek and Gillette, 2004, Muhlbauer et al., 2009, Scheer and Czeisler, 
2005). This upsets the normal functioning of various bodily functions. Some symptoms of 
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circadian disruption include fragmented sleep, changes in mood and gastrointestinal 
disturbances (Waterhouse and Reilly, 2009, Samel et al., 1995, Eastman and Burgess, 2009, Vosko 
et al., 2010). Transient rhythm disruption has been noted in numerous settings including after 
trans-meridian travel, while chronic rhythm disruption has been noted in nighttime shift workers. 
Transient circadian disruption occurs because of the disparity between the internal circadian 
rhythm and the external day-night environment (Lee et al., 2009, Haus and Smolensky, 2006). In 
contrast, chronic disruption is noted pathologically in sleep disorders such as ASPS and DSPS, 
which occur as a result of a body clock advance or delay relative to external time, consequently 
causing the sleep episode to occur at socially abnormal times during the day or night (Boulos et 
al., 1995, Pandi-Perumal et al., 2008, Lack and Wright, 2007).  
 
Shift work involves working outside the normal daylight hours (Loudoun and Bohle, 1997, 
Nachreiner, 1998). The temporal structure of shift work (nighttime vs daytime) interferes with 
both the prevailing time of society and internal body rhythms. In particular, the frequent changes 
in shift schedule and circadian disruption that ensues following nighttime shift work has been 
linked with increased risk of obesity (Buxton et al., 2012), metabolic disorders (Knutson et al., 
2007); cardiovascular diseases (Stevens, 2009) and cancer (Davis and Mirick, 2006). For example, 
significantly more digestive problems have been reported in individuals working nighttime shifts 
compared to those working daytime shifts (Nagaya et al., 2002, Costa, 1996). This suggests that 
a chronically misaligned circadian system may increase the risk of illness. While, nighttime shift 
work results in circadian desynchronisation, its further discussion is beyond the scope of this 
thesis.  
 
Circadian disruption similar to that which occurs following time zone travel result in acute 
changes in the feeding system and hormonal secretion, which is detrimental to metabolism 
(Baron and Reid, 2014, Mullington et al., 2003). This is conceivable given that dysregulation of 
feeding behaviour, changes in appetite stimulating hormones and glucose metabolism have been 
reported in nighttime shift workers (Spiegel et al., 2004, Scheer et al., 2009, Gonnissen et al., 
2012). For example, Scheer et al. (2009) reported a decrease in leptin levels and an increase in 
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glucose levels in eight adults that ate and slept 12h out of phase from their habitual time. Another 
study reported a decrease in leptin levels and elevated ghrelin in a group of sleep deprived 
volunteers from the Wisconsin sleep cohort study (Taheri et al., 2004). Circulating leptin levels 
are responsive to acute changes in energy balance resulting from increased or decreased caloric 
intake. Decreased leptin levels stimulate appetite and decrease intake. While these studies were 
performed in controlled laboratory conditions, circadian disruption following time zone travel 
may lead to changes in hormonal levels affecting metabolism. This may contribute to energy 
imbalances by altering energy balance via changes in the source of fuel being oxidised. 
 
In summary, while recovering from chronic circadian disruption may take months, recovery from 
transient circadian disruption may take a few weeks or days. There is inter-individual variation in 
response to and recovery from transient circadian disruption, for example, following time zone 
travel. However, no one has tried to explain this inter-individual variation in relation to clock gene 
polymorphisms. 
 
1.6.2 Physiological variables measured to assess circadian rhythm disruption 
Several physiological variables including core body temperature, melatonin and cortisol can be 
measured to investigate the normal functioning of the circadian clock following circadian 
disruption activities such as nighttime shift work, frequent time zone travel, space flights and 
submarine missions. The decision about which physiological variable to use in order to measure 
circadian phase is vital as the above-mentioned phase makers are affected differently by 
confounders. For example, body temperature has the advantage of being able to be collected 
continuously using either an ingested thermometric pill (Byrne and Lim, 2007) or wrist-worn 
temperature data loggers (Sarabia et al., 2008). However, variations in body temperature across 
the day are influenced not only by circadian rhythms, but also by factors such as posture, sleep-
wake state and activity level (Sarabia et al., 2008, Donaldson et al., 1996). Furthermore, the 
influence of these behavioural confounders on body temperature is phase dependent, such that 
the change in temperature produced by the behaviour is different depending on when during the 
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24h day the behaviour occurs. As such, diurnal variations in temperature may not reflect the 
underlying circadian variation.  
 
Melatonin levels on the other hand are quite robust to confounders such as posture, activity and 
arousal state compared to temperature (Zeitzer et al., 2007, Deacon and Arendt, 1996). However, 
there is some evidence, suggesting that periodic changes in behaviour (e.g. exercise, posture) can 
influence melatonin levels (Deacon and Arendt, 1994, Monteleone et al., 1990). One 
disadvantage of using melatonin as a circadian phase maker is that collection of samples (i.e. 
salivary) during sleep may require interruption, although specialised blood collection systems 
used in many laboratories do not require interruption (Keijzer et al., 2011). For this reason, 
studies that investigate both sleep patterns and salivary melatonin levels have measured only 
the onset of melatonin secretion as a phase marker, rather than collection over the entire 24h 
period. While the onset of melatonin secretion is sufficient to determine melatonin rhythm 
timing, it misses out any changes in rhythm amplitude, duration or offset timing. The endogenous 
increase of melatonin levels is suppressed by ambient lighting; as such, samples have to be taken 
in dim light throughout all sampling segments.  
 
While cortisol (Figure 1.7) and temperature can be used as circadian phase markers of circadian 
disruption, the onset of endogenous melatonin production is thought to be a more reliable 
marker of the circadian phase (Griefahn, 2002, Benloucif et al., 2005). Furthermore, melatonin 
has been shown to free run in blind animals and humans in line with core body temperature 
(Czeisler et al., 1995, Nakagawa et al., 1992) and following extended wake periods under constant 
routine, dim light conditions (Archer and Mench, 2014, Boivin and James, 2002, Weibel and 
Brandenberger, 1998).  
 




Figure 1.7: Circadian rhythm of saliva cortisol of eight young healthy volunteers (solid line). 
The dotted line indicates saliva cortisol levels when light was shined in the volunteers’ ears. 
Data are presented as mean ± SEM and the arrow indicates time of ear light exposure, 24 min 
(01h10-01h34). The grey area shows lights off (23h00-07h00) (Jurvelin et al., 2014). 
 
1.6.2.1 Melatonin “a marker of innate” circadian rhythm and disruption  
Melatonin is a ubiquitous molecule synthesised from serotonin in the pineal gland and secreted 
at night where it is centrally involved in sleep regulation (Pandi-Perumal et al., 2007). It is also an 
important molecule in terms of spreading the “time-of-day” information to peripheral clocks 
(Pevet and Challet, 2011, Underwood et al., 1984, Gern et al., 1986). Specifically ablation of the 
mammalian pineal gland suppresses melatonin production affecting synchronisation of 
peripheral clocks and regulation of other hormones (Chakir et al., 2015, Bell-Pedersen et al., 
2005). Melatonin secretion happens under dim-light conditions, and is supressed by exposure to 
bright light (Figure 1.8). Its secretion regulates the entire thermoregulatory cascade (i.e. decrease 
in heat production and increase in heat loss) which starts with the rise in endogenous melatonin 
levels in the evening (Cajochen et al., 2003). Onset of melatonin secretion acts as a hormonal 
signal timing the rise in blood flow in distal skin regions, which results in heat loss, the degree of 
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which is the best physiological predictor for the rapid onset of sleep (Krauchi et al., 1999). The 
correlation between sleep and the melatonin rhythm has been reported in blind individuals in 
whom the circadian clock is not entrained (Lockley et al., 1997, Nakagawa et al., 1992) and in 




Figure 1.8. Circadian rhythm of saliva melatonin of eight young healthy volunteers (solid line). 
The dotted line indicates saliva melatonin levels when light was shined in the volunteers’ ears. 
Data are presented as mean ± SEM and the arrow indicates time of ear light exposure , 24 min 
(01h10-01h34). The grey area shows lights off (23h00-07h00) (Jurvelin et al., 2014). 
 
The daily circadian onset of melatonin secretion coincides with dim-light or sunset starting about 
±2-3h before bedtime (Figure 1.8), which correlates with an increase in sleep propensity (Dijk and 
Cajochen, 1997). This natural phenomenon is known as dim-light melatonin onset (DLMO) 
(Gooley et al., 2011, Hofstra and de Weerd, 2008, Lewy et al., 1980, Weitzman et al., 1981) and 
it is the most reliable marker of the timing of the central clock in humans (Danilenko et al., 2014, 
Klerman et al., 2012). Under normal conditions salivary or plasma melatonin concentration 
increase during the evening, levels continue to increase during the sleep period, and gradually 
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deteriorates during the second half of the night (Arendt, 2005, Pandi-Perumal et al., 2007, Hilaire 
et al., 2007). EEG activation during wakefulness is timed at a specific time phase relative to the 
circadian cycle (Cajochen et al., 2002). EEG experiments indicate that the circadian clock drives 
the rhythms of melatonin synthesis, thermoregulation, sleep consolidation and activation during 
wakefulness among other things (Cajochen et al., 2003, Dijk et al., 1999). While there may be 
feedback from the pineal gland to the circadian clock and thermoregulatory centres in the 
hypothalamus, the consensus is that melatonin weakens the circadian signal from the SCN 
promoting heat loss. This induces sleepiness via the preoptic area of the anterior hypothalamus.  
 
It is possible that the effect of melatonin on sleepiness and sleep is relative rather than absolute, 
since individuals who do not secrete melatonin seem to sleep normally (Wehr et al., 2001). 
Therefore, the function of melatonin appears to be the mediation of dark signals and providing 
night information, rather than be the hormone of sleep (Wright et al., 2013). It is also thought to 
be an internal synchroniser that stabilises and reinforces various circadian rhythms in the body. 
During the day, melatonin is not produced in measurable quantities (Gooley et al., 2011, Keijzer 
et al., 2014, Zeitzer et al., 2007). In healthy individuals who have been maintaining a stable sleep-
wake schedule with sleep at night, DLMO can be estimated with reasonable accuracy as it is 
related to environmental light exposure (Keijzer et al., 2011, Martin and Eastman, 2002, Burgess 
and Eastman, 2005, Wright et al., 2013).  
 
1.6.3 Phase shifting of circadian rhythms  
A phase shift is a change in the timing of a rhythm in relation to an environmental time cue 
(Eastman et al., 1995, Minors et al., 1991). This may shift bedtime or wake-up time to either 
earlier or later than usual during the day similar to that which happens following time zone travel. 
Minor phase shifts occur on a daily basis to synchronise the circadian rhythm with the external 
environment (Beaumont et al., 2004, Burgess et al., 2002, Edwards et al., 2000, Gronfier et al., 
2007, Wright et al., 2013). More major adjustments are required to resynchronise one’s internal 
body clock with the temporal environment following trans-meridian travel. For example, 
following long-haul time zone travel, normal sleep-wake patterns may be disrupted and this is 
    
31 
 
likely to persist for a few days. The rhythm of the master circadian clock in the SCN is entrained 
by the rhythmic change of light and dark (Lewy et al., 1998, Warman et al., 2003). The SCN 
subsequently synchronises peripheral clocks in the liver, kidney and pancreas for example, with 
each other and thus aligns the entire circadian system to the external light. These peripheral 
clocks take longer to be resynchronised compared to the SCN. Peripheral clocks can potentially 
be entrained directly by other signals such as rhythmically timed food intake without affecting 
rhythms in the SCN (Buijs et al., 2013, Damiola et al., 2000). A more federated organisation of 
independent clocks offers the opportunity of different signals acting independently on different 
peripheral clocks. In mice, light and feeding rhythms may be uncoupled when sleep rhythms are 
disrupted (e.g. jet-lag), alignment by different zeitgeber signals is impaired, which results in the 
uncoupling of the SCN and peripheral clocks (Barclay et al., 2012). In the event that rhythms from 
the SCN are disrupted, a great number of peripheral clocks would produce disharmony of 
rhythms that would make coordination of circadian behaviour impossible.  
 
Two features of the mammalian circadian system provide flexibility in circadian programming to 
exploit temporal regularities of social stimuli or food availability (Mistlberger and Antle, 2011). 
Sensitivity of the SCN to behavioural arousal stimulated during the sleep period is one of the 
features, which can reset its phase and modulate its response to the light-dark stimuli. For 
example, the cortisol rhythm phase adjusts more slowly compared to other rhythms following a 
circadian phase shift (Sack et al., 2007). As a result, its rhythm will be dissociated in timing for a 
few days relative to rhythms that have synchronised faster. However, the apparent difference in 
the rate of phase shifting may be due to different masking influences of external factors on 
simultaneous entrainment of internal rhythms. For example, differences in the rate at which the 
SCN and peripheral clocks readjust was demonstrated following a simulated phase shift in a 
transgenic rat model in which the mouse PER1 gene promoter was linked to a luciferase reporter 
(Yamazaki et al., 2000). The rats were housed in 12h:12h light-dark cycles, sacrificed 30-60 min 
before lights off and the SCN, liver, lung and skeletal muscle explants cultured under static 
conditions in constant darkness and temperature. Light output was measured continuously from 
individual cultures with a Hamamatsu photomultiplier tube detector assembly (Geusz et al., 
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1997). Light emission from the SCN was robustly rhythmic, implying that the engineered mouse 
PER1-luc transgene was rhythmically transcribed under the regulation of normal circadian 
mechanisms. In contrast, circadian rhythms of light output in the liver, lung and skeletal muscle 
phase lagged the SCN rhythm by 7-11h. This suggests that the SCN may be able to adjust quickly 
compared to peripheral clocks following a phase shift similar to that, which occurs following time 
zone travel. 
 
Several behavioural and pharmacological methods such as timed light exposure or avoidance, 
napping, nutrition, caffeine containing products, exogenous melatonin and physical exercise can 
be employed to accelerate adaptation of physiological and neuroendocrine systems following 
desynchronisation (Forbes-Robertson et al., 2012, Wright et al., 2013, LeGates et al., 2014, 
Carneiro and Araujo, 2012, Edwards et al., 2000, Schroder and Esser, 2013, Beaumont et al., 
2004). Important to note is that there is considerable inter- and intra-individual variation in the 
way individuals respond to these interventions making it difficult to provide general therapeutic 
advice (Waterhouse and Reilly, 2009). For the purposes of this thesis, I will focus on light exposure 
or avoidance, exogenous melatonin and exercise strategies, for interventions that can be 
employed to accelerate adaptation to the new environment. 
 
1.6.3.1 Light exposure and melatonin 
Ocular light exposure at an appropriate time-of-day has been shown to be the most important 
entraining stimulus of the circadian system (Boivin and James, 2002, Gronfier et al., 2007, Forbes-
Robertson et al., 2012). The reason for light exposure is to help not only the SCN 
resynchronisation, but also melatonin levels, which in turn can help peripheral clocks to reset. 
Appropriately-timed light exposure can therefore be used to accelerate resynchronisation of the 
melatonin rhythm so that sleep can be initiated more easily. Light exposure induces a range of 
circadian, neuroendocrine and neurobehavioural responses (Burgess et al., 2002, Lockley et al., 
2006). Timed exposure, dosing pattern, duration and wavelength are all important in determining 
the extent of the response and should be considered when phase shifting one’s circadian rhythms 
(section 1.2.3). For example, in one study, participants were exposed to either 3h of bright light 
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(3 000 lux) or red dim light (10 lux) at 19h00 local time for two consecutive evenings following 
westward travel across six time zones (Boulos et al., 2002). A 1h phase delay in salivary DLMO - 
a marker of innate circadian rhythm was noted in the bright light treated group of participants. 
In another study, three groups of participants underwent a 1h phase advance for three days in a 
simulated jet-lag experiment (Burgess et al., 2003). Specifically, group one was exposed to 3.5h 
of bright light (>3 000 lux), group two to intermittent bright light (alternating 0.5h on and off, >3 
000 lux) and a control group which was exposed to ordinary dim indoor light (about 60 lux). 
Following light treatment, DLMO was phase advanced by about 2.1h in the group treated with 
continuous bright light, 1.5h in the group with intermittent light treatment and 0.6h in the control 
group.  
 
Light avoidance techniques can also be used to effect the phase of adjustment required (Crowley 
et al., 2003, Eastman et al., 1994). Following eastward travel a circadian phase advance is 
required, while a phase delay is required following westward travel, as such time of light 
avoidance may vary depending on the direction of travel (Duffy et al., 1998, Waterhouse et al., 
2007). For example, following westward travel circadian rhythms require a phase delay, as such 
light exposure may be avoided between 02h00-08h00 departure time within the first 24h upon 
arrival in the new time zone in order to realise a phase delay. Daan and Lewy (1984) suggested 
avoiding bright light in the early hours of the morning following long westward travel, and in the 
first few hours of the evening following eastward travel. They suggested wearing low 
transmittance sunglasses or goggles if going out during these hours to reduce exposure. For 
example, Eastman et al. (1994) demonstrated circadian re-alignment in nighttime shift workers 
who wore dark goggles when going home in the morning. Wearing goggles at appropriate times 
during a long-haul flight across time zones is a useful strategy to avoid light at the new “end of 
day” in order to promote melatonin onset. 
 
Exogenous melatonin administration can have both a hypnotic effect as well as a chronobiotic 
effect if administered at the appropriate time-of-day (Turek and Gillette, 2004, Pandi-Perumal et 
al., 2008). Administration in the early evening before sunset produces a phase advance, while 
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administration in the early hours of the morning produces a phase delay effect (Beaumont et al., 
2004). Furthermore, Manfredini et al. (2000) reported that melatonin administration in the 
afternoon resulted in a phase advance following eastward travel across eight time zones in eight 
males who had a delayed core body temperature acrophase. The differences in timing of 
melatonin administration as well as differences in an individual’s endocrinological patterns 
complicate the use of external melatonin in travelling people. This complicates the use of 
melatonin as a strategy for re-entrainment hence; its use should be treated with caution. While 
external melatonin has been shown to be useful in mild jet-lag under laboratory conditions (Paul 
et al., 2011, Manfredini et al., 2000), other studies have failed to show its efficacy following actual 
travel across twelve time zones (Richmond et al., 2004, Edwards et al., 2000). 
 
1.6.3.2 Exercise 
While some studies have reported no effect of phase shift following exercise (Moog and 
Hildebrant, 1987), there is consensus that appropriately timed physical activity can effect a phase 
shift (Brand et al., 2010, Youngstedt et al., 2006, Yamanaka et al., 2010). Appropriately-timed 
exercise may be performed to obtain the desired direction of circadian phase shift; the timing 
depends on whether a circadian phase advance or delay is required. Specifically exercising in the 
morning in the new time zone produces a phase advance and at night a phase delay (Buxton et 
al., 2003, Yamanaka et al., 2010). Exercise at night would be beneficial following westward travel 
in order to phase delay the circadian clock, while exercise in the morning would be beneficial 
after eastward travel where a phase advance would be required.  
 
Timed-exercise has been used as a stimulus to accelerate entrainment to the new sleep-wake 
cycle of healthy young adults in simulated nighttime shift work and constant routine studies 
(Eastman et al., 1995, Miyazaki et al., 2001, Yamanaka et al., 2010, Vanreeth et al., 1994). 
Specifically, in two of these studies exercise at night accelerated melatonin phase delays 
(Eastman et al., 1995, Vanreeth et al., 1994), while daytime exercise accelerated melatonin phase 
advances (Miyazaki et al., 2001). Klein and Wegmann (1974) reported an accelerated 
resynchronisation of the rectal temperature rhythm and psychomotor performance in a group of 
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eight students who were allowed to exercise compared to the group that was not allowed to 
exercise following westward travel across six time zones. In another study, Shiota et al. (1996) 
reported that outdoor exercise increased resynchronisation of the 17-hydroxy-corticosteriods 
rhythm to the new time zone. While the above-mentioned studies indicate that exercise was 
effective in facilitating readjustment into the new environment, it must be acknowledged that a 
great number of time cues (e.g. light) from the environment may have played a role since exercise 
took place outside the experimental facilities.  
 
The intervening effect of light exposure and social cues might explain the accelerated rectal 
temperature phase delay following westward travel in the exercise group only. In addition, the 
people who exercised reported higher levels of fatigue (Klein and Wegmann, 1974), a finding 
which the authors did not address. The obvious importance of controlling for light exposure, in 
addition to accounting for an individual’s prior fitness and level of habitual physical activity 
(Eastman et al., 1995) must be accounted for when using exercise to phase shift circadian 
rhythms. It is however difficult to control activity and other confounding time cues in the new 
time zone in an effort to accelerate adaptation, which then complicates the use of exercise as a 
strategy to facilitate re-entrainment.  
 
1.6.4 Circadian disruption and trans-meridian travel  
Trans-meridian travel is travel east-to-west or west-to-east, i.e. across meridians and not in the 
north-to-south or south-to-north direction. This travel is more common in today’s society where 
air travel is accessible to large portions of the population. The misalignment that occurs following 
trans-meridian travel arises as a function of the disparity between timing of one’s internal body 
rhythms and external environmental time in the new time zone, subsequently leading to 
symptoms of jet-lag (Atkinson et al., 2014, Samuels, 2012, Petit et al., 2014, Sack, 2009). In 
particular, jet-lag symptoms are thought to result from various physiological and psychological 
systems’ inability to resynchronise swiftly to sudden changes of time in the immediate 
environment. These symptoms include impaired concentration, decreased vigour and energy, 
difficulties initiating and maintaining sleep at night, elevated daytime sleepiness, lack of 
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situational awareness, distorted estimation of time, space and distance and impairment of the 
immune system (Leatherwood and Dragoo, 2013, Waterhouse and Reilly, 2009, Samuels, 2012, 
Manfredini et al., 1998, Youngstedt and O'Connor, 1999, Eastman and Burgess, 2009, Reilly et al., 
2005). These symptoms are temporary and improve after a few days in the new time zone. 
 
Jet-lag symptoms are generally experienced after the first 24h in the new time zone until 
entrainment is realised (Atkinson et al., 2014). During the first 24h, it is difficult to separate 
effects of jet-lag from fatigue resulting from the long-haul flights. Jet-lag symptoms make it 
difficult to sustain a normal daily routine and are exacerbated by crossing time zones in quick 
succession (Sasaki et al., 1993). For example, deterioration of leg and grip strength as well as 
reaction time rhythms were reported in 17 individuals following a 9h intercontinental flight 
between the United Kingdom and Florida (Reilly et al., 2001). The abovementioned variables 
were in phase with the circadian rhythm of oral temperature and gradually improved such that 
performance of these variables had stabilised 5-7 days post flight. This indicates that trans-
meridian travel disrupts circadian rhythms, which in turn influence performance variables. 
Circadian disruption also influences an individual’s daily sleep.  
 
It has been reported that prolonged wakefulness by as little as three hours in a single night similar 
to that which may occur following trans-meridian travel can produce performance decrements 
(Arnedt et al., 2001). Likewise, the effects of one to two hours of nightly sleep loss over a week 
have been reported to result in decrements in daytime function which lead to human error and 
accidents (Powell et al., 2001, Mitler et al., 1988). 
 
1.6.4.1 Circadian disruption and the sleep-wake cycle 
The sleep-wake cycle is disrupted because of the desynchronisation between internal and 
external rhythms following a change in time zones. For example, eastward travel from South 
Africa to New Zealand crossing eleven time zones may result in difficulties initiating and 
maintaining sleep for sufficient periods because the circadian rhythm is phase advanced. Thus, 
visitors are likely to experience a lower homeostatic drive for sleep at night as the sleep episode 
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occurs in their biological afternoon (home time); they are required to shorten their innate 
circadian rhythm to match the new environmental time zone time. Figure 1.9 illustrates how 
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Figure 1.9: Diagrammatic representation of the 24h rhythm of core (rectal) temperature in an 
individual who normally sleeps from 23h00-07h00. The “urge to sleep” represents bedtime for 
the individual, coinciding with a drop in core body temperature. In the left hand panel, the urge 
to sleep coincides with local nighttime at the destination, whereas in the central and right -hand 
panels, the urge to sleep coincides with daylight hours at the destinations. Adapted from 
Waterhouse et al. (1997). 
 
Furthermore, following trans-meridian travel the melatonin rhythm is disrupted subsequently 
affecting melatonin levels, as such individuals may find it difficult to initiate sleep in the new time 
zone. Poor sleep quality would therefore exacerbate the effects of jet-lag and negatively affect 
an individual’s performance. In one study, sleep was assessed using polysomnography for 9 
nights in 27 healthy volunteers following eastward travel across seven time zones (Beaumont et 
al., 2004). A longer sleep onset latency was noted in the first three nights in the new time zone, 
while less REM sleep than normal was noted only for the first four nights. This only corrected to 
normal proportions after five nights. Another study reported altered sleep architecture in 15 
participants following both simulated eastward and westward travel across eight time zones after 
a week in the new environment (Hume, 1980). Specifically, Hume (1980) reported that 
participants spent more time in REM sleep following simulated westward compared to eastward 
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travel. Carrier et al. (1996) observed a reduction in sleep efficiency, duration, total sleep time, 
sleep onset latency and an increase in the number of awakenings in the first part of the sleep 
episode in 25 healthy individuals after a simulated 6h phase advance.  
 
The majority of research performed using subjective measures of sleep patterns has been 
focused on sleep disruption and/or recovery following trans-meridian travel in business people 
(Edwards et al., 2000), the military (Beaumont et al., 2004), sedentary individuals (Jamieson et 
al., 2001), academics (Takahashi et al., 2002, Edwards et al., 2000), airline employees (Lowden 
and Akerstedt, 1999, Suvanto et al., 1993) and athletes (Lemmer et al., 2002, Hill et al., 1993, 
O'Connor et al., 1991). The consensus from all these studies is that sleep disruption as a 
consequent of trans-meridian travel is a concern to all travelling individuals. However there is 
great inter-individual variability in sleep response and thus there is a need to understand what 
makes an individual’s response worse/better.  
 
1.6.4.2 Circadian disruption and the immune system 
Most immune cells express circadian clock genes, which exhibit a 24h rhythm. This has an effect 
on the 24h rhythm of immune functions including phagocytosis, synthesis and release of 
cytokines and chemokines as well as trafficking to inflamed or infected tissues (Labrecque and 
Cermakian, 2015). Therefore, circadian disruption either due to inconsistent sleep-wake 
schedules, nighttime shift work or trans-meridian travel has significant consequences for human 
health (Labrecque and Cermakian, 2015, Knutson et al., 2007, Scheiermann et al., 2013). This is 
conceivable given that many functions and parameters key to immune functioning such as 
natural killer cell activity (Arjona and Sarkar, 2005), humoral immune response (Keller et al., 
2009), cytokine levels (Keller et al., 2009), serum cortisol (Fatima et al., 2013) and rhythms of 
absolute and relative numbers of circulating white blood cells (Bridges et al., 1992) are time-of-
day dependent.  
 
Desynchrony of internal body rhythms and external time has been reported to result in several 
behavioural, circuitry, endocrine/metabolic and immune disorders under laboratory conditions 
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(Lechner et al., 2000, Shearer et al., 2001, Dinges et al., 1994). For example, Spiegel et al. (2002) 
reported a 50% decrease in antibody titter 10 days after immunisation with the influenza vaccine 
in individuals who had been subjected to 4h nightly sleep restriction for 6 days prior to 
immunisation compared to individuals who followed usual sleep durations. However, antibody 
levels were shown to be similar between the two groups 3-4 weeks post-immunisation, when 
synchronisation to the local environment had occurred. This indicates that sleep restriction and 
circadian disruption such as that which occurs after time zone transitions alters the immune 
response. Balachandran et al. (2002) reported an attenuation of the febrile response to E. Coli 
endotoxin challenge in individuals who had 4h nightly sleep for 10 days compared to individuals 
who had 8h nightly sleep for the same period. This suggests that misalignment between the 
internal body clock and external time may reduce an individual’s immune response to antigens 
presented in the new time zone.  
 
Under normal sleep-wake cycles immune cells belonging to the innate (specific e.g. natural killer 
cells) or adaptive (antigen-specific e.g. B-lymphocytes) immune systems show robust peaks at 
different times of the day, with some (e.g. naive Th-cells) peaking at night. Therefore, circadian 
disruption that ensues following trans-meridian travel, for example, may negatively affect cells 
responsible for antigen recognition leaving an individual vulnerable to pathogen attack in the 
new time zone. The extent to which each individual’s circadian rhythms are disrupted after time 
zone travel determines the degree to which the immune system is compromised. Therefore, it 
will be important to find out which individuals are more prone to circadian disruption, and thus 
more susceptible to illnesses.  
 
1.6.4.3 Circadian disruption and injury  
Intercontinental travel can lead to a disrupted circadian rhythm, whose consequences may result 
in impaired cognitive function, mood and loss of motivation; subsequently increasing the risk of 
injury (Samuels, 2012). A recent study, reported that baseball teams whose circadian rhythms 
were synchronised to optimal performance times stood a better chance of succeeding in a 
competition, suggesting detrimental effects of intercontinental travel and/or desynchronised 
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circadian rhythm (Winter et al., 2009). To date several studies exist on the epidemiology of 
professional rugby injuries in which matches are played when circadian rhythms are synchronised 
to optimal performance times (Jakoet and Noakes, 1998, Fuller et al., 2010, Brooks et al., 2005, 
Targett, 1998, Quarrie and Hopkins, 2008). While these studies are important for educating 
coaches and athletes, they do not attempt to describe the effect of intercontinental travel on the 
risk of injury in rugby union players. Only one group- The Clinical Sports Medicine Research group 
at the University of Cape Town has conducted a study investigating the 2012 competition injuries 
in Super Rugby athletes (Schwellnus et al., 2014). Of concern was that while New-Zealand and 
Australian teams were able to field a full strength squad in weeks 13-18 of the 2012 Super Rugby 
tournament, most South African teams were hit by injuries and could not field a full strength 
squad. As a result, teams had to make do with players at their disposals at the time. 
 
It is possible that circadian disruption following time zone travel (Forbes-Robertson et al., 2012, 
Youngstedt and O'Connor, 1999, Leatherwood and Dragoo, 2013), which places a high physical 
and psychological demand on the travelling athlete, may be one the reasons why there are more 
injuries in the SA Super Rugby athletes. This is conceivable given that match injuries in the Super 
Rugby tournament where players have to contend with demanding travelling schedules is higher 
(Schwellnus et al., 2012) than in other tournaments that are played in one geographical zone 
(Jakoet and Noakes, 1998, Hagglund et al., 2009, Parkkari et al., 2004, Vanmechelen, 1992). Much 
of what is known about the effect of circadian disruption on injuries has been extrapolated from 
studies in occupational settings and indicates an increased risk of accidents or errors following 
both total and partial sleep deprivation (Smith et al., 1994, Akerstedt, 1998, Folkard et al., 2005). 
Other inferences on the subject of injury risk have been made using known knowledge regarding 
circadian disruption of muscle activity, core temperature and cognition (Shrier and Gossal, 2000, 
Capezuti et al., 1998, Howland et al., 2007).  
 
Circadian disruption under competition conditions may have a more profound effect on 
functioning than circadian disruption under simulated jet-lag conditions in a laboratory. Factors 
such as mood, psychomotor and cognitive function that influence performance have been 
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reported to deteriorate much faster than physical capabilities following circadian disruption in 
military personnel and volunteers in laboratory studies (Dinges, 1995, Rosa, 1995). Such 
deterioration can adversely influence the interaction between a player’s individual motivation 
and emotional response to a situation. For example, changes in mood state were shown to result 
in a significant proportion of injuries in an American College basketball team (Lavallee and Flint, 
1996). Cumulative influences of physical and psychological stressors, which occur following 
circadian disruption (Dijk and Czeisler, 1994, Buxton et al., 2012, Burch et al., 2009) deplete 
perceptual and sensor motor reserves potentially exacerbating the risk of injury 
(Vandekerckhove and Cluydts, 2010). This is conceivable given that the capacity to respond 
appropriately to acute superimposed physical and psychological stressors is limited when 
allostatic load (stressor) is high. Allostatic load is the deviation from homeostatic levels between 
the sympathoadrenal, hypothalamic-pituitary adrenal mediator and hormone secretion (Evans 
et al., 2007, Vandekerckhove and Cluydts, 2010). 
 
This is supported by findings from Illhan et al. (2006), who reported a higher (75.8%) incidence 
of injuries in nurses working rotating nighttime and daytime shifts compared to nurses working 
either daytime- or nighttime-shifts (50%). In this study, rotating shift work was associated with a 
1.7 fold increased risk of sustaining a needle stick injury and a 2.7 fold increased risk that an injury 
was from a contaminated device. Another study reported significantly more injuries (60 injuries 
per hour per 1000 individuals) in a group of 296 personnel working nighttime shifts compared to 
a group of 1 102 personnel (40 injuries per hour per 1000 individuals) working daytime shifts 
(Park et al., 2001). In the same study, a 1.5 fold increased risk of injury was noted in the group 
working nighttime shifts (18h00-05h59) compared to the group working daytime shifts (06h00-
17h59). A decrease in vigilance and performance as well as an increase in the frequency of injuries 
has been reported when exercise was performed at night or in the early morning (Winget et al., 
1985, Horne and Reyner, 1999). As such, there is a high possibility that circadian disruption- the 
mismatch between internal body time and external time in the new environment may increase 
the risk of injury in players.  
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It is plausible to assume that athletes who undergo frequent time zone travel will have a higher 
compound allostatic load and even more diminished threshold for mounting situational 
appropriate responses as a consequent of circadian disruption. This is conceivable given that 
athletes in a competition such as the Super Rugby do not have adequate lead-time to recover 
completely from jet-lag effects before match kick-off. As a result, failure to recover from jet-lag 
effects may decrease the reserves for emergence response to situations during training sessions 
or matches.  
 
1.6.5 Severity of circadian disruption following trans-meridian travel 
The severity of circadian disruption following trans-meridian travel is influenced by several 
factors chief among them being age, sex, chronotype, individual variability, direction of travel, 
number of time zones crossed, rhythm amplitude, strength of local zeitgeber upon arrival and 
physiological systems being measured (Waterhouse and Reilly, 2009, Vosko et al., 2010, 
Waterhouse et al., 2007, Moline et al., 1992).  
 
1.6.5.1 Chronotype 
With respect to chronotype differences, individuals preferring evenings have been shown to be 
less vulnerable to the effects of jet-lag compared to those preferring mornings for both directions 
of travel (Manfredini et al., 1998, Winget et al., 1985). In particular, individuals with low 
amplitudes (ETs) in core body temperature appear to be less affected by a phase shift than those 
with large circadian amplitudes (MTs) (Winget et al., 1984). For example, morning-type 
individuals were reported to have longer resynchronisation periods and rigid sleep-wake cycles 
in comparison to their evening-type counterparts following simulated eastward travel (Suvanto 
et al., 1993). The circadian rhythm of evening-types was reported to take a shorter 
resynchronisation period following a simulated phase delay, further suggesting that evening-type 
individuals may find it easier to adapt following trans-meridian travel, particularly after westward 
travel (Winget et al., 1985).  
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1.6.5.2 Light exposure 
An individual’s ability to synchronise in to the new time zone also depends on the strength of 
zeitgeber upon arrival, for example, light exposure. The amount of daylight in the natural 
environment is a strong predictor of how fast adaptation to the new environment will take 
following trans-meridian travel (Suvanto et al., 1993, Duffy et al., 1996). It has been reported that 
re-adjustment to the new time zone is faster during summer than during winter, as a consequent 
of varying exposure to natural day light (Harma et al., 1994). Specifically, Harma et al. (1994) 
measured salivary melatonin and cortisol levels five days prior to, during and after a four day 
round-trip from Helsinki-to-Los Angeles-to-Seattle-to-Helsinki during summer and winter.  
 
Melatonin and cortisol circadian rhythms adaption was faster after both eastward and westward 
travel in the group that travelled in summer compared to the group that travelled in winter. In 
summer, there is more environmental light during both morning and evenings. Therefore, late 
sleeping times increased exposure to phase delaying evening light; following westward travel, 
while early morning light exposure resulted in a phase advance following eastward travel. In 
another study, physiological processes were reported to resynchronise at a slower rate in 
participants who had limited exposure to outdoor light compared to those who were exposed to 
natural light following eastward travel across six time zones between Germany and the United 
States (Klein et al., 1972). Bright light exposure has also been shown to successfully speed up 
resynchronisation during recovery days following nighttime shift work (Ahasan et al., 2001). The 
above-mentioned studies indicate that the degree of phase shifting will differ depending on light 
intensity, duration and exposure time of day, the degree of phase shifting may vary from one 
individual to the other depending on chronotype.  
 
1.6.5.3 Number of time zones crossed and direction of travel 
The rate of synchronisation to the new time zone following trans-meridian travel is associated 
with the number of time zones crossed (Reilly et al., 2005, Haimov and Arendt, 1999). Alterations 
in physiological function become more evident following three or more time zone crosses (Reilly 
and Edwards, 2007). For example, Suvanto and Ilmarinen (1989) reported a worse response in 
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terms of sleep quality, adaptation and days required for recovery following travel across ten time 
zones compared to travel across seven time zones. In addition to the number of time zones 
crossed, direction of travel also influences the extent of desynchronisation and severity of jet-lag 
symptoms. In general, adaptation following trans-meridian travel follows an orthodromic 
response, whereby physiological systems adapt in the same direction as the phase of adjustment 
(Edwards et al., 2000). Thus, adaptation to the new time zone following eastward or westward 
travel requires a phase advance or phase delay, respectively (Fowler et al., 2015b, Waterhouse 
et al., 2007, Drust et al., 2005). However, when the number of time zones crossed approach near 
the limit of entrainment (10-12 time zones); physiological systems synchronise in the opposite 
direction of the phase shift (Takahashi et al., 2002, Reilly et al., 2005). As a general rule, the rate 
of re-adjustment is faster following westward travel irrespective of time-of-day of departure and 
whether it is an outbound or return flight (Takahashi et al., 2002, Chapman et al., 2012, Sack, 
2010, Reilly et al., 2005).  
 
Klein and Wegmann (1980) reported that the re-entrainment rate is slower when travelling 
eastward (56min/day) than when travelling westward (88min/day). This difference in re-
adjustment shift rate between eastward and westward travel is influenced by the internal body 
clock (O'Connor and Morgan, 1990, Winget et al., 1984, Waterhouse et al., 2007, Klein and 
Wegmann, 1980). For example, Lemmer et al. (2002) reported that rhythmic patterns in body 
temperature and grip strength were greatly disturbed on day one in 15 elite athletes following 
eastward travel compared to westward travel across eight time zones. In the same study, jet-lag 
symptoms were shown to persist between 1-2 days longer in eastbound than westbound 
athletes. 
 
Adaptation following eastward travel requires a phase advance, resulting in a circadian period 
length shorter than 24h (Waterhouse et al., 2007, Burgess et al., 2003, Eastman and Burgess, 
2009). After eastward travel, the environmental clock is effectively brought forward, resulting in 
a shorter day such that the homeostatic drive for sleep at socially acceptable bedtime in the new 
time zone is not high enough yet to initiate sleep (Chapman et al., 2012, Meir, 2002, Eastman et 
    
45 
 
al., 2005). On the other hand, the day is lengthened following westward travel. Bedtime in the 
new time zone is latter than usual such that the homeostatic sleep drive is very high and thus 
promoting sleep. Resynchronisation requires a phase delay, resulting in a period length longer 
than 24h.  
 
Since circadian rhythms in humans tend to have a natural period length slightly longer than 24h 
under free-running conditions (Czeisler et al., 1999, Aschoff, 1965, Roenneberg and Merrow, 
2007), it is thought that adaptation of rhythms is better suited to a phase delay than a phase 
advance. Compounding the direction of travel effect is the day and night relationships. In 
particular, most westward flights are usually scheduled during daytime, while eastward flights 
are scheduled during nighttime (Samel et al., 1995). Travelling at night has been reported to 
result in significant sleep loss and disruption compared to travelling during the day (Samel et al., 
1997, Gander et al., 1998). For example, Preston and colleagues (1973) illustrated that sleep loss 
was associated with number of night flights rather than number of time zones crossed in twenty-
four flight attendants following trans-meridian travel.  
 
In addition to the above-mentioned variables, the intensity and extent of jet-lag symptoms 
exhibit a relationship with other variables such as time of arrival, activity in the first 24h upon 
arrival, the ability to nap while travelling and the availability of external time cues upon arrival 
(Reilly and Edwards, 2007). In practice, more than one of the abovementioned variables can act 
as a significant predictor of jet-lag. There is a huge inter-individual variability and different 
predictors may be more important at different stages of the process of adjustment. Effects 
related to the flights themselves such as fatigue would be most pronounced in the first 24h in 
the new environment, while those associated with the direction of phase of adjustment may 
become more apparent after a few days.  
 
Differences in the way individuals adapt to a phase shift has been previously demonstrated in 
simulated jet-lag and nighttime shift work studies (Hida et al., 2014, Maire et al., 2014, Chellappa 
et al., 2012b, Wirth et al., 2013, Gamble et al., 2011). The above-mentioned studies indicate that 
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there is great inter-individual variability in adaptation response after time zone travel, however, 
none of these studies investigated an individual’s adaptation response based on his/her clock 
gene genotype. Thus, the severity of jet-lag following time zone travel is not just a combination 
of the number of time zones crossed and/or direction of travel, but an individual’s genetics, for 
example, may also warrant consideration.  
 
1.6.5.4 Effect of trans-meridian travel on different physiological systems 
Following trans-meridian travel, the circadian rhythm of various systems has been reported to 
become desynchronised. Complicating this is the fact that various physiological systems including 
sleep-wake patterns, body temperature and the cognitive system re-adjust at a different pace 
following perturbation, for example, after time zone travel (Beaumont et al., 2004, Buxton et al., 
2003). The circadian rhythm of core body temperature (Edwards et al., 2000, Beaumont et al., 
2004), hormones (Lemmer et al., 2002, Bullock et al., 2007), gastro-intestinal function 
(Waterhouse et al., 2005a) and sleep-wake patterns (Edwards et al., 2000, Beaumont et al., 2004, 
Takahashi et al., 2002) have all been shown to desynchronise.  
 
The rate of resynchronisation varies between physiological systems, with some systems 
synchronising more rapidly than others (Winget et al., 1984). For example, following a 9h 
simulated phase advance, core body temperature rhythm was reported to take only two days to 
return to baseline, while sleep patterns, mood and performance took five days (Deacon and 
Arendt, 1996). Similarly, core body temperature and urinary excretions (i.e. sodium and chloride) 
were reported to re-adjust more rapidly than plasma steroids and urinary potassium in 23 
participants following a 6-8h simulated phase advance (Elliott et al., 1972). In another study, 
salivary cortisol and melatonin were shown to resynchronise faster after westward than 
eastward travel across ten time zones in 35 female flight attendants (Harma et al., 1994). 
Furthermore, Klein and colleagues (1972) demonstrated that resynchronisation of the core body 
temperature rhythm occurred after eight days following eastward travel and only after five days 
following westward travel. The abovementioned studies demonstrated a group effect (i.e. overall 
outcome in a cohort) with respect to physiology and jet-lag symptoms; however, accounting for 
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each individual’s response and susceptibility to trans-meridian travel will add more value to jet-
lag studies following time zone transitions.  
 
1.6.6 Trans-meridian travel and sports performance 
The influence of circadian rhythms in athletic performance has long been acknowledged in sport 
(Youngstedt and O'Connor, 1999, Atkinson and Reilly, 1996, Winget et al., 1985). Disruption of 
these rhythms would undoubtedly influence athletic performance negatively. It is very difficult 
to measure individual performance, therefore studies investigating the effects of jet-lag on 
performance have used proxies “for performance”, such as heart rate, aerobic endurance and 
capacity, muscle strength and flexibility or team match outcome (Hill et al., 1993, Atkinson and 
Reilly, 1996, Drust et al., 2005). Circadian misalignment from trans-meridian travel may influence 
circadian variation and peak time for optimal efficiency of several markers of physical 
performance. All the studies that have investigated the impact of trans-meridian travel on both 
specific and non-specific sport indicators of performance are listed in Table 1.2. 
 
While some studies have reported a decrease in markers of performance (Wright et al., 1983, 
O'Connor and Morgan, 1990, Hill et al., 1993, Recht et al., 1995, Jehue et al., 1993), others have 
found no effect (Hill et al., 1993, Bullock et al., 2007, Beaumont et al., 2004, Fowler et al., 2015b, 
Bishop, 2004, Chapman et al., 2012). The available literature on athletic performance following 
trans-meridian travel is confounding and inconclusive. More importantly, most of these studies 
investigated non-sport specific indicators of athletic performance following time zone travel. 
Possible reasons for the lack of consensus include the lack of performance assessment prior to 
trans-meridian travel in some of the studies (O'Connor and Morgan, 1990). Furthermore, the 
disparity in the results may have arisen as a consequent of different participant types, aspect of 
performance being investigated, sex, number of time zones crossed and direction of travel. 
Likewise, the time-of-day that these aspects were investigated varies in different studies, with 
some studies conducted in the morning while others were conducted in the evening (Smith et 
al., 1997). 
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(Fowler et al., 
2015a) 
Westward 8 Squat jump ↓squat jump 









(Bullock et al., 
2007) 
Eastward  7 Grip strength ↓Grip strength US air 
force 
(Lagarde et al., 
2001) 




Students (Hill et al., 
1993) 
Eastward 6 Sprint, muscular 
strength 
↓Distance running and 





Eastward 6 Arm strength, 
sprint, perceived 
exertion 
↓Dynamic arm strength, 
270 m sprint, 2.8 km run and 
RPE 
Military (Wright et al., 
1983) 
Westward 5 Grip strength, 
reaction time  
↓ grip strength, simple 
choice reaction time 
Elite 
athletes  




4 Heart rate, 
muscle soreness 
W-E travel ↑Heart rate  








2 Match win or 
loss 
W-E travel ↓Performance NFL 
athletes 




2 Match win or 
loss 





1-3 Match win or 
loss 
W-E travel↑Performance MLB 
athletes 




1-2 Match win or 
loss 
W-E travel ↑Performance  







1-2 Match win or 
loss 
W-E travel ↑Performance 
E-W travel ↓Performance 
NFL 
athletes 




1-2 Match win or 
loss 
W-E travel ↓Performance American 
baseball 




1 Match win or 
loss 




↓, ↔ ↑ represent a decrease, no change or increase respectively in measured variables. HR- heart rate; 
VO2max- maximum oxygen uptake; RPE- rate of perceived exertion; ANNC- Australian National Netball 
Competition; MLB- Major League Baseball; NBA- National Basketball Association; NCAA- National 
Collegiate Athletic Association; NFL- National Football League; E-W travel- Westward travel; W-E travel- 
Eastward travel and TZ- Time zones. 
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In addition, some studies, which investigated the impact of time zone travel on performance, 
used untrained individuals and student populations (Hill et al., 1993, O'Connor and Morgan, 
1990). Physical performance and physiological systems of non-athlete populations differ to those 
of athletes, given that athletes are trained and thus their physiological systems have adapted and 
may therefore respond differently after trans-meridian travel. For example, repetitive testing 
rather than trans-meridian travel may have decreased performance in a healthy non-athletic 
population where increased fatigue and muscle soreness were noted after trans-meridian travel 
(O'Connor and Morgan, 1990). Studies on non-athletes measuring performance following trans-
meridian travel are flawed for this reason. Therefore, while findings from non-athletic 
populations (O'Connor and Morgan, 1990, Hill et al., 1993) shed some light on the impact of 
trans-meridian travel on performance, it is important not to generalise these findings as they may 
differ in trained populations during actual competitions.  
 
With regards to direction of travel, Jehue et al. (1993) and Steenlands & Deddens (1997) noted 
significant reductions in points scored in professional baseball and Australian teams after 
eastward compared to westward travel. In contrast, Smith et al. (1997) reported that West Coast 
American National Football League teams undergoing eastward travel were more likely to win a 
game than East Coast teams undergoing westward travel. In this study, West Coast teams won 
63.5% of their matches following eastward travel compared to the 36.5% of East Coast teams 
following westward travel. Smith and colleagues (1997) suggested that the 21h00 match kick-off 
time, which was closer to the time that West Coast teams trained may have enhanced their 
athletic performance. Likewise, the night matches possibly eliminated the beneficial effects of 
home-field advantage for East Coast teams. This complicates the interpretation of direction of 
travel effect (i.e. extent of circadian rhythm disruption) on both an individual’s performance and 
the overall outcome of the competition.  
 
The above-mentioned studies do not however indicate direct evidence that the reduction in the 
performance indicators was due to individual differences in coping with the effects of jet-lag, 
since team measures (win/loss) of performance were used. Of the studies that have actually 
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measured match outcome performance, the problems encountered include individual vs team 
performance, strength of the opposition, match location, environmental conditions as well as the 
time-of-day the match took place (Taylor et al., 2008, Atkinson and Reilly, 1996, Thomas et al., 
2008, Smith et al., 1997). Overall, these confounders make it difficult to know what the true effect 
of trans-meridian travel on performance at an individual level is. 
 
1. Team versus individual performance- Team performance does not reflect each individual’s 
contribution on the pitch. Some individuals may adapt faster and perform better; while 
others may take a bit longer to adapt resulting in performance decrements, however, this is 
not reflected in the global match outcome.  
2. Opponents- Opposing team’s performance is not accounted for. For example, the visiting 
team may encounter a stronger and better skilled opposition. Thus, poor team performance 
may be attributed to a superior opponent; rather than effects of jet-lag from trans-meridian 
travel.  
3. Number of time zones crossed- The effects of jet-lag become obvious following three or more 
time zone crosses (Waterhouse et al., 2007). This partly explains the discrepancies in athletic 
performance following a single time zone transition (Steenland and Deddens, 1997) 
compared to two time zones (Jehue et al., 1993, Recht et al., 1995), specifically failure to 
show the linkage between poor performance and jet-lag.  
4. Match status- Tactics employed and physical aspects of performance have been extensively 
explored (Bloomfield et al., 2005, Taylor et al., 2010). A team is likely to register an improved 
match performance in, for example, the semi-final match compared to a mid-season match 
after travelling across the same number of time zones and in the same direction.  
5. Match location- Factors contributing to match location have been well documented in 
literature and include crowd behaviour, venue familiarity, travel fatigue and referee bias 
(Tenga et al., 2010, Taylor et al., 2008). For example, Recht et al. (1995) reported that teams 
had more victories when playing at home (54%) compared to away matches (46%) in 19 North 
American NFL teams.  
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While the information gathered on team performance is helpful, it is highly confounded and thus 
difficult to interpret the effects of trans-meridian travel on performance. Therefore, studies are 
needed in which individual performance is assessed instead. 
 
1.7 Summary and conclusions 
Trans-meridian travel across multiple time zones results in the disruption of the normal 24h 
rhythms and social schedules (Waterhouse et al., 2007, Roenneberg et al., 2013). In the context 
of sports performance, circadian rhythm disruption may influence an individual’s immune 
function, physical performance, and injury risk (Waterhouse and Reilly, 2009, Samuels, 2012). 
This has potential implications on both an individual’s training efficacy, and competition 
performance. Furthermore, circadian disruption is a major concern not only for the travelling 
athlete, but also for team coaches who have to make decisions on player combinations and 
replacements when certain players are not fit to play or become ill following trans-meridian 
travel.  
 
In addition, the circadian clock adapts slowly to new time cues following trans-meridian travel. 
Specifically the phase relationship between circadian rhythms and external time cues is out of 
synchronisation for a number of days (LeGates et al., 2014, Waterhouse et al., 2005b). Equally 
important, adaptation following time zone travel varies from 4-12 days in those individuals who 
resynchronise with difficulty as well as for various physiological variables (Desir et al., 1981, 
Harma et al., 1994, Klein and Wegman, 1980). This suggests that while the circadian clock is slow 
to adapt to time cues in the new environment, different rates of resynchronisation for a host of 
physiological and behavioural measures persist until the correct phase relationship between 
internal body rhythms and external time cues is realised (Deacon and Arendt, 1996, Waterhouse 
et al., 2002).  
 
Resynchronisation to a new time zone depends on several factors chief among them being an 
individual’s chronotype, number of time zones crossed as well as the direction of travel. This 
affects the duration of circadian disruption potentially exacerbating jet-lag symptoms (Winget et 
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al., 1985, Eastman and Burgess, 2009, Vosko et al., 2010). These symptoms are a significant factor 
for nearly two thirds of athletes and negatively influence physical performance in matches played 
before circadian rhythms have resynchronised in to the new time zone. While, no individual is 
immune to the effects of jet-lag, the extent to which each individual responds to circadian 
disruption determines how quickly they will be able to resynchronise into the new environment.  
 
Rhythm disruption of cognitive and neuromuscular functions including, reaction time, decision 
making and alertness may result in impaired physical performance and subsequently injuries. For 
example, lack of situational awareness and decision-making may result in a rugby player holding 
onto the ball longer than necessary, which increases the chances of him being tackled. 
Specifically, a significant number of injuries in rugby have been shown to occur as a result of 
tackles (Fuller et al., 2010, King and Gabbett, 2008). An injury to a single player could affect a 
team’s game plan, motivation and/or match outcome on a given day.  
 
In addition, the degree to which one’s sleep and circadian rhythms are disrupted determines the 
extent to which their immune function is compromised given that different cells key to immune 
functioning peak at different times during the 24h day. Therefore, identifying which players are 
more prone to illnesses and injuries following time zone travel is key to improving performance 
in sporting activities. Identifying a player’s chronotype may play a fundamental role in assessing 
their susceptibility to illnesses and/or injuries. 
 
Chronotype has been reported to vary greatly in various general and athletic populations around 
the world (Lastella et al., 2010, Henst et al., 2015, Zavada et al., 2005, Kunorozva et al., 2012, 
BaHammam et al., 2011). A recent chronotype finding from UCT’s circadian rhythms research 
group (Kunorozva et al., 2012) has shown that South African individual sport athletes tend to be 
more morning-oriented than the control population. This led to the question that is the 
chronotype distribution in team sport athletes similar or different to individual sport athletes. It 
was therefore, hypothesised that team sport athletes may have different proportions of 
morning- and evening-types compared to individual sport athletes as a consequence of time of 
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competition of the sport. However, one needs to consider chronotype in association with 
external factors. The interaction between an individual’s genetics and external factors play an 
important role in shaping chronotype, which may subsequently influence performance. This 
highlights the need to study the extent to which different chronotypes desynchronise to a new 
time zone following trans-meridian travel in team sport athletes, since chronotype may strongly 
influence the efficacy of training and individual match performance. This is particularly important 
today when athletes are required to travel across multiple time zones (up to 12 time zones) for 
matches and competitions with little lead-time for synchronisation to the new time zone.  
 
At present, nothing is known about the inter-individual effects of trans-meridian travel on 
individuals with various PER3 VNTR genotypes with respect to injuries, illnesses and 
performance. Since there are physiological and psychological differences in the three PER3 VNTR 
groups noted in sleep deprivation and nighttime shift work studies (Wirth et al., 2013, Chellappa 
et al., 2012b, Maire et al., 2014), it seems logical that these individuals may be affected differently 
by time zone travel. Specifically, understanding how each PER3 VNTR genotype desynchronises 
and resynchronises into a new time zone could help improve the care of athletes. Furthermore, 
it could facilitate implementation of preventative measures especially for those PER3 VNTR 
groups more susceptible to circadian disruption.  
 
Since the day is shortened following eastward travel and the PER35/5 genotype has been shown 
to have a greater sleep propensity following sleep loss and a shorter circadian period compared 
to the PER34/4 genotype (Goel et al., 2009, Viola et al., 2007), it is possible that PER35/5 individuals 
may find it easier to initiate and maintain sleep in the new time zone. Likewise, the PER35/5 
genotype has been shown to be more sensitive to blue-light exposure during a sleep deprivation 
study (Chellappa et al., 2012b). It was therefore hypothesised that PER35/5 Super Rugby players 
would adapt better (i.e. more advanced DLMO phase) to eastward travel compared to their 
PER34/4 counterparts.  
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Therefore, the aims of this thesis were:  
(1) To compare the chronotype and PER3 VNTR genotype distribution of Super Rugby players to 
individuals of low physical activity (i.e. those who train ≤2 times per week). 
(2) To determine whether PER3 VNTR genotype can explain inter-individual variation in the 
extent to which physical performance is affected following trans-meridian travel.  
(3) To compare the impact of time zone travel during the 2012 Super Rugby competition in South 
African players genotyped as PER34/4, PER34/5 and PER35/5 on the incidence of injuries and 
illnesses. 
(4) To compare the extent to which individuals genotyped as PER34/4 or PER35/5 respond to 
appropriately-timed blue light exposure in order to resynchronise their circadian rhythm, 
following simulated eastward travel, based on changes in dim-light melatonin onset and 
cortisol circadian phases. 
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CHAPTER 2: PERIOD3 VARIABLE NUMBER TANDEM REPEAT POLYMORPHISM 
AND CHRONOTYPE DISTRIBUTION IN THE SOUTH AFRICAN SUPER RUGBY AND 
CONTROL POPULATIONS.  
 
2.1 Introduction 
A previous study carried out by Kunorozva et al. (2012), showed a very good correlation between 
chronotype and PER3 VNTR genotype in Caucasian male athletes participating in individual 
endurance sports in South Africa. There were more individuals preferring mornings compared to 
those preferring evenings in the athletic populations compared to a control population of 
recreationally active, but non-competitive individuals. More of the individual sport athletes 
carried the PER3 VNTR 5-repeat allele, which has been shown to be associated with morningness 
(Archer et al., 2003), compared to the control population. Furthermore, there was a positive 
association between chronotype and genotype such that individuals carrying the 5-repeat allele 
were more likely to be morning-types and those carrying the 4-repeat allele were more likely to 
be evening-types (Kunorozva et al., 2012).  
 
Of interest is the fact that these distributions are not reflective of what other studies around the 
world have reported in the general population. Typically the evening-type chronotype is more 
common than the morning-type chronotype (Kabrita et al., 2014, Tonetti et al., 2010, Zavada et 
al., 2005), and the PER3 4-repeat allele is more common than the 5-repeat allele (Ciarleglio et al., 
2008, Pereira et al., 2005, Nadkarni et al., 2005). This led to questions: Were the chronotype and 
genotype distributions observed by Kunorozva et al. (2012) specific to individual sport endurance 
athletes, who typically train and race in the early morning? Are the same distributions of 
chronotype and PER3 VNTR genotype observed in team sport athletes who have more varied 
training session times and match schedules? These questions were necessary, given that 
chronotype and PER3 VNTR genotype distributions of active controls (i.e. train ≥3 times per week) 
have already been described in South African populations (Rae et al., 2015, Kunorozva et al., 
2012, Henst et al., 2015). These studies reported a high prevalence of morning-types compared 
to evening-types in active South African populations.  
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Team sport players may be less morning-oriented than individual sport athletes may, but more 
morning-oriented than the general population. This may be explained in part by timing 
differences in the training, and match or race schedules between individual and team sport 
athletes. Individual sport athletes tend to be free to choose their preferred training times unlike 
their team sport counterparts who typically train according to a set team schedule. The aim of 
this study was to compare the chronotype and PER3 VNTR genotype distribution of Super Rugby 
players to individuals of low physical activity (i.e. those who are physically active ≤2 times per 
week).  
 
Therefore, the objectives of this study were:  
1. To describe and compare the chronotype distribution of South African Super Rugby players 
(RUG) and a control population of individuals who have low levels of physical activity (CON).  
2. To genotype the same two populations for the VNTR polymorphism within the PER3 gene. 
3. To determine whether there is an association between chronotype and PER3 VNTR genotype 
in these two groups.  
 
It was hypothesised that individual sport athletes will have more morning-types than team sport 
athletes. Further, it was hypothesised that the rugby group would have a higher frequency of the 
PER34 allele compared to the low physical activity control group. Lastly, it was hypothesised that 
there would be an association between chronotype and PER3 VNTR genotype in both the rugby 
and control groups. Specifically, that the PER34 allele would be associated with lower HÖ-scores 






Professional male rugby players (RUG, n=205) from five South African Super Rugby teams 
participated in this study. Players were recruited with the help of each of the respective South 
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African provincial Super 15 team physicians, who were given detailed information about the 
nature of the research. Each team physician was able to explain the details of the study to the 
players, and all players received a participant information sheet (Appendix 1A), detailing the 
study purpose, outline, requirements, as well as all the potential risks and benefits. Players from 
both the 2011 and 2012 Super Rugby tournaments, who had played at least half of the Super 
Rugby tournament matches and had travelled with the team to play Super Rugby matches in 
Australia/New Zealand, were included in this study. The control group (CON, n=191) comprised 
males with habitually low levels of physical activity. This was assessed based on a questionnaire 
on which participants indicated the type of physical activity they usually undertook, for example, 
running, going to the gym, soccer, tennis, swimming and the frequency. Low levels of physical 
activity were defined as exercise no more than twice a week. CON participants were recruited at 
the Bayside and Cascades shopping malls, Cape Town Gardens Park and at the University of Cape 
Town and the University of Kwazulu Natal campuses at all times of the day to avoid bias in 
sampling that could arise by recruiting only in the mornings or evenings. The control group 
exercised no more than twice a week in the past year. 
 
To be included in this study, all participants (RUG and CON) were required to be (i) between the 
ages of 18-40 years, (ii) in self-reported good mental and physical health, and (iii) free from any 
chronic medical condition. Participants who had taken any of the following substances: 
amphetamines, modafinil, soporific drugs, hypnotics or melatonin in the past three months prior 
to participation were excluded from the study as these drugs affect the sleep-wake cycle and/or 
circadian system. The descriptive characteristics of both groups are presented in Table 2.1. 
 
2.2.2 Study design 
This is a cross-sectional genetic association study comparing the PER3 variable number tandem 
repeat polymorphism and chronotype distributions between the RUG and the CON populations. 
All volunteers were informed of the purpose of the study and gave written informed consent to 
participate (Appendix 1B). Participants completed a brief personal, health, training and 
competition-history questionnaire to determine their eligibility for the study and to document 
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their general characteristics (Appendix 1C). They also completed the Horne-Östberg (HÖ) 
morningness-eveningness personality questionnaire to determine their chronotype (Appendix 
1D). Buccal cell samples or blood samples were obtained from participants for DNA extraction. 
Genomic DNA was used to genotype each individual for the VNTR polymorphism within the PER3 
gene (Archer et al., 2003). The study was approved by the University of Cape Town’s Faculty of 
Health Sciences Human Research Ethics Committee (HREC Ref No: 412/2009), and performed in 
accordance with the principles of the Declaration of Helsinki (Fortaleza, Brazil 2013), the 
International Conference on Harmonisation and South African Good Clinical Practice guidelines. 
 
2.2.3 Detailed testing procedures 
2.2.3.1 Horne-Östberg Morningness-Eveningness Personality Questionnaire  
A sub-group of the RUG (n=120) and all CON (n=191) participants completed the HÖ-
questionnaire. This is the most widely used questionnaire that describes chronotype, and is 
highly correlated to the timing of melatonin release and core body temperature changes over a 
24h period, the two most important markers of innate circadian phase (Horne and Ostberg, 
1976). The questionnaire consists of 19 items relating to sleep-wake behaviour, and schedules 
and yields overall scores ranging from 16-86. Based on their score, individuals were placed into 
one of three main chronotype categories: evening-type (score: 16-41), neither-type (score: 42-
58) and morning-type (score: 59-86). The internal consistency of the HÖ-questionnaire for this 
study was “good” with a Cronbach’s α score of 0.82 (George and Mallery, 2003). 
 
2.2.3.2 Genomic DNA extraction 
2.2.3.2.1 Buccal cell samples 
Buccal cell samples were obtained by scraping the inside of both cheeks using Epicentre Catch-
AllTM Sample Swabs (Epicentre Biotechnologies, Madison, USA). Following collection, the swabs 
were stored at room temperature, for no more than seven days. A simple salting out protocol 
was used to extract total human gDNA from the buccal cell swabs (Aljanabi and Martinez, 1997), 
with some modifications. After 1h incubation at room temperature in lysis buffer (0.4 M NaCl, 10 
mM Tris-HCl (pH 8.0), 2 mM EDTA and 50 µl of 10% sodium dodecyl sulphate (SDS)), 10 µl of 
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proteinase-K was added to tubes containing the swabs. The tubes were incubated for 3h in a 
water bath at 55°C to allow the cells to lyse. Two hundred and twenty five microliters of 6 M NaCl 
was added to each tube. Samples were centrifuged for 10 min at 9200 g at room temperature 
using a bench centrifuge (Labnet International, Edison, USA) to remove NaCl and lysed cell debris. 
The supernatant was transferred to a clean microfuge tube and the centrifugation process 
repeated. After extraction and purification, samples were either left to air dry at room 
temperature for 1h or dried for 10 min at 37oC. The pellet was re-suspended in 25 µl of 1 X sterile 
1 mM Tris 1 mM EDTA (TE) buffer and DNA quantified using a NanoDrop® ND-1000 
spectrophotometer (NanoDrop® Technologies, Wilmington, Delaware, USA). The quality was 
assessed after electrophoresis through a 1% (w/v) agarose gel in 1 X Tris Acetate EDTA (TAE; 40 
mM Tris, 1 mM EDTA and 0.11% (v/v) glacial acetic acid) buffer. DNA samples were stored at -
20°C until further analysis. 
 
2.2.3.2.2 Blood samples 
Blood samples were collected from the antecubital vein by a qualified phlebotomist into 5 ml 
EDTA vacutainer tubes (Becton Dickinson, New Jersey, USA). The vacutainer tubes were stored 
at -20oC until further analysis. Total gDNA was extracted from the 5 ml blood samples according 
to the procedure described by Lahiri (1991), with slight modifications (Collins et al., 2004). The 
blood samples were transferred to sterile 15 ml polypropylene tubes, to which 10 ml of TKM1 
buffer (10 mM Tris-HCl pH 7.6, 10 mM KCl, 10 mM MgCl2 and 2 mM EDTA) containing 2.5% 
Nonidet P-40 was added in order to lyse the blood cells. Centrifugation of samples was performed 
at 3000 g for 10 min at room temperature in a Beckman TJ-6 Tabletop Centrifuge (Beckman 
Coulter, Minnesota, USA). Fifty microliters of 10% SDS was added to 800 µl of TKM2 buffer (10 
mM Tris-HCl pH-7.6, 10 mM KCl, 10 mM MgCl2) suspension, mixed thoroughly by pipetting back 
and forth several times and incubated for 1h in a water bath at 55°C. Extracted DNA was 
suspended in 50 µl of TE buffer and stored at -20oC until further analysis.  
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2.2.3.2.3 PER3 VNTR amplification and confirmation 
In order to genotype individuals for the PER3 VNTR polymorphism, exon 18 of PER3 and its 
adjoining regions were amplified by PCR from 80-100 ng of gDNA using standard methods 
described by Ebisawa et al. (2001) and Archer et al. (2003). Polymerase chain reaction products 
were digested with Ncol restriction enzyme, and products assessed after electrophoresis through 
a 2% (w/v) agarose gel in 1 X Tris Acetate EDTA (TAE; 40 mM Tris, 1 mM EDTA and 0.11% (v/v) 
glacial acetic acid) buffer and viewed under ultra-violet (UV) light using ethidium bromide 
staining. Those individuals homozygous for the 5-repeat allele were shown by a banding pattern 
of 420 bp and 200 bp, respectively. While those homozygous for the 4-repeat allele had a banding 
pattern of either 600 bp only or 600 bp, 380 bp and 200 bp, or 380 bp and 200 bp. The individuals 
that were heterozygous for the PER3 gene had a combination of either 600 bp, 420 bp and 200 
bp or 420 bp, 380 bp and 200 bp. The 4- and 5-repeat alleles of the PER3 VNTR polymorphism 
were genotyped as previously described by Kunorozva et al. (2012). Each PER3 VNTR genotype 
was checked and confirmed by an independent person other than the candidate. 
 
2.2.4 Data and statistical analyses 
Data are reported as mean ± standard deviation (SD, for parametric data) and median with 
interquartile range (IR, for non-parametric data) or frequency (%). A Shapiro-Wilks test was 
performed to check for normality of the data. Hardy Weinberg 
(http://genepop.curtin.edu.au/genepop_op1.html) exact tests were performed to determine if 
the percentage frequencies of the 4- and 5-repeat alleles were normally distributed. Group 
characteristics were compared using an independent t-test and Mann-Whitney U test. A Chi-
squared or Fisher’s Exact test were performed to compare both the chronotype and PER3 VNTR 
polymorphism frequency distributions between the two groups. Correlations were performed 
using multinomial logistic regression. Data were analysed using Statistica version 11 (StatSoft 
Inc., Tulsa, Oklahoma, USA). Significance was assumed for p<0.05. 
  





2.3.1 Participant characteristics 
Characteristics of the RUG and CON groups are presented in Table 2.1. There were differences in 
all the variables except for age between the RUG and CON groups. The RUG group was taller 
(p<0.001), heavier (p<0.001) and had a higher body mass index (p<0.001). The RUG group trained 
on more days each week compared to the CON group (p<0.001). The RUG group consisted of 171 
(83.4%) Caucasians, 20 (9.7%) mixed ancestry and 14 (6.8%) black African individuals, while the 
CON group consisted of 71 (37.2%) Caucasians, 56 (29.3%) mixed ancestry, 63 (32.9%) black 
Africans and 1 (0.5%) Indian. There were significant differences in ethnicity distribution between 
the RUG and CON groups (p<0.001).  
 
Table 2.1: General characteristics of the Rugby and Control groups. 
 RUG (n=205) CON (n=191) p-value 
Age (y) 25.0 (5.0) 25.0 (8.0) 0.835 
Weight (kg) 102.0 (20.0) 74.0 (20.0) <0.001 
Height (cm) 186.4±7.4 175.5±8.7 <0.001 
BMI (kg·m-2) 28.7 (3.5) 23.8 (4.4) <0.001 
Training (days·week-1) 4.3±0.9 1.7±0.4 <0.001 
Data are presented as the median with IR and mean ± SD. BMI: Body mass index, CON: Low physical 
activity control group and RUG: Super Rugby group. Training data for the RUG group are for the two weeks 
prior to the tournament starting. The p-values represent significance as determined by either a Mann-
Whitney U test or an independent t-test. 
 
2.3.2 Chronotype distribution  
The scores for all participants ranged from 26 to 77, but the HÖ-score data were significantly 
skewed towards the higher scores (p<0.001) in the RUG group. The RUG group had a higher mean 
HÖ-score compared to the CON group (RUG: 57.4±8.4 and CON: 50.6±10.4, p<0.001). Figure 2.1 
depicts the frequencies of morning-types (MT), neither-types (NT), and evening-types (ET) in both 
groups. A significant difference in the chronotype distribution between the two groups was found 
(p<0.001). A post-hoc analysis indicated that there were more MT individuals in the RUG group 
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than in the CON (p<0.001) group. In contrast, there were more ET individuals in the CON group 



























Figure 2.1: Proportion of chronotype categories in the RUG (n=120) and CON (n=191) groups.  
CON: Low physical activity control group, ET: evening-type, MT: morning-type, NT: neither-type, 
and RUG: Super Rugby group. The p-value represents significance determined using the Fisher’s 
exact test.  
 
2.3.3 PER3 VNTR polymorphism frequency distribution  
All of the RUG group, but only 120 individuals in the CON group were genotyped successfully. Of 
the 191 CON participants, gDNA from 48 CON individuals was non-amplifiable, and 23 of the CON 
participants were lost to follow-up for the DNA sample collection. The genotype and allele 
frequencies were not different between the two groups (Figure 2.2). In both groups, 
approximately one third of the individuals carried the 5-repeat allele while two thirds carried the 
4-repeat allele. 
  

















































Figure 2.2: Frequency distributions of the PER3 VNTR genotypes (A) and alleles (B) in the RUG 
(n=205) and CON (n=120) groups . 4/4: PER34/4, 4/5: PER34/5, 5/5: PER35/5, CON: Low physical 
activity control group and RUG: Super Rugby group. The p-values represents significance 
determined using a Chi-squared test. 
 
2.3.4 Relationship between chronotype and the PER3 VNTR genotype  
The association between the HÖ-questionnaire score for each individual in relation to his PER3 
VNTR genotype is presented in Figure 2.3. There was no significant correlation between the HÖ-
score and an individual’s genotype when data from both the RUG and CON groups were pooled 
for analyses. When analysed separately, the CON group showed a low, but significant association 
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between HÖ-score and the PER3 VNTR polymorphism (p=0.008, r=0.293); but the RUG group data 
showed no association (p=0.574, r=0.009).  
 
























Figure 2.3: Relationship between PER3 VNTR genotype and the HÖ-score in the RUG (n=120) 
and CON (n=120) groups. 4/4: PER34/4, 4/5: PER34/5, 5/5: PER35/5, CON: Low physical activity 
control group, DET: definite evening-type, DMT: definite morning-type, HÖ: Horne-Östberg 
questionnaire, MET: moderate evening-type, MMT: moderate morning-type, NT: neither-type, 
RUG: Super Rugby group and VNTR: variable number tandem repeat. The p-value represents 
significance determined using multinomial logistic regression.  
 
The chronotype distributions within each of the three genotype groups for both the RUG and 
CON groups are presented in Figure 2.4. Chronotype distribution was significantly different 
between the three PER3 VNTR genotype groups in the CON group (p=0.011, Figure 2.4A). A post-
hoc analysis indicated that there were more MTs in the PER35/5 group than the other two groups 
(p=0.009). Furthermore, there were more ETs in the PER34/4 group compared to the other two 
groups (p=0.030). The number of NTs in each of the three groups was similar. The same pattern 
was not observed in the RUG group (Figure 2.4B). 




































































Figure 2.4: Chronotype distribution in the three PER3 VNTR genotype groups in the CON (A, 
n=120) and RUG (B, n=120) groups. ET: evening-type, MT: morning-type and NT: neither-type. 
The p-value represents significance determined by Chi-squared (CON) and Fisher’s exact (RUG) 
tests, respectively.  
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2.4 Discussion  
The main aim of this study was to describe the genotype and chronotype distribution in the South 
African, Super Rugby population and an age- and gender-matched control population of 
individuals with low levels of physical activity. The main findings were that while the two groups 
had similar PER3 VNTR genotype distributions (Figure 2.2), the chronotype distribution in the 
Super Rugby population was significantly different to that of the control group (Figure 2.1). More 
importantly, an association between genotype and chronotype was only observed in the control 
group. The chronotype and genotype results of the control group in this study are similar to a 
control group of individuals with low levels of physical activity of previous study (unpublished 
data). 
 
Regarding the genotype data, the Super Rugby and control populations in the present study had 
similar PER3 VNTR genotype and allele frequencies. Specifically, these groups had high 
frequencies of individuals who were homozygous for the PER3 4-repeat allele compared to those 
individuals who were homozygous for the PER3 5-repeat allele (Figure 2.2A). Furthermore, the 
majority (two thirds) of participants in both the RUG and CON groups carried the PER3 4-repeat 
allele, while only one third carried the PER3 5-repeat allele (Figure 2.2B). This result is congruent 
with findings from other studies around the world (Henst et al., 2015, Rae et al., 2015, Archer et 
al., 2003, Nadkarni et al., 2005, Ciarleglio et al., 2008), in which the PER3 4-repeat allele has also 
been predominant in the general population and marathon runners. For example, Ciarleglio et 
al. (2008) reported a higher frequency of the PER3 4-repeat allele in African American (59%), 
Ghanaian African (64%) and European American (65%) populations.  
 
The PER3 5-repeat allele has only been found to be the predominant allele in a few studies 
investigating Papua New Guinea (81%), South African Caucasian (male athletes) (60%) and 
Yemenis (52%) populations (Ciarleglio et al., 2008, Nadkarni et al., 2005, Lazar et al., 2012, 
Kunorozva et al., 2012). The similarity between the PER3 VNTR genotype distribution observed 
in the present study and other populations (Nadkarni et al., 2005, Ciarleglio et al., 2008, Archer 
et al., 2003, Pereira et al., 2005), suggests that the observed differences are not due to random 
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selection or differences in geographical location, but rather due to random selection through 
sexual selection. 
 
The chronotype spread in the CON group was normally distributed with the majority of 
participants being characterised as neither-types (Figure 2.1). This finding concurs with results 
from Li et al. (2011), who reported ratios of 18:47:35 of ET:NT:MT in a Chinese population from 
the Beijing district consisting of 188 males and females in a ratio of 1:1 and aged between 19-51 
years (mean age: 30.8±7.8). Of interest however is the fact that neither the CON group nor RUG 
chronotype findings in the present study are reflective of what other studies around the world 
have reported in the general population, where typically the evening chronotype is more 
prevalent than the morning chronotype (Kabrita et al., 2014, Zavada et al., 2005, Tonetti et al., 
2010). These researchers reported ET:NT:MT ratios of 25:68:7 in a Lebanese population (mean 
age: 19.8±1.5, 1:1 males to females, Kabrita et al., 2014), 24:65:11 in a Spanish population (mean 
age: 22.8±2.9, 1:1 males to females, Tonetti et al., 2010) and 33:55:14 in a Dutch population (age 
range: 10-80 years, Zavada et al., 2005). 
 
Taking a closer look at the chronotype data from this study, one observes that the RUG group 
contained twice as many morning-types (48.8%) compared to the CON group (24.6%). In contrast, 
very few RUG players were characterised as evening-types (<5%), while a notable proportion of 
individuals in the CON group were categorised as evening-types (18.9%). In general, there was a 
higher proportion of morning-types compared to evening-types in both the RUG and CON 
populations compared to previous studies (Adan and Natale, 2002, Kabrita et al., 2014, Osland 
et al., 2011, Kudielka et al., 2007). This is interesting because this finding is similar to results from 
other age-matched male SA individual endurance sport and recreationally active populations 
(Henst et al., 2015, Kunorozva et al., 2012, Rae et al., 2015). A higher proportion of morning-
types in this study may have been a result of habitual early morning training times, also referred 
to as “conditioning” in the rugby group. This means that habitual early morning training times 
might be driving the morning-chronotype. In response to this problem “conditioning”, an 
argument can be made for the inclusion of sleep diaries in future. The sleep diaries will give 
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information pertaining to the athletes’ bedtime and wake-up time, which might facilitate 
interpretation of the HÖ-score better.  
 
The chronotype distribution in the RUG group was however skewed towards morning-
orientation, with a high proportion of participants being characterised as morning- or neither-
types (Figure 2.1). This finding is in line with previous studies (Rae et al., 2015, Kunorozva et al., 
2012, Lastella et al., 2010), which investigated chronotype distribution in trained athletes. For 
example, these researchers reported ET:NT:MT ratios of 0:48:52 in an Australian population 
(mean age: 20.9±2.9, 2:1 males to females, Lastella et al., 2010), 0:42:58 (mean age: 32.6±5.7, 
2:1 males to females, Rae et al., 2015) and 8:28:64 (mean age: 36.5±6.8, males only, Kunorozva 
et al., 2012) in Caucasian South African populations. The RUG chronotype distribution is however 
different to numerous other studies around the world just like the CON group in this study 
(Tonetti et al., 2010, Zavada et al., 2005, BaHammam et al., 2011).  
 
It is interesting to note that the rugby and control populations had more morning-types than 
evening-types compared to other populations. A possibility for having a high proportion of 
morning- compared to evening-chronotypes in both the SA rugby and control populations in this 
study could be societal/cultural differences between SA and other countries. For example, the 
average school start time in SA is 07h45 vs 09h00 for most parts of Europe and the United States 
of America. Studies by Hidalgo et al. (2009) and Pedrazzoli et al. (2007) reported that most of the 
Brazilian population, for example, tend to be evening-types. In Brazil, individuals have been 
shown to start their personal activities in the evening and thus may be more active and alert in 
the late afternoon into the early evening. Therefore, perhaps one is conditioned to being more 
morning- or evening-type in nature by the society in which he/she resides in. This is plausible 
since the HÖ-questionnaire scoring is based on answers where precise times are given, thus 
societal norms may influence the questionnaire scoring in different countries (Taillard et al., 
2004, Li et al., 2011, Smith et al., 2002). 
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Another potential reason for this finding may be geographical differences between cities or 
countries. Specifically, differences in latitude may contribute to the differences observed as 
latitude influences photoperiod experienced in a given city or country during a particular season 
(Borisenkov et al., 2010, Randler, 2008, Miguel et al., 2014, Masal et al., 2015). For example, 
Borisenkov (2010) observed a higher frequency of evening-types in the Republic of Komi in 
Russia. He reported differences in chronotype between towns that were 4.5o apart in latitude. 
Likewise, he compared chronotype distribution between high latitude lying towns in the Republic 
of Komi and lower latitude European cities. He observed a significantly higher proportion of late 
chronotypes in those towns in high latitude areas, suggesting that photoperiod may contribute 
to differences in chronotype distribution. South Africa has a latitude of 30o S compared to the 
lower latitude of 19o S in Turkey (Masal et al., 2015), 22o S of Paraiba do Sul (Hidalgo et al., 2009) 
and 23o S of Sao Paulo (Rique et al., 2014) where higher percentages of evening-types were 
found. The latitude of Cape Town (34o S) is similar to 34o S of Adelaide, South Australia where a 
high percentage of morning-types were observed in athletes (Lastella et al., 2010). Therefore, 
latitude may play a role in influencing chronotype. 
 
In addition to latitude, ambient temperature in a given society may also influence chronotype. 
Specifically, climate zones differ significantly in ambient temperature (e.g. mean annual 
temperature- tropics 25oC, subtropics 18oC and temperate zones 10oC) (Randler, 2008). The 
tropics have similar daylength nearly all year round, while daylength near the poles increases 
with increasing latitude in the summer and decreases with latitude in winter. Prolonged periods 
of ambient lighting (e.g. during summer) might extend the time individuals retire to bed by an 
hour in a given society. For example, an eight year longitudinal study (Lehnkering and Siegmund, 
2007) indicate a significantly longer actual sleep time in autumn than in spring in 2 697 
participants. Another study using the Composite Scale of Morningness reported that late 
chronotypes were more prevalent in subtropics than tropic regions in a group of adolescent 
participants (Randler, 2008). Based on the abovementioned evidence, it can be said with relative 
certainty that ambient temperature may affect chronotype distribution in a given region.  
    
70 
 
Chronotype has also been shown to vary considerably with age in many populations (Horne and 
Ostberg, 1976, Taillard et al., 1999, Randler et al., 2012, Roenneberg et al., 2004). Specifically, 
adolescent individuals tend to have a propensity for delayed sleep periods, which are associated 
with eveningness; while young adults and the elderly have a tendency for advanced sleep periods 
associated with morningness. Therefore, it is possible that the differences observed between this 
study and the above-mentioned studies could be due to age differences. For example, the Kabrita 
et al. (2014) and Tonetti et al. (2010) studies which had high prevalence of evening-types used 
young student (17-25 years) and university (18-30 years) populations, respectively, an age group 
known to be biased towards evening behaviour.  
 
An important finding of the current study was that there was no association between chronotype 
and PER3 VNTR genotype when the two groups were analysed together (Figure 2.3). However, 
there was a positive association between chronotype and genotype in the CON group when data 
were assessed separately, such that individuals homozygous for the 5-repeat allele were more 
likely to be categorised as morning-types; while those homozygous for the 4-repeat allele were 
more likely to be scored as evening- or neither-types. This is in line with previously published 
studies that reported an association between the PER3 VNTR genotype and chronotype 
(Kunorozva et al., 2012, Archer et al., 2003, Pereira et al., 2005, Archer et al., 2010, Jones et al., 
2007). Based on the high proportion of the PER3 4-repeat allele result in the CON group, a high 
percentage of evening- and neither-types was expected.  
 
In contrast to the CON group, there was no association between chronotype and genotype in the 
rugby population. Based on the players’ genotype, a higher proportion of evening-types was 
expected; instead, a high proportion of morning-types was noted. This is different to most studies 
that have reported an association (Archer et al., 2003, Archer et al., 2010, Ebisawa et al., 2001, 
Pereira et al., 2005, Kunorozva et al., 2012), but similar to a few other studies (Henst et al., 2015, 
Goel et al., 2009, Barclay et al., 2011), which reported no association between genotype and 
chronotype. A few studies have reported that repeated training at a particular time-of-day may 
influence chronotype (Chtourou and Souissi, 2012, Chtourou et al., 2012, Hill and Smith, 1991). 
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However, other studies in literature suggest that highly active individuals tend towards morning 
orientation (Antunez et al., 2013, Urban et al., 2011, Shechter and St-Onge, 2014). This is further 
supported by previous findings at the University of Cape Town in Associate Professor Roden and 
Dr Rae’s research group (unpublished data) that individuals with higher levels of physical activity 
tend towards morning orientation.  
 
What is potentially interesting is the finding of evening-types in the rugby’s PER35/5 group which 
have not been observed before. Perhaps conditioning could explain the lack of association 
between chronotype and PER3 VNTR genotype in the RUG group. South African Super Rugby 
teams perform most of their training sessions in the morning between 08h00-11h00 (training 
time information obtained from the participant questionnaires). Thus, RUG players may have 
become used to the repeated early morning training times, such that their chronotype shifted to 
a more morning-orientation, despite their PER3 VNTR genotype being associated with the 
evening-chronotype. Accordingly, this conditioning may have resulted in the mismatch of the 
players’ chronotype with their PER3-based genetic predisposition weakening any association 
between chronotype and PER3 genotype.  
 
Another aspect is that morning-type individuals typically have earlier sleep schedules compared 
to their evening-type counterparts and therefore differ in their bed and wake-up times (Lo et al., 
2014, Mongrain et al., 2006). It is possible that heavy training loads in the morning, such as is the 
case in most Super Rugby teams, may lead to players being more tired at the end of the day, and 
thus players may sleep earlier than they usually would on days without training. Perhaps some 
PER35/5 individuals nap, leading to them staying up later and considering themselves as evening-
types. In addition, research on sleep habits in elite athletes indicate that attaining adequate sleep 
prior to training or competition is important for achieving optimum performance and satisfaction 
(Mah et al., 2011, Juliff et al., 2015). For example, Mah et al. (2011) demonstrated a faster sprint 
time as well as an improved shooting accuracy in the Stanford University men’ s basketball 
players following sleep extension (≥10h) compared to baseline (6-9h). In this study, basketball 
players also reported improved overall ratings of physical and cognitive function during training 
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and matches, suggesting that adequate sleep is beneficial for optimal performance. While sleep 
timing was not measured, it is possible that South African Super Rugby players retire to bed 
earlier on the majority of training days. Either early morning training times or heavy training load 
appear to be driving the morning-type phenotype in the rugby population in this study as players 
are tired at the end of the day. 
 
2.4.1 Limitations 
Data collection spanned over 18 months, from March 2012-September 2013. Therefore, seasonal 
variations in photoperiod, known to affect chronotype, may have influenced the results. The use 
of a subjective tool to measure chronotype was a limitation in this study. Specifically, the 
questions on the HÖ-questionnaire are fixed and do not allow for flexibility when there is no 
suitable option for an individual’s preferred answer. This likely affected those individuals, whose 
preferred answer was not on the multiple choice options list. For this reason, the questionnaire 
does not reflect an individual’s true chronotype, but a close approximation of an individual’s 
chronotype. Likewise, the HÖ-questionnaire has not been validated for use in a team sport 
structure, where individuals do not have the flexibility to choose their preferred time for physical 
performance. Thus, individuals were likely to choose team-training times as the times they prefer 
to train, and not their actual preferred training time-of-day. Use of sleep diaries (at least two 
month prior to tournament kick-off) would have assisted in determining prior sleep history for 
the Super Rugby population since it is unlikely that they chose their own sleep time during 
training days and days prior to a match. This would have helped explain some of the mismatch 
between chronotype and genotype in this study.  
 
2.5 Conclusion 
The PER3 VNTR genotype and chronotype distributions were different between the SA Super 
Rugby and control populations. There was no chronotype and PER3 VNTR genotype association 
in the RUG group. Perhaps repeated exposure to morning training sessions or heavy training load 
lead to early wake times or increased fatigue both of which may shift chronotype. This is 
conceivable, because the two groups had similar PER3 allele frequency distributions, but the lack 
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of association was only observed in the RUG group. The only aspect that was different between 
the two populations was the level of physical activity. It appears that with a combination of 
repeated morning training times and a higher level of physical activity, individuals tend towards 
more morning orientation (Henst et al., 2015, Rae et al., 2015, Lastella et al., 2010). While the 
CON group in this study extends the work of previous studies (Kunorozva et al., 2012, Pereira et 
al., 2005, Archer et al., 2003, Ebisawa et al., 2001); the RUG group raises interesting questions 
with regards to the relationship between chronotype and PER3 VNTR genotype in active 
individuals. Therefore, future studies in other team sport athletes that will make use of a sleep 
diary or actigraphy to measure sleep habits may be warranted to explore this hypothesis. 
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CHAPTER 3: THE IMPACT OF TRANS-MERIDIAN TRAVEL DURING COMPETITION 




Travelling across multiple time zones leads to a mismatch between the internal body clock and 
the external environment at the destination venue, resulting in an assortment of symptoms 
known as jet-lag (Waterhouse et al., 2007, Sack, 2010). These symptoms include impaired 
judgement, reaction time, alertness, daytime fatigue and disruption of the sleep-wake cycle 
(Edwards et al., 2000, Manfredini et al., 1998, Reilly et al., 2005). Physical performance following 
time zone transitions in particular is greatly affected by jet-lag and circadian rhythm disruption. 
Jet-lag and circadian rhythm disruption have been shown to influence not only cognitive function 
(e.g. decision making, alertness), but also neuromuscular and physiological parameters that are 
crucial for achieving optimum physical performance (Reilly et al., 2005, Leatherwood and Dragoo, 
2013). For instance, time zone transition disrupts circadian rhythms in muscle flexibility (Reilly et 
al., 2007), muscle strength (Jasper et al., 2009) as well as reaction time (Reilly et al., 1997a), all 
of which are fundamental for an individual’s match performance. 
 
Research has shown that the extent to which individuals are affected by jet-lag and circadian 
rhythm misalignment varies following trans-meridian travel (Winget et al., 1984, Eastman and 
Burgess, 2009, Chapman et al., 2012). One possible explanation may be that polymorphisms in 
clock genes, such as those found in the PERIOD3 gene, may influence individual tolerance to 
circadian rhythm disruption caused by time zone transitions. For example, individuals with 
various PER3 VNTR genotypes have been shown to respond differently to sleep deprivation and 
disruption (Dijk and Archer, 2010, Chellappa et al., 2012b), such as that which occurs following 
time zone transitions. Specifically, the PER35/5 individuals are more susceptible to sleep 
deprivation than the PER34/4 individuals. 
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These differences in susceptibility may arise due to differences that have been observed in sleep 
pressure and cognitive performance following sleep deprivation between PER34/4 and PER35/5 
individuals (Maire et al., 2014, Viola et al., 2007). The genotype groups may also entrain to new 
light/dark cycles differently due to the differences in sensitivity to blue light suppression of 
melatonin in PER34/4 and PER35/5 genotypes (Chellappa et al., 2012a). The aim of this study was 
to determine whether PER3 VNTR genotype might contribute to inter-individual variation in the 
extent to which game involvement and quality of play are affected following trans-meridian 
travel. To do this, game activity and play quality were analysed in the South African Super Rugby 
players competing in the 2011 and 2012 Super Rugby tournaments. The Super Rugby tournament 
involves teams from three Southern hemisphere countries (South Africa (SA), Australia (AUS) and 
New Zealand (NZ)) and is a unique competition in that teams are required to undergo repeated 
trans-meridian travel, crossing up to 12 time zones between matches. This provides a good 
platform to study the effects of trans-meridian travel on subsequent match involvement and 
quality of play.  
 
Therefore, the objectives of the study were:  
(1) To compare players genotyped as PER35/5, PER34/5 and PER34/4 with respect to game activity 
rate and quality of play in games preceded either by no time zone travel, east-to-west or 
west-to-east travel. 
(2) To determine whether the number of time zones crossed prior to a match influences 
individual game activity rate and quality of play in these three groups of players.  
 
It was hypothesised that individuals carrying the PER35/5 genotype would have a higher game 
activity rate and quality of play than the other two PER3 VNTR groups following time zone travel. 
Further, it was hypothesised that game activity rate and quality of play would decrease as the 
number of time zones crossed prior to a match increases in the three PER3 genotypes. Lastly, it 
was hypothesised that game activity rate and quality of play would be higher following westward 
travel compared to eastward travel. 
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3.2 Methods  
3.2.1 Setting 
Each country has five teams participating in the tournament. Teams play matches weekly for the 
duration of the 21-week tournament period, with the exception of two byes, one of which is 
when teams travel between countries for subsequent matches. The competition involves both 
home and away matches as well as frequent trans-meridian travel to play at Australian (AUS) and 
New Zealand (NZ) match venues. While the gruelling travel schedule during the competition 
places exceptional physiological and psychological stresses on players, it also provides an 
opportunity to study the effects of jet-lag adaptation in athletes. Each team participates in a 
round robin over 16 weeks beginning towards the end of February or early March each year until 
August, with a one-month break from the tournament during June allowing selected players to 
represent their respective countries in international matches. After the round-robin stage, four 
teams (viz. teams in position 3-6 on the combined Super Rugby log) participate in the two play-
offs of the tournament with winners proceeding to join the first and second ranked teams on the 
combined Super Rugby log in the two semi-final matches. Lastly, the two teams that win the 
semi-final games proceed to play in the Super Rugby final match of the tournament. 
 
3.2.2 Participants  
Sixty Super Rugby players from all five SA teams were included in this study based on the 
genotype results from Chapter 2. Players genotyped as PER35/5 (n=20), PER34/5 (n=20) and PER34/4 
(n=20) who had played a minimum of 70% of their 2011 or 2012 Super Rugby matches were 
randomly selected for this study. However, if a player played ≥70% of his matches in both the 
2011 and 2012 tournaments, the 2012 data were used. The HÖ-questionnaire data were 
disregarded when randomly selecting players for this study, because no association was found 
between the HÖ-score and genotype in the rugby group analysed in Chapter 2. The 
characteristics of the three groups of players (PER35/5, PER34/5 and PER34/4) are presented in Table 
3.1. 
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3.2.3 Study design  
In this retrospective observational study, individual quality of play and involvement of players 
grouped by PER3 VNTR genotype was compared when players travelled east-to-west (E-W), west-
to-east (W-E) and when there was no time zone difference (NTZD) between match venues. Given 
the nature of a team game like rugby and the differences in play between positions (i.e. lock vs 
full back), it was not possible to directly measure and compare involvement or play quality of 
players to each other in each match. Using post-match video analysis, the extent to which an 
individual was involved in a match was determined, and a “game activity (GA) rate” score was 
calculated. Change in GA rate score for the W-E travel or E-W travel was calculated as the 
difference in GA rate for the match after trans-meridian travel and the last match played in the 
NTZD environment. Change in GA rate score between matches when no time zones were crossed 
was calculated as the difference between GA rate score of the latest match minus that of the 
previous match.  
 
All Super Rugby matches in which South African teams played during the 2011 and 2012 
competitions were recorded digitally, edited to remove adverts and half time commentary, and 
stored on the Human Biology server at the University of Cape Town. The Human Research Ethics 
Committee of the Faculty of Health Sciences at the University of Cape Town approved this study 
(HREC Ref No: 008/2011). Prior to commencement of both the 2011 and 2012 Super Rugby 
tournaments, all participants gave written informed consent agreeing to participate in this study 
(Appendix 1B, Chapter 2). The study was performed in accordance with the principles of the 
Declaration of Helsinki (Fortaleza, Brazil, 2013), the International Conference on Harmonisation 
and South African Good Clinical Practice guidelines. 
 
3.2.4 Detailed testing procedures 
3.2.4.1 PER3 VNTR genotype and descriptive characteristics of players 
The genotype and other descriptive data presented in this chapter were obtained as described 
in section 2.2.3 of Chapter 2.  
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3.2.4.2 Super Rugby tournament statistics, travel and match schedules 
Collectively, all five SA teams played 59 games in SA (i.e. no time zone difference) during weeks 
1-12 of the 2011 and 2012 tournaments. They then travelled to AUS and NZ for five weeks to play 
a further four matches each (i.e. 40 matches for all five SA teams in the 2011 and 2012 
tournaments). Then teams travelled back to SA for a further 1-10 weeks of play (63 matches), 
depending on progression through the tournament. Furthermore, two SA teams travelled back 
to AUS/NZ during the knockout stages of the tournament in three different weeks to play three 
more games.  
 
Match outcome data were obtained from the South African Rugby Union (SARU) official website 
(www.sarugby.net). In addition, each SA team provided their travel itinerary schedule for the 
whole tournament each year, so that precise departure and arrival dates and times for both local 
and international travel could be used for analysis. A combination of information from the travel 
itinerary schedules and SARU website allowed the construction of a table with match outcomes 
for matches played at home and away as well as following E-W or W-E travel. 
 
Matches were grouped into those played after crossing 6-8 time zones, >10 time zones and when 
no time zone crosses took place. Specifically, matches played after crossing 6-8 time zones were 
combined to boost the sample size. Matches played after crossing two time zones were not 
considered in these analyses. A match was defined as being preceded by “W-E travel” if a team 
travelled in an easterly direction and played within a number of days after arrival that would not 
have allowed complete re-entrainment. To calculate this, the concept that for every time zone 
crossed a player needs approximately a day to resynchronise to the new time-zone environment 
was employed (Manfredini et al., 1998, Waterhouse and Reilly, 2009). For example, if a team 
travelled from SA to Perth, AUS crossing six time zones and played within six days of arrival, the 
match was defined as being preceded by W-E travel. The same concept was used to categorise 
“E-W travel” when teams travelled in the opposite direction. Matches were categorised as being 
preceded by “no time zone change (NTZD)” when (i) it was a home game for the player of interest 
    
79 
 
not preceded by E-W or W-E travel, or (ii) the match took place after “domestic” travel (i.e. travel 
between cities within SA, AUS or NZ during which no time zones were crossed). 
 
3.2.4.3 Player game activity rate and quality of play determination 
A total of 166 matches were analysed for both the 2011 and 2012 Super Rugby tournaments. 
During these matches, the 60 players of interest in this study played an average of 15 games each 
during the tournament period. The GA rate score for each player in each match was determined 
objectively using post-play video coding analysis with specifically designed sports coding software 
(SportsCode Elite, version 8, Sportstec, England). The video data were used retrospectively to 
analyse the game statistics for each of the 60 players in each match throughout the two 
tournaments, from which GA rate was calculated and used as the outcome of interest. The GA 
rate score is thought to be a reasonable marker of an individual’s involvement during a particular 
match (Hughes and Bartlett, 2002, Ortega et al., 2009). The first step for GA rate analysis in this 
study was to identify and measure a range of ‘Key Performance Indicators (KPIs)’, that have a real 
bearing on the outcome of a game, for each player during each match (Glazier, 2010, Hughes and 
Bartlett, 2002). A performance indicator is an action variable or selection of action variables that 
defines an aspect of an individual’s involvement during a match. The methods to define KPIs of 
play in rugby have been described previously (James et al., 2005). Play instances were labelled 
using the standard KPIs that were divided into five possible play scenarios: tackles, lineouts, 
handling, breakdowns, and infringements (as defined by World Rugby).  
 
Thus, using this method, a GA score was calculated for each player for each match he played 
throughout the tournament. This score reflected the number of events counted for each KPI for 
the player for that particular game. This score was then converted to a GA rate by dividing it by 
the number of minutes that the player was on the field for during a particular match 
(events/min). Finally, each player’s GA rate was normalised to his first match of the tournament. 
This approach was necessary to account for differences in GA levels that could arise due to an 
individual’s playing position. Changes in the GA rate of each player were then correlated with 
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aspects of trans-meridian travel, such as number of time zones crossed, and direction of travel 
as the tournament progressed. 
 
A player’s quality of a play in a given match was calculated by summing all scored KPIs (with those 
considered to be a positive quality of play being preceded by a + sign and negative aspects of play 
were allocated a score of zero), and expressing this number as a percentage of the total KPIs 
counted for that player in that match. For example, a good pass, a poor pass and a broken tackle, 
would add up to three events (say Score A). The quality of those events (say Score B) was 
calculated as good pass (+1), poor pass (0) and broken tackle (+1), which is 2. Thus, the overall 
quality of play was obtained by dividing Score B by Score A and multiplying by one hundred (Score 
B/Score A X 100) to obtain a percentage quality of play score, which in the example above (2/3 X 
100) would be 67%. 
 
3.2.5 Data and statistical analyses  
Descriptive data are reported as mean ± standard deviation (SD, for normally distributed data) 
or median with interquartile range (IR, when data are not normally distributed), counts or 
frequency (%). A Shapiro-Wilks test was used to test for normality of the data. Chi-squared or 
Fisher’s exact tests were used to determine differences between counts. Three group 
comparisons were made with one-way ANOVA or Kruskall-Wallis ANOVA tests. Repeated 
variables were assessed using either dependent t-tests, Wilcoxon matched pair’s tests, ANOVA 
with repeated measures or Friedman’s ANOVA tests. Post-hoc analyses were performed using 
Tukey, Fishers LSD or Dunnett multiple comparison tests. Data were analysed in Statistica 
(version 11, StatSoft Inc., Tulsa, Oklahoma, USA) and Stata (version 14, StataCorp, Texas, USA). 
Significance was assumed for p<0.05. 
 
3.3 Results  
3.3.1 Participant characteristics  
Participant characteristics of the Super Rugby players for this study are presented in Table 3.1. 
There were no significant differences between the three genotypes for any of the variables.  
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Table 3.1: General characteristics of the three PER3 VNTR groups of rugby players. 
 PER34/4 (n=20) PER34/5 (n=20) PER35/5 (n=20) p-value 
Age (y) 25.4±3.1 26.4±2.9 25.7±2.9 0.489 
Weight (kg) 100.1±11.7 105.8±10.0 103.8±10.1 0.459 
Height (cm) 187.3±6.6 188.0±7.6 187.0±5.4 0.950 
BMI (kg·m-2) 29.2±2.8 30.0±2.5 29.8±3.2 0.321 
The data are presented as the mean ± standard deviation. BMI: Body mass index. The p-value represents 
significance as determined by a one-way ANOVA test. 
 
3.3.2 Tournament related data 
Match outcomes for the 2011 and 2012 tournaments, as well as those for both tournaments 
combined, without taking into account home ground advantage, are presented in Table 3.2. The 
data represent that of all five SA teams combined. There were no significant differences in the 
number of matches won or lost in the 2011 or 2012 Super Rugby tournaments when analysed 
independently. Similarly, there were no significant differences in the number of matches won or 
lost in the combined 2011 and 2012 Super Rugby tournaments.  
 
Table 3.2: Success of South African teams in the 2011 and 2012 Super Rugby tournaments . 
Tournament Won Lost p-value 
2011 41 (50.6) 40 (49.4) 0.652 
2012 45 (52.3) 41 (47.7) 0.792 
Both 86 (51.5) 81 (48.5) 0.378 
Data are presented as counts, with the percentages in parentheses. Significance was determined using a 
Chi-squared test. 
 
3.3.2.1 Match outcomes: Effect of home ground advantage  
Match outcomes for the 2011 and 2012 tournaments, as well as those for both tournaments 
combined, taking into account home ground advantage, are presented in Table 3.3. The data 
represent that of all five SA teams combined. No significant differences were observed in the 
number of matches won compared to matches lost by SA teams either when playing at home or 
when playing away in the 2011 and 2012 tournaments, or when data for both tournaments were 
combined (Table 3.3).  
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Similarly, the ratio of matches won: lost was similar for home vs away matches during the 2011 
tournament. In contrast, significantly more matches were won compared to matches lost in the 
2012 tournament for home versus away matches. Specifically, more matches were won when 
playing at home (p=0.018) compared to matches played away. However, the ratio of matches 
won: lost was similar for home versus away matches when the data for the 2011 and 2012 
tournaments were combined.  
 
Table 3.3: Effect of SA teams’ home ground advantage in the 2011 and 2012 Super Rugby 
tournaments. 
 Location Won  Lost  p1-value  p2-value 
2011 Home 17 (47.2) 19 (52.8) 0.542 0.584 
Away 24 (53.3) 21 (46.7) 0.674 
2012 Home 28 (65.1) 15 (34.9) 0.133 0.018 
Away 17 (39.5) 26 (60.5) 0.349 
Both Home 45 (57.0) 34 (43.0) 0.476 0.181 
Away 41 (46.6) 47 (53.4) 0.562 
Data are presented as counts, with the percentages in parentheses. p1: significance between matches won 
or lost when either playing at home alone or away alone, p2: significance for matches won or lost between 
home and away. Significance was determined using a Chi-squared test. 
 
3.3.2.2 Match outcomes: Effect of prior trans-meridian travel 
Match outcomes of the 2011 and 2012 tournaments taking into account pre-match trans-
meridian travel are presented in Table 3.4. The data represent that of all five SA teams combined. 
There were no significant differences in the number of matches won compared to matches lost 
by the SA teams following W-E travel, E-W travel or NTZD, in the 2011 tournament alone. 
Similarly, no significant differences were observed in the number of matches won compared to 
matches lost by the SA teams in the 2012 tournament, or when data for both tournaments were 
combined.  
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Table 3.4: Match outcomes of all SA teams during the 2011 and 2012 Super rugby tournaments 
- the effect of prior trans-meridian travel. 
 W-E (n=19) E-W (n=18) NTZD (n=126) p-value 
 Won Lost Won Lost Won Lost 
2011 5 (62.5) 3 (37.5) 1 (33.3) 2 (66.7) 14 (50.0) 14 (50.0) 0.875 
2012 3 (27.3) 8 (72.7) 3 (60.0) 2 (40.0) 12 (41.4) 17 (58.6) 0.284 
Both  8 (42.1) 11 (57.9) 4 (50.0) 4 (50.0) 26 (45.6) 31 (54.4) 0.937 
Data are presented as counts with the percentages in parentheses. W-E: west-to-east travel, E-W: east-
to-west travel, NTZD: no time zone difference. Significance was determined using a Fisher’s exact test. 
 
3.3.3. Game activity rate  
3.3.3.1 PER3 genotype and change in game activity (GA) rate with tournament progression 
All GA rate data presented in this section represents the 2011 and 2012 tournaments combined. 
Figure 3.1 illustrates how GA rate changes with tournament progression. There was a significant 
change in GA rate over time during the combined 2011 and 2012 Super Rugby tournaments 
(Figure 3.1A). However, no significant differences were noted in the GA rate between the PER35/5 
and PER34/4 VNTR groups as the tournament progressed (Figure 3.1B). Similarly, no significant 
differences were observed between the three PER3 VNTR groups (Figure 3.1C).  
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Figure 3.1: Change in player game activity rate with tournament progression . (A) All players 
(n=60), (B) PER35/5 (n=20) and PER34/4 (n=20) players and (C) all three genotype groups, PER34/4 
(n=20), PER34/5 (n=20) and PER35/5 (n=20). Data are presented as mean ± SD. 4/4: PER34/4, 4/5: 
PER34/5 and 5/5: PER35/5. Significance was determined using Friedman’s ANOVA test (A), an 
independent t-test (B) and one-way ANOVA test (C) to compare each group’s area under the 
curve (AUC) values. 
 
3.3.3.2 Direction of travel and change in player game activity rate  
Changes in player GA rates grouped by direction of travel prior to the match are presented in 
Figure 3. 2. There were no significant differences between the three groups.  
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Figure 3.2: Change in game activity rate in players grouped by direction of travel prior to the match. 
Data are presented as median with IR and individual data points are plotted. NTZD: No time zone 
difference, E-W: Westward travel, W-E: Eastward travel. Significance was determined using Friedman’s 
ANOVA test. 
 
3.3.3.3 Number of time zones crossed and change in player game activity rate 
Figure 3.3 shows change in GA rate in players grouped by number of time zones crossed (i.e. 
NTZD, 6-8 TZD and >10 TZD) immediately preceding a match. There were no significant 
differences between the three groups. 
 
    
86 
 








N u m b e r o f  t im e  z o n e s  c ro s s e d























(n = 6 0 ) (n = 5 0 ) (n = 5 8 )
 
Figure 3.3: Change in game activity rate in players grouped by number of time zones crossed 
prior to a match. Data are presented as median with IR and individual data points are plotted. 
NTZD: No time zone difference, 6-8 TZD: Between six and eight time zone difference, >10 TZD: 
More than ten time zone difference. Significance was determined using Friedman’s ANOVA test. 
 
3.3.3.4 Direction of travel, number of time zones crossed and change in player GA rate 
Change in GA rate grouped by direction of travel and number of time zones crossed prior to a 
match are presented in Figure 3.4. There were no significant differences between the two 
directions of travel (i.e. eastward or westward) when data from the 6-8 TZD and >10 TZD were 
combined for analysis (Figure 3.4A). Furthermore, no significant differences were noted between 
the two directions of travel following either 6-8 TZD (Figure 3.4B) or >10 TZD (Figure 3.4C) travel. 
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Figure 3.4: Change in player game activity rate grouped by direction of travel immediately 
prior to a match taking into account number of time zones crossed . Data are presented as 
median with IR and individual data points are plotted. (A) 6-8 and >10 TZD (time zone 
differences) combined, E-W (Westward travel): n=57, W-E (Eastward travel): n=52; (B) 6-8 TZD, 
E-W: n=24, W-E: n=35; (C) >10 TZD, E-W: n=39, W-E: n=39. Significance was determined using a 
Wilcoxon matched pairs test. 
 
3.3.3.5 PER3 VNTR genotype, direction of travel and player game activity rate  
Change in player GA rate scores from one match to the next grouped by PER3 VNTR genotype 
taking into account direction of travel are presented in Figure 3.5. There were no significant 
differences in the three genotype groups when the E-W or W-E travel data were combined for 
analysis (Figure 3.5A). Likewise, no significant differences were noted between the three 
genotype groups following either E-W or W-E travel (Figure 3.5B and Figure 3.5C, respectively).  
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Figure 3.5: Change in game activity rate in players grouped by PER3 VNTR genotype taking 
into account direction of travel prior to the match. Data are presented as median with IR and 
individual data points are plotted. (A) E-W travel and W-E travel combined: (PER35/5: n=20, 
PER34/5: n=20 and PER34/4: n=20); (B) E-W travel: (PER35/5: n=18, PER34/5: n=19 and PER34/4: 
n=20); (C) W-E travel: (PER35/5: n=15, PER34/5: n=17 and PER34/4: n=20). Significance was 
determined using the Kruskal-Wallis ANOVA test. 
 
3.3.3.6 PER3 VNTR genotype, number of time zones crossed and change in player GA rate. 
Change in player GA rates from one match to the next grouped by PER3 VNTR genotype following 
either NTZD, 6-8 TZD or >10 TZD travel are presented in Figure 3.6. There were no significant 
differences between the three PER3 VNTR groups when the groups were combined for analyses 
(Figure 3.6A). Furthermore, no significant differences were noted between the three genotype 
groups after either travel across 6-8 TZD or >10 TZD travel (Figure 3.6B and Figure 3.6C, 
respectively). 
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Figure 3.6: Change in game activity rate in players grouped by PER3 VNTR genotype taking 
into account number of time zones crossed prior to the match. Data are presented as median 
with IR (A, C) or mean ± SD (B) and individual data points are plotted. (A) 6-8 and >10 time zone 
differences (TZD) combined: (PER35/5: n=20, PER34/5: n=20 and PER34/4: n=20); (B) 6-8 TZD: 
(PER35/5: n=17, PER34/5: n=18 and PER34/4: n=15); (C) >10 TZD: (PER35/5: n=18, PER34/5: n=20 and 
PER34/4: n=20). Significance was determined using one-way ANOVA and Kruskal-Wallis ANOVA 
tests.  
 
3.3.3.7 PER3 VNTR genotype, direction of travel, number of time zones crossed and change in 
player GA rate  
Change in GA rate from one match to the next in players grouped by PER3 VNTR genotype taking 
into account both direction of travel and number of time zones crossed is presented in Figure 
3.7. There were no significant differences between the three PER3 VNTR groups after 6-8 TZD 
travel in either westward or eastward travel (Figure 3.7A, Figure 3.7B). Furthermore, no 
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significant differences were noted between the three PER3 VNTR groups for >10 TZD travel after 
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Figure 3.7: Change in game activity rate in players grouped by PER3 VNTR genotype taking 
into account direction of travel and number of time zones crossed prior to the match. Data 
are presented as mean ± SD (C, D), median with IR (A, B) and individual data points are plotted. 
6-8 TZD in (A) E-W travel: (PER35/5: n=8, PER34/5: n=7 and PER34/4: n=8) and (B) W-E travel: 
(PER35/5: n=13, PER34/5: n=13  and PER34/4: n=9); (C) More than ten time zone differences, E-W 
travel: (PER35/5: n=13, PER34/5: n=13  and PER34/4: n=13) and (D) W-E travel: (PER35/5: n=8, 
PER34/5: n=14  and PER34/4: n=17). Significance was determined using one-way ANOVA and 
Kruskal-Wallis ANOVA tests. 
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3.3.4 Quality of play data  
3.3.4.1 PER3 VNTR genotype and quality of play 
All quality of play data presented in this section represents the 2011 and 2012 tournaments 
combined. Quality of play data in the three PER3 VNTR groups of players regardless of direction 
of travel or number of time zones crossed are presented in Figure 3.8. There were no significant 
differences in the quality of play between the three PER3 VNTR groups. 
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Figure 3.8: Quality of play in players grouped by PER3 VNTR genotype. Data are presented as 
median with IR. Significance was determined using the Kruskal-Wallis ANOVA test. 
 
3.3.4.2 Direction of travel and quality of play  
Quality of play data in players grouped by direction of travel between matches preceded by either 
no time zone travel, eastward or westward travel are presented in Figure 3.9. Quality of play was 
significantly different between the three directions of travel (p=0.020). Post-hoc analysis 
indicated a lower quality of play following eastward travel compared to no time zone travel 
(p=0.024).  
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Figure 3.9: Player quality of play following either NTZD, E-W travel or W-E travel during the 
combined 2011 and 2012 Super Rugby tournaments . Data are presented as median with IR and 
individual data points are plotted. NTZD: No time zone difference, E-W: Westward travel, W-E: 
Eastward travel. Lines above the graph represent significant differences between groups at 
either end of the line. Significance was determined using Friedman’s ANOVA test.  
 
3.3.4.3 Number of time zones crossed and quality of play  
Quality of play data in players grouped by number of time zones crossed prior to a match are 
presented in Figure 3.10. There were significant differences in the quality of play between the 
three groups (p=0.033). Post-hoc analysis indicated that quality of play was higher in the NTZD 
environment compared to >10 TZD travel (p=0.043). 
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Figure 3.10: Quality of play in players grouped by the number of time zones crossed prior to 
the match. Data are presented as median with IR and individual data points are plotted. NTZD: 
No time zone difference, 6-8 TZD: Between six and eight time zone difference, >10 TZD: More 
than ten time zone difference. Lines above the graph represent significant differences between 
groups at either end of the line. Significance was determined using Friedman’s ANOVA test. 
 
3.3.4.4 Number of time zones crossed, direction of travel and quality of play 
Quality of play data in players grouped by direction of travel taking into account number of time 
zones crossed prior to the match are presented in Figure 3.11. Quality of play was higher when 
players travelled west over more than six time zones compared to when they travelled east 
across the same number of time zones (p=0.031, Figure 3.11A). When analysed separately, there 
were no significant differences between E-W and W-E travel when only 6-8 time zones were 
crossed prior to the match (Figure 3.11B). However, when the players crossed >10 time zones 
quality of play was higher following E-W travel compared to W-E travel (p=0.040, Figure 3.11C).  










































































Figure 3.11: Quality of play in players grouped by direction of travel taking into account 
number of time zones crossed prior to the match. Data are presented as median with IR, and 
individual data points are plotted. (A) E-W travel: n=58, W-E travel: n=55; (B) E-W travel: n=40, 
W-E travel: n=26; (C) E-W travel: n=44, W-E travel: n=40. Significance was determined using a 
Wilcoxon matched pairs test. 
 
3.3.4.5 PER3 VNTR genotype, direction of travel and quality of play 
Quality of play data in players grouped by PER3 VNTR genotype taking into account direction of 
travel prior to the match are presented in Figure 3.12. Quality of play was significantly different 
between the three PER3 VNTR groups when E-W and W-E travel were combined for analysis 
(p=0.035, Figure 3.12A). Post-hoc analysis indicated that quality of play was higher in the PER35/5 
group compared to the PER34/4 group (p=0.033). However, no significant differences were noted 
following E-W travel (Figure 3.12B) and W-E travel (Figure 3.12C), respectively.  
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Figure 3.12: Quality of play in players grouped by PER3 VNTR genotype taking into account 
direction of travel prior to the match. Data are presented as mean ± SD (A) and median with 
IR (B, C), and individual data points are plotted. (A) E-W and W-E travel combined: (PER35/5: 
n=20, PER34/5: n=20 and PER34/4: n=20); (B) E-W travel: (PER35/5: n=19, PER34/5: n=19 and 
PER34/4: n=20) and (C) W-E travel: (PER35/5: n=17, PER34/5: n=20 and PER34/4: n=18). Lines above 
the graph represent significant differences between groups at either end of the line. 
Significance was determined using one-way ANOVA and Kruskal-Wallis ANOVA tests. 
 
3.3.4.6 PER3 VNTR genotype, number of time zones crossed and quality of play 
Quality of play data grouped by PER3 VNTR genotype taking into account number of time zones 
crossed prior to the match are presented in Figure 3.13. There were no significant differences in 
the three PER3 VNTR groups when data were combined for analysis (Figure 3.13A). While there 
were no significant differences in the quality of play between the three genotype groups for 6-8 
TZs crossed (Figure 3.13B), significant differences were noted for >10 TZs crossed (p=0.039, 
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Figure 3.13C). Post-hoc analysis indicated a higher quality of play in the PER35/5 (p=0.030) and 
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Figure 3.13: Quality of play in players grouped by PER3 VNTR genotype taking into account 
number of time zones crossed prior to the match. Data are presented as mean ± SD (A, C), 
median with IR (B) and individual data points plotted. (A) 6-8 and >10 time zone differences 
(TZD) combined: (PER35/5: n=18, PER34/5: n=20 and PER34/4: n=20); (B) 6-8 TZD: (PER35/5: n=17, 
PER34/5: n=19 and PER34/4: n=18); (C) >10 TZD: (PER35/5: n=18, PER34/5: n=20 and PER34/4: n=20). 
Lines above the graph represent significant differences between groups at either end of the 
line. Significance was determined using one-way ANOVA and Kruskal-Wallis ANOVA tests. 
 
3.3.4.7 PER3 genotype, number of time zones crossed, direction of travel and quality of play  
Quality of play data in players grouped by PER3 VNTR genotype taking into account both direction 
of travel and number of time zones crossed prior to the match are presented in Figure 3.14. There 
were no significant differences between the three genotype groups when players crossed 6-8 
time zones and direction of travel prior to the match was taken into account (Figure 3.14A and 
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Figure 3.14B). However, there were significant differences between the three groups after E-W 
travel across more than ten time zones (p=0.047, Figure 3.14C). Post-hoc test indicated a higher 
quality of play in the PER35/5 (p=0.026) and PER34/5 (p=0.041) groups compared to the PER34/4 
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Figure 3.14: Quality of play in players grouped by PER3 VNTR genotype taking into account direction 
of travel and number of time zones crossed prior to the match. Data are presented as median with IR 
and individual data points are plotted. (A) 6-8 time zone differences (TZD), E-W travel: (PER35/5: n=9, 
PER34/5: n=9 and PER34/4: n=8); (B) W-E travel: (PER35/5: n=14, PER34/5: n=14 and PER34/4: n=12); (C) >10 
TZD, E-W travel: (PER35/5: n=15, PER34/5: n=14 and PER34/4: n=14); (D) W-E travel: (PER35/5: n=7, PER34/5: 
n=15 and PER34/4: n=17). Lines above the graph represent significant differences between groups at 
either end of the line. Significance was determined using a Kruskal-Wallis ANOVA test.  




The purpose of the present study was to determine whether PER3 VNTR genotype moderates 
the effects of trans-meridian travel on player game involvement and quality of play in Super 
Rugby players. Specifically, the change in game activity (GA- a marker of involvement) rate and 
quality of play in players grouped by PER3 VNTR genotype taking into account direction of travel 
and number of time zones crossed prior to a match were investigated. The extent to which 
players were involved in a game did not change when grouped by number of time zones crossed 
or direction of travel. This could have been because physically active people were used, and GA 
rate only measures the extent of involvement/participation rather than the quality of play, which 
is more likely to be indicative of any detrimental effects of time zone travel.  
 
3.4.2 Changes in player quality of play taking into account number of time zones crossed and 
direction of travel prior to the match. 
An important finding was that irrespective of PER3 VNTR genotype quality of play was worse 
following both eastward travel and travel across >10 time zones compared to no time zone travel 
(Figure 3.9 & Figure 3.10). This indicates that the magnitude and direction of travel were 
important, with quality of play deteriorating as the number of time zones crossed increased, 
particularly in an eastward direction. Resynchronisation into the new environment was not 
measured in this study. In spite of this players were likely to have been jet-lagged, thus they may 
have suffered reductions in physical and mental capacity. It may be that jet-lag effects manifested 
themselves through a worsening quality of play. This is conceivable given that mood, cognitive 
and neuromuscular functions are understood to deteriorate significantly following sleep and 
circadian disruption (Golombek et al., 2013, Reilly et al., 2005, Waterhouse et al., 2005b, 
Davenne, 2009), similar to that which may occur following trans-meridian travel. However, 
factors other than circadian disruption and jet-lag may have changed quality of play such as 
opponent quality, playing out of position, tournament fatigue and homesickness.  
 
While sleep was not measured in this study, speculation on its role in jet-lag adaptation will be 
made. The extent to which sleep is disrupted following time zone travel differs depending on the 
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direction of travel. Specifically, sleep episodes shift to an earlier time following eastward travel 
and to a later time following westward travel. Sleep quality may deteriorate following eastward 
travel because the sleep episode is phase advanced, which makes it difficult to initiate and 
maintain sleep at night in the new environment (Waterhouse and Reilly, 2009). Perhaps team 
physicians may want to schedule travel to AUS/NZ at night so that arrival in the new time zone is 
in the afternoon (preferably after 3pm), which could make a phase advance easier making use of 
exposure to outdoor light for a few hours before nighttime approaches. This may make it easier 
for individuals to sleep, as they may be fatigued from the journey. As a result, circadian rhythms 
in grip strength (Hill et al., 1993, Reilly et al., 2001), leg power (Chapman et al., 2012), body 
temperature (Miyazaki et al., 2002), muscle strength and flexibility (Sedliak et al., 2008, Drust et 
al., 2005), sprint and anaerobic efforts (Chtourou et al., 2012, Giacomoni et al., 2006), which 
influence performance may be less compromised compared to when travel is scheduled at other 
times of the day.  
 
The above-mentioned physiological measures may however, be compromised following trans-
meridian travel because biological timing for peak performance is out of synchronisation with 
local time at destination venue. Numerous physiological measures of performance peak when 
core body temperature is at its peak, which is usually in the late afternoon to early evening (Reilly 
et al., 2007, Reilly and Down, 1992, Hill and Smith, 1991). A significant proportion of Super Rugby 
matches were played between 14h00-17h00 local time. Between 14h00-17h00 New Zealand 
local time is equivalent to 04h00-06h00 in South Africa if resynchronisation has not yet occurred, 
which corresponds to the core body temperature nadir. It is therefore possible that incomplete 
resynchronisation could have influenced quality of play by reducing aspects of performance such 
as grip strength, reaction time and flexibility, due to differences in core body temperature.  
 
Quality of play was lower for all players irrespective of PER3 VNTR genotype after eastward 
compared to westward travel, only for travel across >10 time zones (Figure 3.11), however, there 
is great inter-individual variation. This further supports the notion that eastward travel is 
deleterious to the quality of play when the magnitude of time zone travel approaches the limit 
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of entrainment (10-12 time zones). This implies that players had not synchronised to the new 
time zone following eastward travel to the extent they had when playing after westward travel. 
This is conceivable given that individuals undergoing eastward travel tend to experience worse 
symptoms of jet-lag compared to westward travel including failure to maintain sleep at night and 
poor neuromuscular performance (Sack, 2010, Reilly and Edwards, 2007, Eastman and Burgess, 
2009). Likewise, symptoms of jet-lag persist for longer and require a lengthier time for 
synchronisation after eastward compared to westward travel (Winget et al., 1984, Lemmer et al., 
2002, Meir, 2002), due to the circadian clock’s inability to quickly adjust by phase advance. 
 
Findings in this study support that direction of travel and magnitude of time zone travel influence 
quality of play in the Super Rugby tournament. This poses a challenge to teams in the Super Rugby 
tournament who may not always have enough time to resynchronise into the new environment 
before match kick-off. It would have been ideal to analyse GA rate and quality of play data 
following W-E travel or E-W travel taking into account whether a team travelled to play a home 
or away match. However, this was not possible as there were no home matches for SA teams 
following W-E travel. Likewise, the grouping by W-E travel or E-W travel taking into account home 
or away matches would have reduced the sample size in each group. This would have 
subsequently made it difficult to interpret the findings due to small sample sizes potentially 
reducing the statistical power and leading to a type 1 statistical error.  
 
3.4.3 Changes in quality of play in players grouped by genotype taking into account number 
of time zones crossed and direction of travel. 
The three genotype groups had similar quality of play irrespective of direction of travel or number 
of time zones crossed (Figure 3.8), indicating that there were no starting differences in quality of 
play. However, differences in play quality were evident in the three genotypes following W-E 
travel or E-W travel (Figure 3.12A) regardless of number of time zones crossed, with quality of 
play lower in the PER34/4 group compared to the PER35/5 group. In particular, PER35/5 individuals 
have been reported to have better cognitive throughput (measured using a digit substitution 
test) and subjective sleepiness responses compared to the other two PER3 genotypes, across five 
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nights during a partial sleep deprivation study (Goel et al., 2009). This may indicate that PER35/5 
individuals are less vulnerable to jet-lag and thus quality of play was not as badly affected in this 
group.  
 
While quality of play was not different between the three genotype groups after W-E or E-W 
travel when fewer than six time zones were crossed, it was different between the three genotype 
groups when more than ten time zones were crossed. Specifically, the PER34/4 group had a lower 
quality of play compared to the PER34/5 and PER35/5 groups when more than ten time zones were 
crossed (Figure 3.13C). Similarly, quality of play was lower in the PER34/4 group compared to the 
PER34/5 and PER35/5 groups following westward travel across more than ten time zones (Figure 
3.14C). This suggests that PER34/5 and PER35/5 groups might have found it easier to adapt to the 
new environment or it could be that the PER34/4 group may have remained jet-lagged during 
matches reducing their capacity to perform well.  
 
The exact mechanism by which PER34/5 and PER35/5 genotypes may use to adapt to the new 
environment is not known. However, it’s possible that individuals carrying a single PER3 5-repeat 
allele may be able to utilise external time cues, for example, outdoor light in the new time zone 
faster, given that the PER35/5 genotype was reported to be more sensitive to blue-light (Chellappa 
et al., 2012). Super Rugby matches were not played immediately upon arrival in the new time 
zone. As such, high quality of play in the PER34/5 and PER35/5 groups compared to the PER34/4 
group following time zone travel further suggests that carrying a single 5-repeat allele might have 
facilitated faster adaptation to the new time zone. There are however, no similar studies in 
literature with which to directly compare these findings. Therefore, further research in a 
competition environment, with larger sample sizes, across seasons and in multiple sports should 
be performed, to confirm this finding.  
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3.4.4 Match outcomes - effect of home ground advantage  
A minor finding was that home ground advantage was evident for matches in the 2012 Super 
Rugby tournament, but not in the 2011 or the combined 2011 and 2012 Super Rugby 
tournaments. In the 2012 tournament, teams won 65% of their home matches, which is similar 
to the 73% found in the tri-nations Rugby Union and the 63% in the 2010 Super 12 Rugby 
tournament (Morton, 2006). This confirms that home ground advantage exists in the Super Rugby 
tournament, which is in line with previous studies (Du Preez and Walpole, 2004, Du Preez and 
Lambert, 2007). Home ground advantage has been noted in other sports such as soccer (Pollard, 
2006), American Football (Pollard and Pollard, 2005, Watson and Krantz, 2003), baseball (Bray et 
al., 2005) and field hockey (Carre et al., 2006). One explanation for the lack of evidence for home 
ground advantage during the 2011 tournament might be that SA Super Rugby teams rested their 
key national team players. This might have been done to keep these players fresh for the Rugby 
World Cup tournament played later that year, which means that teams may not have had depth 
in their squads, thereby losing home ground advantage.  
 
3.4.5 Match outcomes - effect of prior trans-meridian travel 
Match outcomes were similar for matches played after eastward or westward travel and matches 
played after no time zone travel. This suggests that although players may have been at a 
disadvantage when undergoing eastward or westward travel due to the effects of jet-lag, match 
outcomes were not affected by eastward or westward travel. This result is in line with previous 
studies which reported that direction of travel accounted for less than 1% of the variance in 
match outcomes (Du Preez and Lambert, 2007, Goumas, 2014, Nevill et al., 1996). Some studies 
have however demonstrated a direction of travel effect on match outcomes, although these 
findings are contrasting (Jehue et al., 1993, Smith et al., 1997, Steenland and Deddens, 1997, 
Nutting, 2010, Winter et al., 2007, Nichols, 2012). Nichols (2012) for example, found that West 
Coast teams won 17% of their games after travelling to the East Coast, while East Coast teams 
won 53% of their matches after travelling to the West Coast during the 2008 NFL tournament. In 
contrast, Smith et al. (1997) reported that travelling westward is worse than travelling eastwards 
for NFL athletes. The variances in these findings are likely due to match kick off times. For 
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example, studies which indicated a lower percentage of matches won following westward travel, 
was typically matches which took place at night, and thus close to the visiting team’s home bed-
time.  
 
Those studies, which reported lower percentages of matches won after eastward travel, were 
matches played in the early afternoon, which is the visiting team’s home morning time. While 
these studies demonstrated a direction of travel effect, data from this study exhibit no 
measurable effect of eastward or westward travel in comparison to no time zone travel in terms 
of match outcomes. In a very long tournament such as the Super Rugby competition, extrinsic 
factors may have masked any effect of direction of travel on match outcome. These may include 
unequal number of matches played in a given travel direction, changes in squad size composition 
due to injury, stage of tournament (e.g. knock-out or round robin) and strength of opposition. 
Other factors that may influence a team performance on a particular day include tactical 
strategies of play, weather conditions (e.g. humidity and temperature), jet-lag, motivation, will 
to win, pressures from family, friends and media as well as an individual’s personality, just to 
mention a few. 
 
3.4.6 Limitations and future studies 
A limitation of this study was that situational (e.g. opponents, weather conditions) or behavioural 
variables (e.g. mood, anxiety, arousal level) were not taken into account when analysing GA rate 
and quality of play data. These are difficult to account for since they are constantly changing, 
however, it will be interesting if a future study could consider this. Likewise, the strength of the 
opposition and position on the combined Super Rugby log was not taken into account. This would 
have provided a full account of the opponents as this is one of the factors that influence GA. 
Players in this study did not play in all matches following trans-meridian travel. This limited the 
sample sizes when GA rate and quality of play data were explored by number of time zones 
crossed or direction of travel. 
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The effect of the PER3 VNTR genotype on trans-meridian travel and performance was indirectly 
determined. Perhaps in future a study with greater temporal resolution or planned times of 
sampling for example, 24h, 48h and 72h post travel or over the course of the new day in the new 




An individual’s PER3 VNTR genotype may explain some of the differences in quality of play in 
Super Rugby players after eastward and westward travel. The quality of play was lower in the 
PER34/4 group compared to the PER34/5 and PER35/5 groups following W-E travel or E-W travel, 
especially when the magnitude of travel was more than ten time zone crosse, suggesting that the 
PER3 genotype may have had an impact on quality of play. It also suggests that the PER3 VNTR 
genotype may play a role in entrainment through differential susceptibility to jet-lag effects. 
Perhaps the PER3 genotype may mediate changes in the quality of play, which varied between 
the three genotypes through differential ability to resynchronise into the new environment. 
However, clock genes other than PER3 or non-clock genes may confer susceptibility or create 
tolerance to the effects of jet-lag, subsequently influencing game activity rate.  
 
The quality of play was worse after eastward compared to westward travel, suggesting that 
players had not synchronised to the new time zone after eastward travel to the same extent they 
had following westward travel. This implies that the magnitude and direction of travel are both 
important and should be considered when preparing for matches in the Super Rugby 
tournament. It is possible that implementing appropriate jet-lag alleviation strategies, such as 
timed exposure to light (Vosko et al., 2010, Fowler et al., 2015b), and use of external melatonin 
(Paul et al., 2011, Edwards et al., 2000) to contain the effects of jet-lag may enhance performance 
following time zone travel. This is the first study to investigate the PER3 VNTR genotype with 
respect to adaptation to new time zones in a team sport of this magnitude and its effects on 
performance. Further research with larger sample sizes (especially during periods of international 
travel), ideally over multiple seasons and in other sports is warranted to confirm these findings.  
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CHAPTER 4: A COMPARISON OF THE EFFECT OF TRANS-MERIDIAN TRAVEL ON 
THE INCIDENCE OF ILLNESS AND INJURY IN SOUTH AFRICAN SUPER RUGBY 
PLAYERS GENOTYPED AS PER34/4, PER34/5 AND PER35/5. 
 
4.1 Introduction  
Trans-meridian travel is a challenge for athletes since it results in circadian disruption imparting 
a physical and emotional burden in the form of jet-lag. Therefore, team physicians try to ensure 
that such travel occurs with minimal disruption to health. As part of protecting an athlete’s 
health, prevention of illnesses and injuries are key mandates for World Rugby. Appreciation of 
the significance of illness and injury surveillance studies is growing, with many governing bodies 
such as the International Association of Athletics Fédération and the Fédération Internationale 
de Football Association also regularly carrying out illness and injury epidemiological projects 
(Dvorak et al., 2011, Fuller et al., 2013, Schwellnus et al., 2013). Understanding factors that may 
increase or decrease a player’s risk for illness or injury in the context of trans-meridian travel may 
be fundamental to team physicians for future planning during competitions such as the Super 
Rugby tournament. Specifically, knowledge from this research may provide data that will 
facilitate prevention initiatives to be properly arranged.  
 
If it is possible to reduce the number and impact of illnesses and injuries experienced by players 
undergoing trans-meridian travel, some of the harmful effects to player health, performance 
limitations and time loss to training and competition may be reduced. This in turn could affect 
player performance, not just in the rugby population, but in other sports as well. Previous studies 
have reported that trans-meridian travel across multiple time zones negatively influences the 
incidence of illnesses and injuries in athletes with athletes who travelled across ≥5 time zones 
having a greater risk of getting ill and/or injured compared to those competing domestically 
(Schwellnus et al., 2012, Fuller et al., 2015). While individuals appear to cope differently, no 
individual is immune to the physiological and cognitive effects of jet-lag (Sack, 2010, Eastman and 
Burgess, 2009). Perhaps some aspect of an individual’s circadian system might be key to 
understanding individual differences in susceptibility or tolerance to jet-lag.  
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The differences in susceptibility or tolerance to jet-lag may arise due to differences that have 
been reported in sleep pressure and cognitive performance between PER34/4 and PER35/5 
individuals following sleep deprivation (Maire et al., 2014, Viola et al., 2007). Likewise, 
differences in the extent of sleep disruption may lead to altered hormonal levels and immune 
functions between the two PER3 genotypes. The two genotype groups may also entrain to new 
light/dark cycles differently due to the differences in sensitivity to blue light suppression of 
melatonin in PER34/4 and PER35/5 genotypes (Chellappa et al., 2012a). Players genotyped as 
PER35/5 were compared to those genotyped as PER34/4 and to those heterozygous for the 4- and 
5-repeat alleles. The aim of this study, therefore, was to compare the impact of time zone travel 
during the 2012 Super Rugby competition in South African players genotyped as PER34/4, PER34/5 
and PER35/5 on the incidence of illnesses and injuries.  
 
The objectives were to:  
(1) Describe the incidence of illnesses and injuries in the three PER3 VNTR genotype groups, and 
(2) Compare these incidences taking into account direction of travel (i.e. west-to-east or east-to-
west) and the number of time zones crossed (i.e. two or less and six or more time zones). 
 
It was hypothesised that the risk of illness or injury would be higher in the PER34/4 genotype than 
the other two PER3 genotype groups following time zone travel. Furthermore, it was 
hypothesised that illness and injury incidence rates would increase as the magnitude of time zone 
travel increases, and following west-to-east travel compared east-to-west travel.  
 
4.2 Methods  
4.2.1 Participants 
Participants for this study comprised players from the five SA teams who participated in the 2012 
Super Rugby tournament. The players (n=145) descriptive characteristics are presented in Table 
4.1. 
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4.2.2 Study design 
In this observational study, the illness and injury rates of three groups of players (PER34/4, PER34/5 
and PER35/5) were compared when players travelled Westwards (E-W), Eastwards (W-E), and 
when there was no travel across time zones (NTZ) between matches. Team physicians for the five 
SA Super Rugby teams recorded illness and injury data for all players in their respective squads 
on a daily basis throughout the 2012 tournament. The tournament period included the week 
prior to the start of the first game and the day after the last match for each team. Each team 
physician collected this data using standardised daily medical illness and injury report forms, 
which were in electronic format (Appendices 4C and 4D). The team physician acquired the data 
through clinical assessment, kept the data secure and only submitted the completed report forms 
to the Division of Exercise Science and Sports Medicine, Department of Human Biology, 
University of Cape Town at the end of the tournament. There was full compliance on the return 
of completed data capture forms. Prior to commencement of the 2012 Super Rugby tournament, 
all participants gave written informed consent (Appendix 4B). The study was performed in 
accordance with the principles of the Declaration of Helsinki (Fortaleza, Brazil 2013), the 
International Conference on Harmonisation and South African Good Clinical Practice guidelines. 
Only the illnesses and injuries of individuals who gave written informed consent to participate 
were monitored (145 of 200 players). The study was approved by the University of Cape Town’s 
Faculty of Health Sciences Human Research Ethics Committee (HREC Ref No: 008/2011).  
 
4.2.3 Detailed testing procedures  
4.2.3.1 Chronotype, genotype, match and travel schedules 
Chronotype and genotype methods were described in Chapter 2, sections 2.2.3.1, 2.2.3.2 and 
2.2.3.3. Match and travel schedules are described in Chapter 3, section 3.2.4.2. 
 
4.2.3.2 Illnesses and injuries 
For the purposes of this study, a medical illness was defined as any non-trauma related symptom 
or sign presenting in an individual that required medical attention from the team physician on a 
particular day (Schwellnus et al., 2012). Likewise, a medical injury was defined as any physical 
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complaint, ensuing from the transfer of energy that exceeded the body’s ability to uphold its 
structural and/or functional integrity that was sustained by an individual during a match, training 
or gym session and required medical attention from the team physician on a particular day (Fuller 
et al., 2007b, King et al., 2006). Illnesses and injuries were defined as new (pre-existing and not 
fully rehabilitated were not logged) or recurring (individuals having resumed full participation 
after a previous condition). In cases where an illness was observed within seven days of the initial 
diagnosis it was recorded once only during the first diagnosis. Furthermore, in cases where a 
single event caused several injury types or affected various body parts, only the most severe 
diagnosis was recorded as determined by the team physicians. Severe illnesses and injuries were 
defined as illnesses or injuries requiring an estimated absence from training or competition of 
more than one week.  
 
Each team’s physician recorded the following information for illnesses experienced by an 
individual: venue, date of onset and frequency of symptom/s, description of symptom/s, 
suspected cause, final diagnosis and treatment as well as prescribed time off from training and/or 
match. Likewise, the following information was recorded for injuries: venue, date of injury, type 
of injury, mechanism of injury, final injury diagnosis, decision to continue or discontinue play, 
predicted number of days lost from training and/or matches and the severity of the injury. 
Furthermore, the stage of the match, facet of play, activity engaged in at time of injury (i.e. 
match, training, or gym) as well as the position the player was fielded were recorded.  
 
4.2.3.3 Calculation of player days  
The number of player days, necessary to determine illness incidence rates, was calculated 
separately for each of the five SA teams. While the study took place over a period of 21 weeks, 
the start and end dates of the competition were different for each team as these were dependent 
on the dates of the first and last matches played. For example, some teams commenced their 
tournament matches a few days later than other teams; and others were knocked out of the 
tournament before the quarterfinals, semi-finals or the final. Therefore, the total tournament 
days for each team and the daily squad size varied between teams. The team physician reported 
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the ‘daily squad size’ on each day, which varied from 5-18 players per team. This variation was in 
part due to squad sizes often being reduced during international travel times relative to matches 
played domestically. Moreover, since only illnesses for the individuals who gave written informed 
consent to participate was followed, some of the participating players may not have been part 
of the first team squad on a particular day. As such the total player days for each team was 
calculated as follows: total team tournament days × average daily squad size. The player days for 
all five SA teams combined were as follows: total player days for entire tournament: n=5 928; no 
time zone difference (NTZD) player days: n=4 656; Westward travel (E-W) player days: n=680; 
Eastward travel (W-E) player days: n=592; two time zone difference (2 TZD) player days: n=136 
and six or more time zone difference (>6 TZD) player days: n=1 132.  
 
4.2.3.4 Calculation of the illness incidence rate  
Illness incidence data were calculated as the number of illness events expressed per 1 000 player 
days. During the competition, illness data were logged for a total of 5 928 player days for all five 
teams combined.  
 
4.2.3.5 Calculation of exposure hours 
Exposure hours were used to determine injury incidence rate. Total exposure hours were 
calculated as follows: total number of tournament matches/training sessions (for each team) X 
length of match/training session (hours) X total number of players in the study on the pitch in 
each match/training session (for each team). The exposure hours for all five SA teams combined 
were as follows: total exposure hours for entire tournament: n=3 957; NTZD exposure hours: n=3 
082; W-E travel exposure hours: n=376; E-W travel exposure hours: n=498; 2 TZD exposure hours: 
n=142 and >6 TZD exposure hours: n=538, respectively. 
 
4.2.3.6 Calculation of the injury incidence rate 
Injury incidence data were calculated as the number of injuries per 1 000 exposure hours for each 
team for both training and match injuries. During the competition, injuries were logged for a total 
of 3 957 exposure hours for all five teams combined.  
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4.2.4 Data and statistical analyses  
Data are reported as mean ± standard deviation (SD) for parametric data and median with 
interquartile range (IR, for non-parametric data), incidence rate (per 1 000 player days for 
illnesses and per 1 000 exposure hours for injuries), counts or frequency (%). A Shapiro-Wilks test 
was performed to check for normality of the data. A one-way ANOVA and Kruskal-Wallis ANOVA 
tests were performed to compare descriptive characteristics between the three PER3 VNTR 
groups. Fisher’s exact and Chi-squared tests were used to compare frequency count differences 
between groups for both illness and injury. Post-hoc analyses were performed using a Fisher’s 
exact test. The data were analysed in Statistica version 11 (StatSoft Inc., Tulsa, Oklahoma, USA) 
and Stata MP/14, (StataCorp, Texas, USA). Significance was assumed when p<0.05.  
 
4.3 Results  
4.3.1 Participant characteristics  
Participant characteristics of the Super Rugby players for this study are presented in Table 4.1. 
There were no significant differences between the three PER3 genotype groups for any of the 
variables.  
 
Table 4.1: General characteristics of the three PER3 VNTR groups of rugby players. 
 PER34/4 (n=59) PER34/5 (n=68) PER35/5 (n=18) p-value 
Age (y) 24.6±3.6 25.2±3.2 24.5±2.7 0.547 
Weight (kg) 100.7±11.6 103.4±12.3 100.2±12.7 0.360 
Height (cm) 187.0±6.5 187.0±7.2 186±7.2 0.972 
BMI (kg·m-2) 28.7 (3.7) 29.0 (3.3) 28.4 (3.1) 0.385 
The data are presented as the mean ± SD and median with IR for BMI. BMI: Body mass index. The p-values 
represent significance as determined by a one-way ANOVA and Kruskal-Wallis (BMI) tests.  
 
4.3.2 Illness during the 2012 tournament  
A total of 124 illnesses were reported in 74 (51%) of the 145 players analysed. Of these, 119 (96%) 
were new illnesses. The overall incidence of illness was 20.9 per 1 000 player days. The illness 
incidence rate for each system is presented in Table 4.2. The respiratory and digestive systems 
were most affected by illness. 
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Table 4.2: Illness incidences for each system for all participating players during the 
tournament. 
System  n Incidence rate 
(per 1 000 player days) 
Total (%) 
Respiratory 88 15.0 (11.8-8.1) 71.0 
Digestive 25 4.2 (2.6-5.9) 20.2 
Skin  5 0.8 (0.1-1.6) 4.0 
Nervous 3 0.5 (-0.1-1.1) 2.4 
Ears and mastoid 1 0.2 (-0.2-0.5) 0.8 
All other systems  2 0.3 (-0.1-0.8) 1.6 
Data are presented as incidence rates (with 95% confidence intervals in parentheses) and percentages.  
 
Table 4.3 shows the documented cause of each illness, as diagnosed by the team doctors. 
Infections were the predominant cause of illness, which together with environmental and pre-
existing causes, accounted for nearly all reported illnesses.  
 
Table 4.3: Causes of illnesses reported in the 2012 tournament.  
Cause of illness n Incidence rate 
(per 1 000 player days) 
Total (%) 
Infection 81 13.8 (10.8-16.8) 65.4 
Environmental 32 5.4 (3.6-7.3) 25.8 
Pre-existing (e.g. asthma, allergy) 5 0.8 (0.1-1.6) 4.0 
Diarrhoea 1 0.2 (-0.2-0.5) 0.8 
Other  5 0.8 (0.1-1.6) 4.0 
Data are presented as incidence rates (with 95% confidence intervals in parentheses) and percentages.  
 
4.3.2.1 Direction of travel and illness 
Seventy-seven illnesses were recorded in players in the NTZD environment, 18 following E-W 
travel and 29 following W-E travel during the tournament. Figure 4.1 shows the illness incidence 
rates when illnesses were grouped by direction of travel immediately prior to the onset of 
symptoms. The incidence rates were significantly different between the three directions of travel 
(p<0.001). Specifically, a post-hoc analysis indicated that the illness incidence rates were higher 
following E-W (p=0.028) and W-E (p<0.001) travel compared to NTZD.  




Figure 4.1: Illness incidence rates in players grouped by direction of travel immediately prior 
to the onset of symptoms. Data are presented as incidence rates with 95% confidence intervals. 
Error bars represent the 95% confidence intervals. NTZD: No time zone difference, E-W: 
Westward travel, W-E: Eastward travel. Significance was determined using a Chi -squared test. 
Lines above the graph represent significant differences between groups at ei ther end of the 
line as determined by post-hoc analysis. 
 
4.3.2.2 Number of time zones crossed and illness 
Seventy-seven illnesses were recorded in players in the NTZD environment, 8 following travel 
across two time zones (2 TZD) and 39 following travel across six or more time zones (>6 TZD) 
during the tournament. Figure 4.2 shows the illness incidence rates in rugby players when 
illnesses were grouped by the number of time zones crossed immediately before appearance of 
symptoms. The incidence rates were significantly different between the three groups (p<0.001). 
Post-hoc analysis indicates that the incidence rates were higher following 2 TZD (p=0.004) and >6 
TZD (p<0.001) compared to NTZD.  
 




Figure 4.2: Illness incidence rates in players grouped by number of time zones crossed 
immediately prior to the onset of symptoms. Data are presented as incidence rates with 95% 
confidence intervals. Error bars represent the 95% confidence intervals. NTZD: No time zon e 
difference, 2 TZD: Two time zone difference, >6 TZD: Six or more time zone difference. 
Significance was determined using a Chi-squared test. Lines above the graph represent 
significant differences between groups at either end of the line  as determined by post-hoc 
analysis. 
 
4.3.2.3 PER3 VNTR genotype, direction of travel and illness  
Figure 4.3 shows the illness incidence rates in players grouped by PER3 VNTR genotype when 
direction of travel was taken into account. The incidence rate distributions were similar in the 
three genotype groups following NTZD, W-E and E-W travel. However, the incidence rate was 
higher in the PER35/5 (p<0.001) and PER34/5 (p=0.018) groups following W-E travel compared to 
NTZD when each PER3 VNTR group was analysed independently. Furthermore, within the PER34/5 
group the incidence rate was higher following E-W travel compared to NTZD (p=0.076).  
 




Figure 4.3: Illness incidence rates in players grouped by PER3 VNTR genotype taking into 
account direction of travel immediately prior to the onset of symptoms. Data are presented 
as incidence rates with 95% confidence intervals. Error bars represent the 95% confidence 
intervals. NTZD: No time zone difference, E-W: Westward travel, W-E: Eastward travel. PER35/5: 
NTZD: n=12, E-W: n=2, W-E: n=9; PER34/5: NTZD: n=36, E-W: n=10, W-E: n=11; PER34/4: NTZD: 
n=28, E-W: n=5, W-E: n=11. Significance was determined using a Fisher’s exact test. The p -value 
on the graph represents the direction of travel -by-PER3 VNTR group comparison. Lines above 
the graph represent significant differences between groups at either end of the line  as 
determined by post-hoc analysis. 
 
4.3.2.4 PER3 VNTR genotype, number of time zones crossed and illness 
Figure 4.4 shows the illness incidence rates in players grouped by PER3 VNTR genotype when the 
number of time zones crossed immediately before appearance of symptoms, was taken into 
account. The illness incidence rate was significantly different between the three genotype groups 
(p<0.001), with incidence rate higher in the PER34/5 group following >6 TZD compared to the 
other two groups (p=0.044). Furthermore, the illness incidence rates were higher in the PER35/5 
(p=0.016) and PER34/5 (p<0.001) groups following >6 TZD compared to the NTZD environment 
when each PER3 group was analysed independently. Likewise, the incidence rate was higher 
following 2 TZD compared to the NTZD environment in the PER34/4 group (p=0.002). 
 




Figure 4.4: Illness incidence rates in players grouped by PER3 VNTR genotype taking into 
account the number of time zones crossed immediately prior to onset of symptoms . Data are 
presented as incidence rates with 95% confidence intervals. Error bars represent the 95% 
confidence intervals. NTZD: No time zone difference, 2 TZD: Two time zone difference, >6 TZD: 
Six or more time zone difference. PER35/5: NTZD: n=12, 2 TZD: n=0, >6 TZD: n=9; PER34/5: NTZD: 
n=36, 2 TZD: n=3, >6 TZD: n=18; PER34/4: NTZD: n=28, 2 TZD: n=5, >6 TZD: n=9. Significance was 
determined using a Fisher’s exact test. The p-value on the graph represents time zone-by-PER3 
VNTR group comparison. Lines above the graph represent significant differences between 
groups at either end of the line as determined by post-hoc analyses. 
 
4.3.2.5 PER3 VNTR genotype, direction of travel, number of time zones crossed and illness 
Figure 4.5 shows the illness incidence rates in players grouped by PER3 VNTR genotype when 
both direction of travel and number of time zones crossed were taken into account. When >6 TZ 
were crossed, there was a trend for the incidence rate distributions to be different between the 
genotype groups when direction of travel was considered (p=0.052). Within group analysis 
showed significant differences in the PER35/5 group (p<0.001), with higher illness incidence rate 
following W-E travel compared to E-W (p=0.019) and NTZD (p<0.001) groups.  
 
When only 2 TZs were crossed, the incidence rate distributions between the three genotype 
groups were different (p<0.001). The incidence rates were higher following W-E travel in the 
PER34/5 group (p=0.014) and E-W travel in the PER34/4 group (p=0.014) compared to NTZD.  
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Figure 4.5: Illness incidence rates in players grouped by PER3 VNTR genotype when direction of travel 
and number of time zones crossed immediately prior to the onset of symptoms were taken into 
account. Data are presented as incidence rates with 95% confidence intervals. Error bars represent the 
95% confidence intervals. NTZD: No time zone difference, E-W: Westward travel, W-E: Eastward travel, 2 
TZD: Two time zone difference, >6 TZD: six or more time zone difference. >6 TZD panel: PER35/5: NTZD: 
n=12, E-W: n=2, W-E: n=9; PER34/5: NTZD: n=36, E-W: n=11, W-E: n=8; PER34/4: NTZD: n=12, E-W: n=2, W-
E: n=8; 2 TZD panel: PER35/5: NTZD: n=12, E-W: n=0, W-E: n=0; PER34/5: NTZD: n=36, E-W: n=0, W-E: n=3; 
PER34/4: NTZD: n=28, E-W: n=3, W-E: n=2. p0: represents significance for >6 TZD panel. p1: represents 
significance for the 2 TZD panel. Significance was determined using a Fisher’s exact test. Lines above the 
graph represent significant differences between groups at either end of the line as determined by post-
hoc analysis. 
 
4.3.3 Injuries during the 2012 tournament 
The overall injury incidence rate in South African players in the 2012 Super Rugby tournament 
was 40.1 per 1 000 exposure hours. Of the 145 players analysed, 77 (53%) players sustained 
injuries. A total of 160 injuries were recorded in the 77 players who sustained injuries. Of these 
injuries, 136 (85%) were new injuries. Of all recorded injuries, 138 (86%) happened during a 
match, 13 (8%) happened during rugby skills training, 4 (3%) occurred during weight training and 
5 (3%) occurred during various other activities. Injuries were further classified according to 
severity. During the tournament, most recorded injuries were of minimal, mild and moderate 
disturbance to match or training activities as indicated in Table 4.4. The mean time lost from a 
match or training due to an injury was three days for all injuries. Figure 4.6 shows injury incidence 
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rates expressed per injury type. Contusions, sprained ligaments, muscle ruptures and lacerations 
were the most predominant types of injuries recorded. 
 
Table 4.4: Injury severity in the 2012 Super Rugby tournament (n=160) . 
Severity of injury n Incidence rates  
(per 1 000 exposure hours) 
Total (%) 
Slight (0-1 day missed) 26 6.6 (4.0-9.1) 13.8 
Minimal (2-3 days missed) 44 11.1 (7.8-14.4) 29.7 
Mild (4-7 days missed) 37 9.4 (6.3-12.4) 23.9 
Moderate (8-28 days missed) 36 9.1 (6.1-12.1) 22.5 
Severe (>28 days missed) 16 4.0 (2.1-6.0) 10.1 
Data are presented as incidence rates (with the 95% confidence intervals in parentheses) and 
percentages. 
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Figure 4.6: Injury incidence rates expressed per injury type. Error bars represent the 95% 
confidence intervals.  
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4.3.3.1 Direction of travel and injury  
One hundred and twelve injuries were recorded for players in the NTZD environment , 
24 following E-W travel and 25 following W-E travel. Injury incidence rates in players 
grouped by direction of travel undertaken immediately before the occurrence of an injury are 
presented in Figure 4.7. There were significant differences in the incidence rates between the 
three groups (p=0.022). A post-hoc analysis indicated that the incidence rate was higher following 
W-E travel compared to NTZD (p=0.010). 
 
 
Figure 4.7: Injury incidence rates in players grouped by direction of travel immediately prior 
to sustaining an injury. Data are presented as incidence rates with 95% confidence intervals. 
Error bars represent the 95% confidence intervals. NTZD: No time zone difference, E-W: 
Westward travel, W-E: Eastward travel. Significance was determined using a Chi -squared test. 
Lines above the graph represent significant differences between groups at either end of the 
line as determined by post-hoc analyses. 
 
4.3.3.2 Number of time zones crossed and injury  
One hundred and twelve injuries were recorded for players in the NTZD environment , 
seven following travel crossing two time zones and 42 following travel crossing six or 
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more time zones. The injury incidence rates of rugby players grouped by number of time zones 
crossed immediately prior to the injury are presented in Figure 4.8. The injury incidence rates 
were different between the three time zone groups (p<0.001), with a higher incidence rate 
occurring following travel across >6 TZs compared to NTZD (p<0.001).  
 
 
Figure 4.8: Injury incidence rates in players grouped by number of time zones crossed 
immediately prior to sustaining an injury.  Data are presented as incidence rates with 95% 
confidence intervals. Error bars represent the 95% confidence intervals. NTZD: No time zone 
difference, 2 TZD: Two time zone difference, >6 TZD: Six or more time zone difference. 
Significance was determined using a Chi-squared test. Lines above the graph represent 
significant differences between groups at either end of the line  as determined by post-hoc 
analyses. 
 
4.3.3.3 PER3 VNTR genotype, direction of travel and injury  
The injury incidence rates of players grouped by PER3 VNTR genotype when direction of travel 
was taken into account are presented in Figure 4.9. The distributions of injury incidence rates 
were similar for all three groups when direction of travel immediately prior to the injury was 
considered. The incidence rates were also examined for each group independently, but no 
significant differences in the rates represented by direction of travel were found. 




Figure 4.9: Injury incidence rates in players grouped by PER3 VNTR genotype taking into 
account direction of travel immediately prior to the injury.  Data are presented as incidence 
rates with 95% confidence intervals. Error bars represent the 95% confidence intervals. NTZD: 
No time zone difference, E-W: Westward travel, W-E: Eastward travel. PER35/5: NTZD: n=22, E-
W: n=4, W-E: n=7; PER34/5: NTZD: n=53, E-W: n=8, W-E: n=10; PER34/4: NTZD: n=37, E-W: n=12, 
W-E: n=8. Significance was determined using a Fisher’s exact test.  
 
4.3.3.4 PER3 VNTR genotype, number of time zones crossed and injury 
The injury incidence rates in players grouped by PER3 VNTR genotype when the number of time 
zones crossed was taken into account are presented in Figure 4.10. Injury incidence rates differed 
significantly between the three groups (p<0.001), with higher incidence rates in the PER34/5 group 
compared to the PER35/5 (p<0.001) when there was no change in time zone, and in the PER34/4 
group compared to the PER35/5 group (p=0.013) following >6 TZD travel. Furthermore, 
independent analysis of each PER3 VNTR group showed significant differences in the incidence 
rates within the PER35/5 (p<0.001) and PER34/4 (p<0.001) groups. In the PER35/5 group, the 
incidence rate was higher following 2 TZD compared to NTZD (p=0.027). While in the PER34/4 
group, the incidence rate was higher following >6 TZD compared to NTZD (p<0.001).  
 




Figure 4.10: Injury incidence rates in players grouped by PER3 VNTR genotype taking into 
account number of time zones crossed immediately prior to the injury . Data are presented as 
incidence rates with 95% confidence intervals. Error bars represent the 95% confidence 
intervals. NTZD: No time zone difference, 2 TZD: Two time zone difference, >6 TZD: Six or more 
time zone difference. PER35/5: NTZD: n=22, 2 TZD: n=4, >6 TZD: n=7; PER34/5: NTZD: n=53, 2 TZD: 
n=3, >6 TZD: n=15; PER34/4: NTZD: n=37, 2 TZD: n=0, >6 TZD: n=20. The p-value on the graph 
represents the time zone-by-PER3 genotype group comparison. Significance was determined 
using a Fisher’s exact test.  Lines above the graph represent significant differences between 
groups at either end of the line as determined by post-hoc analyses. 
 
4.3.3.5 PER3 VNTR genotype, direction of travel, number of time zones crossed and injury  
The injury incidence rates in players clustered by PER3 VNTR genotype, number of time zones 
crossed and direction of travel are presented in Figure 4.11. When the players crossed six or more 
time zones, there were no significant differences in the incidence rates between the three PER3 
VNTR groups when direction of travel was accounted for. However, independent analysis of each 
PER3 VNTR group showed significant within group differences in the PER34/4 group, such that 
injury incidence rate was higher following E-W travel compared to the NTZD environment 
(p=0.009).  
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When the players crossed only two time zones, the incidence rates between the three groups 
were similar, when direction of travel was accounted for. However, independent analysis of each 
PER3 VNTR group showed significant within group differences in the PER35/5 group, such that 
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Figure 4.11: Injury incidence rates in players grouped by PER3 VNTR group when direction of travel and 
number of time zones crossed were taken into account. Data are presented as incidence rates with 95% 
confidence intervals. Error bars represent the 95% confidence intervals. NTZD: No time zone difference, 
E-W: Westward travel, W-E: Eastward travel, 2 TZD: Two time zone difference, >6 TZD: Six or more time 
zone difference. >6 TZD panel: PER35/5: NTZD: n=22, E-W: n=3, W-E: n=4; PER34/5: NTZD: n=53, E-W: n=8, 
W-E: n=7; PER34/4: NTZD: n=37, E-W: n=12, W-E: n=8; 2 TZD panel: PER35/5: NTZD: n=22, E-W: n=1, W-E: 
n=3; PER34/5: NTZD: n=53, E-W: n=0, W-E: n=3; PER34/4: NTZD: n=37, E-W: n=0, W-E: n=0. The p0: 
represents overall significance for >6 TZD panel. p1: represents overall significance for 2 TZD panel 
Significance was determined using a Fisher’s exact test. Lines above the graph represent significant 
differences between groups at either end of the line as determined by post-hoc analyses. 
 
4.4 Discussion  
The purpose of the present study was to compare the incidence of illnesses and injuries in rugby 
players grouped by PER3 VNTR genotype following trans-meridian travel during the 2012 Super 
Rugby competition. This study was unique in that it is the first to investigate the association 
between PER3 VNTR genotype and the incidence of illnesses and injuries in team sport athletes 
travelling during a tournament. As the sample sizes of the PER34/4 and PER34/5 groups were nearly 
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double that of the PER35/5 group, the comparison of illness or injury incidence rates between the 
three genotypes would not have been meaningful. In order to obtain the same number of 
illnesses or injuries, an individual carrying the PER35/5 genotype would have to sustain an injury 
or experience an illness at least more than once. Equally important, the calculation of 
illness/injury incidence rates rely on the number of player days or exposure hours, which do not 
factor the sample size in each group into account. Therefore, this would have affected the 
outcome of the analysis, as the sample sizes were different. 
 
4.4.1 Illness incidence rate  
The overall illness incidence rate of 20.9/1000 player days in this study is similar to the 20.7/1000 
player days reported in a 2010 Super 14 rugby study (Schwellnus et al., 2012). A sub-analysis of 
the data presented by Schwellnuss et al. (2012) indicated an illness incidence rate of 32.6/1000 
player days immediately following time zone travel. This was as twice high as the 15.4/1000 
player days value reported at baseline when there was no travel across time zones in the same 
study. This is consistent with findings from a previous study (Newman-Klee et al., 2007) who 
reported an illness incidence rate of 48.4/1000 person days in a group of adolescent and young 
adults who attended pre-clinic travel counselling and adhered to prescribed advice following time 
zone travel. This incidence rate was calculated based on the assumption that 100 person weeks 
was equivalent to 700 person days.  
 
Using the same assumption, an illness incidence rate of 8.14/1000 person days was reported in 
the four week period following time zone travel, when the individuals had adapted to the new 
environment. While the above-mentioned studies suggest an increase in the risk of illness 
following time zone travel in athletes and general population participants, caution must be 
exercised when interpreting these findings. Specifically, the definition and classification of illness, 
nature of travel and population studied in the Newman-Klee et al. (2007) study was different to 
this study and that of Schwellnus et al. (2012).  
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The distribution of these illnesses was higher in the respiratory and digestive systems, which 
concurs with findings from a larger Super Rugby study (Schwellnus et al., 2012), football studies 
(Dvorak et al., 2011, Theron et al., 2013), and winter Olympic Games studies (Mountjoy et al., 
2010, Soligard et al., 2015). In this study, one might hypothesise that changes in the circadian 
system or stresses associated with the nature of the Super Rugby competition such as repeated 
trans-meridian travel, demanding travel schedule and high training intensities as noted in other 
studies leave the respiratory and digestive systems more vulnerable to infections (Thompson et 
al., 2014, Schwellnus et al., 2012, Castanon-Cervantes et al., 2010). Repeated trans-meridian 
travel disrupts the circadian system and sleep-wake cycles, resulting in increased anxiety and a 
suppressed immune system (Nieman, 2000, Neville et al., 2005), leaving individuals susceptible 
to illnesses.  
 
The high illness incidence rate in this study may also be due to the fact that players were exposed 
to different populations, pathogens, climatic and environmental conditions (e.g. pollens and 
humidity) at overseas match venues (Schwellnus et al., 2012). This high illness rate is disturbing 
bearing in mind that to make a living rugby players rely on being healthy so that they can derive 
the best possible benefit from training sessions and optimising match performance. 
Furthermore, so that players can train effectively and are available for as many matches as 
possible during the tournament. Losing players to illness is a concern because coaches then have 
fewer players to work with, giving the coach fewer options for line-up changes. This often forces 
coaches to play players out of position, which may reduce performance and increase injury risk.  
 
4.4.2 Direction of travel, number of time zones crossed and illness 
The second finding was that regardless of direction travelled (Figure 4.1) or numbers of time 
zones crossed (Figure 4.2) illnesses were higher when travelling longhaul compared to no time 
zone travel. This suggests that it was rather time zone travel, which influenced illness incidence 
rates. This is consistent with findings which reported no direction of travel effect, but higher 
illness incidence rates in athletes who travelled across >5 time zones compared to those athletes 
competing in their domestic leagues (Schwellnus et al., 2012). This is further supported by the 
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finding that illness incidence rates for both two and six or more time zone crosses were higher 
compared to when there was no time zone travel, but similar to each other in this study. Although 
unexpected, this suggests that travelling across two time zones is no better than travelling across 
six or more time zones. If this were not the case then illness incidence rates between eastward 
and westward travel, and two and six or more time zones would be expected to be different. This 
was surprising since previous studies have reported that sleep and circadian disruption are 
directly proportional to the magnitude of time zone travel, with the degree of disruption 
increasing as the number of time zones crossed increases (Golombek et al., 2013, Carrier et al., 
1996). Likewise, sleep and circadian disruption the two factors that negatively influence immune 
function are greatly affected following eastward than westward travel (Reilly et al., 2005, Recht 
et al., 1995, Waterhouse et al., 2007). 
 
In this study, the degree of misalignment between the internal body clock and external 
environmental time was expected to be greater after travel crossing six or more time zones, and 
thus a greater degree of immune compromisation was expected. Sleep and the circadian clock 
cooperate at the systemic (SCN) and cellular (gene) levels to regulate temporal immune functions 
through neuroendocrine and sympathetic effector mechanisms (Arjona and Sarkar, 2008, Imeri 
and Opp, 2009), conferring an adaptive immune response during the day. However, circadian and 
sleep disruption that ensues following time zone travel may lead to altered hormonal levels and 
immune functions, consequently dampening circadian rhythms and conferring susceptibility to 
illnesses (McEwen, 2006, Trinder et al., 2015, Voigt et al., 2014). 
 
Circadian and sleep disruption have been reported to disrupt circadian oscillations in colonic 
motility, production of digestive enzymes, maintenance and repair of the protective barrier (Bron 
and Furness, 2009, Knutson and Boggild, 2010). For example, maximal colonic motility has been 
reported to peak during daytime, while minimal motility has been reported to occur during 
nighttime (Bechtold et al., 2010). Rhythmic expression of clock genes, modulate colonic motility 
directly and indirectly through clock-mediated transcription of genes such as, acetylcholine 
transferase and neuronal nitric oxide synthase. Therefore, disruptions to the sleep-wake cycle 
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and the body clock as a result of the misalignment between the body clock and the day-night 
cycle in the new time zone may have adverse consequences on the gastrointestinal tract and 
nutrient transport in the small intestines. Although not directly comparable, this is in line with a 
recent study which demonstrated significant irregular bowel movement in rotating shift work 
nurses compared to nurses working either nighttime or daytime shifts only (Nojkov et al., 2010). 
However, it is also possible that viruses contracted through on-board air circulatory systems, 
dehydration and close contact with other passengers during international flights may have 
contributed to the high illness incidence rate in this study (Schwellnus et al., 2012).  
 
Activation of the immune system affects clock gene expression in the SCN and peripheral tissues 
including, the 24h rhythms of hormones such as cortisol and growth hormone (Nader et al., 
2010). Gallagher et al. (2008) reported that vaccination before nocturnal sleep affects the 
immune system. Specifically, they indicated that antibody titre were significantly higher when 
inoculation with hepatitis A vaccine was performed in the morning than in the evening. This 
reflects differences in the speed with which an antigen is processed in combination with the 
function of nighttime sleep, as a time when the initiation of the adaptive immune system is 
facilitated. Furthermore, it implies that a complex relationship exists between sleep, the circadian 
and immune systems, and thus nighttime flights across time zones likely increased players’ 
susceptibility to illnesses.  
 
4.4.3 PER3 VNTR genotype, number of time zones crossed, direction of travel and illness  
The number of time zones crossed and direction of travel seemed to affect each PER3 VNTR group 
differently. Specifically, higher illness incidence rates were evident within the PER35/5 group 
following eastward travel across six or more time zones compared to no time zone travel. In 
contrast, within the PER34/5 group, higher illness incidence rates were noted following six or more 
time zone crosses, regardless of travel direction compared to when there was no time zone 
travel. This suggests that PER3 genotype may confer protection or create susceptibility to illness 
when there is significant circadian disruption. Perhaps, individuals carrying the PER3 5-repeat 
allele are more likely to get ill after time zone travel, especially following eastward travel. This is 
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plausible since circadian and sleep disruption have been reported to be greater in the PER35/5 
individuals during sleep deprivation studies (Goel et al., 2009, Chellappa et al., 2012b). 
Specifically, the PER35/5 genotype has been shown to experience higher homeostatic sleep 
pressure, slow wave sleep, and shorter sleep onset latency than the PER34/4 genotype during 
sleep deprivation studies (Viola et al., 2007, Goel et al., 2009, Mongrain and Dumont, 2007). This 
suggests that PER35/5 individuals may experience the effects of jet-lag more than PER34/4 
individuals, as a result of partial sleep loss, which may be compounded by the misalignment 
between the internal body clock and the external environment. 
 
These effects of jet-lag are more severe after eastward travel, particularly when the magnitude 
of time zone travel approaches near maximum further disrupting circadian rhythms and sleep in 
the PER3 genotypes. Implementation of appropriate jet-lag alleviation protocols may therefore 
be useful, especially within the first 72h upon arrival in the new time zone. This will likely reduce 
the degree of misalignment and sleep disruptions facilitating faster adaptation. The lack of a 
significant difference in the illness incidence rate of the PER35/5 genotype after westward travel 
should be treated with caution; and can be attributed to the broad 95% confidence intervals, 
smaller sample size and fewer player days, after westward travel across two time zones. 
Regardless, this is the first study to assess the effects of PER3 genotype on the illness incidence 
rates taking number of time zones crossed and direction of travel into account, and thus further 
research is warranted.  
 
4.4.4 Injury incidence rate  
The injury incidence rate was 40.1/1000 exposure hours, which is similar to the 45.0/1000 
exposure hours reported in a single Super 12 Rugby team (Targett, 1998) and the 38.7/1000 
exposure hours in semi-professional rugby players (Hodgson et al., 1998). However, it was higher 
than the incidence rate of 32.0/1000 exposure hours reported during the 1995 Rugby World Cup 
in South Africa (Jakoet and Noakes, 1998). It is also higher than the 8.0/1000 exposure hours in 
European professional football players (Hagglund et al., 2009), 2.4/1000 exposure hours in 
marathon runners (van Mechelen, 1992), 2.5/1000 in triathletes (Burns et al., 2003) and between 
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6.6-18.0/1000 exposures hours in squash, volleyball and wrestling (Parkkari et al., 2004). In all 
the above-mentioned studies, athletes competed in their home country or travelled without 
crossing any geographical time zones between competitions. The differences in the incidence of 
injuries between this study and others vary and range from use of different protocols, age, level 
of play to type of sport. For example, methodological differences between this study and other 
studies make it difficult to directly compare findings across different tournaments or sports. 
Furthermore, other studies report only match or training injuries (Fuller et al., 2007a, Gabbett et 
al., 2012b), while this study reports combined match and training injuries. Combining training 
and match injuries tend to lower the incidence rate compared to the incidence rate of matches 
alone.  
 
The high injury incidence rate in this study may have been due to jet-lag effects as a result of 
circadian disruption from the repeated trans-meridian travel compared to studies where athletes 
are not required to travel. The fact that more than half (53%) of the players sustained an injury 
is particularly disturbing given that 23% of players sustained a moderate injury (8-28 days missed) 
and 10% sustained a severe injury (>28 days lost). Thus, nearly one third of players missed at least 
a match due to injury, a situation that may force the coach to field some players out of position, 
potentially increasing a player’s risk to injury. Of the reported injuries, contusions, sprained 
ligaments and muscle ruptures were the most predominant a finding which concurs with other 
Super Rugby studies (Schwellnus et al., 2012, Schwellnus et al., 2014), Olympic Games (Soligard 
et al., 2015) and Rugby Union studies (Gabbett et al., 2012a, Fuller et al., 2010).  
 
4.4.5 Direction of travel, number of time zones crossed and injury 
The direction of travel and number of time zones crossed were both important, as evidenced by 
the higher injury incidence rates after eastward travel, and following travel across six or more 
time zones compared to no time zone travel (Figures 4.7 and 4.8). Players seemed to be at an 
advantage when playing at home or when there was no time zone travel, suggesting that the 
effects of jet-lag, which may predispose players to injuries, worsen as the magnitude of time zone 
travel increase, particularly in an eastward direction. Moreover, the necessary exposure to a light 
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stimulus in order to realign the circadian system does not fit in with the day and night cycle at 
the destination venue during the first few days. For example, a New Zealand local time of 09h00, 
the time that most morning training sessions take place is equivalent to 23h00 South African local 
time, which is bed-time for most people in South Africa. Therefore, instead of phase advancing 
the circadian clock, exposure to a light stimulus at this time-of-day may phase delay the circadian 
clock rather than promoting the phase adjustment required. This might exacerbate the effects of 
jet-lag such as fatigue, daytime sleepiness and sleep disturbances, which influence fine motor 
skills, alertness, concentration and decision making (Maire et al., 2014, Drust et al., 2005, Goel et 
al., 2009), potentially increasing the risk of injury. Reilly and Edwards (2007) reported that 
swimmers who underwent partial (2.5h) sleep deprivation experienced negative mood states, 
confusion and fatigue. A change in mood state such as that experienced following time zone 
travel may possibly be another factor associated with increased injury risk in the Super Rugby 
tournament. This is conceivable, given that high competitive state anxiety, negative mood state 
and tension were shown to be responsible for the high injury rates in varsity level American 
Football and rugby players (Lavallee and Flint, 1996).  
 
Sleep is important for psychological and physical restoration of the body and useful for muscle 
recovery and optimal performance (Skein et al., 2011). Disruption to the sleep-wake cycle could 
possibly hinder muscle recovery and impair mental faculties (Skein et al., 2013, Reilly and 
Edwards, 2007); especially since athletes have a stronger rhythmicity than sedentary individuals 
(Davenne, 2009). It has been demonstrated in both human and animal studies that an increase 
in physical daily activity is correlated with changes in the period, phase and amplitude of circadian 
rhythms (Mistlberger et al., 2003, Atkinson et al., 1993, Koteja et al., 2003). In contrast, a 
sedentary way of life may lead to a reduced circadian period, phase and amplitude (Davenne, 
2009). Appropriately-timed physical activity has been reported to play an important role in 
counteracting circadian desynchronisation either due to nighttime shift work or time zone travel 
(Waterhouse et al., 2007, Mauvieux et al., 2003, Waterhouse et al., 2000). The stronger 
rhythmicity in athletes compared to sedentary people may be due to differences in the level of 
physical activity that these two groups receive. Thus, it is likely that the synchronisation and 
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amplitude of circadian rhythms in athletes would be higher than in sedentary people. Circadian 
disruption following time zone travel may be exacerbated by the fact that athletes are highly 
sensitive to jet-lag (Waterhouse et al., 2000) and also because athletes require more sleep than 
sedentary people (Davenne, 2009). Another study, Murgia (2013) reported that fatigue as a result 
of insufficient rest or recovery time following time zone transitions resulted in injuries in hockey 
players. The failure by fatigued muscles to produce enough force to support movement activity 
(i.e. decreasing impact force on contact) may increase the risk of future injuries including strains, 
ligament damage and muscle tears (Takarada, 2003, Murgia, 2013). This may possibly explain the 
high number of tendon and muscle injuries noted in this study.  
 
4.4.6 PER3 VNTR genotype, direction of travel, number of time zones crossed and injury 
The distribution of injuries was similar in the three PER3 genotype groups when accounting for 
direction of travel, but different when number of time zones crossed were considered. Perhaps 
jet-lag due to lack of synchronisation of the body clock to the new environment may increase the 
risk of injury following intercontinental travel. Circadian disruption similar to that, which may 
occur following intercontinental travel, can alter mood and cognitive function, with complex 
mental performance tasks deteriorating faster than simple tasks (Sack, 2010, Waterhouse et al., 
2004, Reilly and Edwards, 2007, Meney et al., 1998). This is consistent with inattention and an 
increase in errors and injuries, which have been reported in overtime and nighttime shift workers 
(Dinges et al., 1994, Costa, 1996, Dembe et al., 2005). In another study, a decline in performance 
involving complex mental activities, lack of energy and a general loss of motivation was reported 
in athletes immediately following time zone travel (Reilly and Edwards, 2007). Other symptoms 
of jet-lag that may increase the risk of injury in athletes include reductions in anaerobic power, 
dynamic strength and capacity (Reilly et al., 2005). Given that rugby is a high contact sport, a 
reduction in aerobic power, capacity and dynamic strength may negatively affect a player’s game 
involvement and increase the risk of injury.  
 
Higher injury incidence rates were evident in individuals carrying the PER34/4 genotype compared 
to those with the PER35/5 genotype. This difference in the risk of injury may have arisen due to 
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the inter-individual variation in sleep pressure and cognitive performance noted between the 
PER34/4 and PER35/5 genotypes following sleep deprivation studies (Maire et al., 2014, Viola et al., 
2007). While, the PER35/5 genotype has been shown to have a faster build-up of sleep pressure 
than the PER34/4 genotype, it is also reported to dissipate sleep pressure faster during a sleep 
episode compared to the PER34/4 genotype (Dijk and Archer, 2010, Goel et al., 2009, Maire et al., 
2014, Chellappa et al., 2012b). This suggests active readjustment into the new environment by 
the PER35/5 genotype. Thus, the PER35/5 genotype may be able to, for example, restore complex 
mental functions, dynamic strength, aerobic power and mood to levels prior to intercontinental 
travel, reducing a player’s risk to injury.  
 
The PER35/5 genotype has been shown to be more sensitive to blue light exposure than the 
PER34/4 genotype in a laboratory study (Chellappa et al., 2012a). This finding suggest that the two 
genotypes may entrain differently following time zone transition. For example, the PER35/5 
genotype might be able to utilise outdoor light faster for entrainment than the PER34/4 genotype. 
Perhaps the PER34/4 individuals may have remained jet-lagged, thus predisposing them to injury. 
This is plausible, since most injuries happened during matches, and matches took place within 3-
5 days upon arrival in the new time zone. Therefore, the PER34/4 individuals may have been 
unable to resynchronise rapidly to the new time zone to the extent that the PER35/5 individuals 
had. Within the PER34/4 group, higher injury rates were evident after travelling across six or more 
time zones compared to no time zone travel, further suggesting that number of time zones 
crossed rather than direction of travel affected the three PER3 genotypes. It also suggests that 
the PER3 genotype may confer protection or create susceptibility to injuries following travel 
across time zones.  
 
The high injury rates evident within the PER35/5 group following travel across two time zones 
compared to no time zone travel should be treated with caution. This may be explained by the 
broad 95% confidence intervals, smaller number of injuries and fewer exposure hours, 
particularly following travel across two time zones. The exact mechanism by which the PER3 
genotype may confer protection or create susceptibility to injuries is not known, however, it is 
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possible that it acts through differences in the ability to resynchronise in to the new environment. 
Therefore, affording players adequate rest, proper implementation of jet-lag alleviation 
protocols and lowering training workloads, especially within the first 72h upon arrival in the new 
time zone, might be key to reducing the risk of injury. There are no similar studies in the literature 
with which to compare these findings to at present. Therefore, further research with bigger 
sample sizes across multiple sports, and seasons is required to determine if the PER3 genotype 
interacts with number of time zones crossed or direction of travel to increase injury risk. 
Specifically, one needs to actually measure the extent of desynchronisation and 
resynchronisation in the new time zone in order to properly understand the effects of jet-lag on 
the different PER3 genotype groups. Without actual data, it is difficult to ascertain if differences 




The heavy reliance on team physicians to report all illnesses and injuries experienced by players 
was a limitation. Specifically, there was no way of determining if there was under-reporting of 
illnesses or injuries. This is conceivable given that players have a tendency to play with injuries 
during important matches (e.g. play-offs, finals), instead of resting and undergoing treatment 
(Kneeland, 2014). Thus, while this study attempts to quantify injuries in the three genotype 
groups during the Super Rugby tournament, there is no way to fully quantify injuries since players 
may play through injury if possible. The result is that the injury incidence rate is probably a 
conservative quantification of injuries in the Super Rugby tournament.  
 
The small sample size of illnesses and injuries when grouped by PER3 genotype, number of time 
zones crossed and direction of travel was a limitation. This reduced statistical power, potentially 
leading to a type 1 statistical error. As a result, it is difficult to tell if the statistical significance 
observed or the lack thereof was real. While there may be uncertainty in some of the findings 
due to small simple sizes, trends found in this study are worth exploring further and may serve 
to stimulate further research in this area of study. These findings warrant further research since 
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illnesses and/or injuries are modifiable risk factors that can be detrimental to either an individual 
or a team. Reliability and interpretation of these findings could have been improved by imputing 
missing data when direction of travel and number of time zones crossed were accounted for. 
Specifically, building a multivariate imputation model, for example, creating several (say five) 
imputed values for each missing value, each of which is predicted from a slightly different model 
and each of which reflects sampling variability. To obtain an overall point estimate for each 
individual for each of the missing data, the five imputed data sets can then be averaged. This will 
boost the sample size and improve the reliability and interpretation of the illness and injury data 
outcome.  
 
4.5 Conclusion  
The PER3 VNTR genotype may have influenced the occurrence of both illnesses and injuries when 
number of time zones crossed and direction of travel were accounted for during the 2012 Super 
Rugby tournament. Specifically, the PER35/5 and PER34/5 groups were more susceptible to 
illnesses than the PER34/4 group after travel across six or more time zones compared to when 
there was no time zone travel. Furthermore, within the PER35/5 and PER34/5 groups, illness 
incidence rates were higher following more than six time zone crosses, and eastward travel 
compared to no time zone travel. This suggests that players carrying one of the PER3 5-repeat 
alleles were more likely to experience an illness after travelling across time zones, especially in 
an eastward direction.  
 
The PER34/4 group was more susceptible to injuries after travelling across more than six time 
zones than when there was no time zone travel, suggesting that this group of players may have 
remained jet-lagged, especially during matches. While carrying a single PER3 5-repeat allele was 
sufficient to predispose players to illnesses after six time zone crosses, it required one to be 
homozygous for the PER3 4-repeat allele to be predisposed to injuries. In this respect, there was 
some evidence to suggest that the three genotypes may have been affected differently by trans-
meridian travel. However, the lack of significant differences between the three genotypes for 
both illness and injury incidence rates when direction of travel was accounted for suggests that 
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other genes may be important. Alternatively, it is possible that direction of travel or number of 
time zones crossed will affect injury more than the PER3 genotype.  
 
4.6 Perspectives 
The PER3 VNTR genotype may explain the inter-individual variation in infection and injury 
susceptibility following trans-meridian travel. As such, coaches may want to implement robust 
entrainment protocols such as timed blue-light exposure and exercise training sessions to 
resynchronise players into the new environment in order to reduce injury and illness risk in their 
players. This is necessary so that illness or injury prevention and management strategies for 
rehabilitation and return to play can be implemented and outcome strategies reviewed. Likewise, 
it has the potential to improve the longevity of an individual’s playing career if properly 
implemented.  
 
These findings are applicable to other sports, tournaments, recreational and business travellers 
who undergo frequent trans-meridian travel. They also improve upon the thin collection of 
studies in literature with respect to the effect of trans-meridian travel on illness and injury 
incidence rates. However, further studies with larger sample sizes, across multiple tournaments 
allowing for scrutiny of number of time zones crossed and direction of travel on illness and injury 





CHAPTER 5: THE EFFECT OF BLUE-LIGHT EXPOSURE ON CIRCADIAN 
RESYNCHRONISATION IN INDIVIDUALS GENOTYPED AS PER34/4 AND PER35/5. 
 
5.1 Introduction  
In the modern day society, trans-meridian travel across multiple time zones is a common 
phenomenon not only for the general population, but also for many elite sports athletes and 
business people travelling for work. The primary consequence of trans-meridian travel is a cluster 
of symptoms known as jet-lag that can impart a physical and emotional burden to those 
undergoing air travels. Jet-lag is caused by the desynchronisation of the internal body clock from 
the external environment (Waterhouse et al., 2007, Reilly et al., 2005, Sack, 2010) and recovery 
from jet-lag symptoms requires resynchronisation to the new time zone. The aim of jet-lag 
recovery strategies is to realign the innate circadian system with the new environmental time as 
rapidly as possible. Current strategies designed to enhance recovery from trans-meridian travel 
include appropriately-timed light exposure, meal times and exercise, manipulation of sleep 
schedules and the use of sedative or stimulant medication. Light exposure (especially blue light, 
wavelength 450-495 nm) at an appropriate time-of-day is the strongest entraining stimulus for 
the human circadian system, making it an ideal protocol for counteracting jet-lag (Duffy and 
Czeisler, 2009, Roenneberg et al., 2013, Forbes-Robertson et al., 2012).  
 
While the general rule is that for every time zone crossed, 24h of recovery time is required 
(Manfredini et al., 1998, Youngstedt and O'Connor, 1999, Waterhouse et al., 2007), it appears 
that this recovery time varies significantly between individuals (Waterhouse et al., 2007, Lee and 
Galvez, 2012). The variation in the human clock genes, in particular the PER3 VNTR, may in part 
explain this inter-individual variation in recovery time given their associations with factors such 
as sleep timing (Viola et al., 2007, Goel et al., 2009, Archer et al., 2010), cortisol and melatonin 
hormonal secretion (Wirth et al., 2013, Dijk and Archer, 2010, Chellappa et al., 2012b). A study 
by Chellappa et al. (2012b) reported that sensitivity to blue light in terms of entrainment may be 
dependent on PER3 VNTR genotype, as individuals homozygous for the PER3 5-repeat allele 
appeared more sensitive to blue-light than their PER3 4-repeat allele counterparts. Therefore the 
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PER3 VNTR genotype may influence efficacy of re-entrainment following trans-meridian travel 
when blue light exposure is used as a recovery modality. There is need for optimal 
resynchronisation strategies and blue-light is a good candidate, however, no one has used this 
specific strategy to compare two clock gene genotype groups in order to explain the apparent 
inter-individual variability in response to resynchronisation. Therefore, the aim of this study was 
to compare the extent to which individuals genotyped as PER34/4 or PER35/5 respond to 
appropriately-timed blue light exposure in order to resynchronise their circadian rhythm, 
following simulated eastward travel, based on changes in dim-light melatonin onset and cortisol 
circadian phases.  
 
It was hypothesised that individuals carrying the PER35/5 genotype would resynchronise faster 




Sixteen males genotyped as either PER35/5 (n=8) or PER34/4 (n=8) were recruited for this study. 
Criteria for inclusion required that participants (i) be between 18-40 years of age, (ii) be free of 
sleep complaints, (iii) be in good self-reported physical and mental health, (iv) normally sleep 
between 6 and 10 hours per night, (v) have low habitual levels of physical activity, and (vi) have 
either the PER34/4 or PER35/5 VNTR genotype. While the National Sleep Foundation in the United 
States recommends that adults obtain 7-9h of sleep per night (Natale et al., 2009, Ferrara and De 
Gennaro, 2001), they also note that 6-10h of sleep per night may be appropriate given the inter-
individual variation in sleep need. For this reason, individuals sleeping between 6-10h per night 
were included in this study. 
 
Exclusion criteria were (i) diagnosed chronic medical conditions requiring medication, (ii) any 
sleep disorder, (iii) any chronic medication known to affect sleep, cortisol, melatonin and/or 
circadian rhythms (previous six months), (iv) night-time or rotating shift work in the previous 
three months, (v) trans-meridian travel of three time zones or more within the previous two 
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months, (vi) smoking, (vii) normal caffeine consumption greater than 300 mgd-1, (viii) red-green 
colour blind condition (may affect blue-light response (Smith et al., 2009)), (ix) engaged in any 
sport/physical activity which requires more than two training sessions per week, (x) a body mass 
index ≥30 kgm-2 or (xi) PER34/5 VNTR genotype. Relatively inactive male participants were used 
to be matched to the control population in Chapter 2, and because the protocol required long 
periods of sedentary behaviour. Participants were recruited using flyers, posters and radio 
advertisements (Appendices 5A and 5B). Prior to formal entry into the study, participants were 
screened for eligibility (section 5.2.2.1). Descriptive characteristics of the two groups are 
presented in Table 5.1. 
 
5.2.2 Study design  
This intervention trial was designed to compare circadian resynchronisation differences between 
two groups (PER34/4 and PER35/5) exposed to blue light following simulated jet-lag. Following the 
screening visit, eligible participants underwent an 82h intervention. Baseline measures of their 
innate circadian system were taken, following which jet-lag was induced by manipulating the 
environmental conditions to mimic an eastward flight across six time zones. On awaking in the 
new time zone, all participants were exposed to blue light for 3h. The rate at which the innate 
circadian systems of the two groups resynchronised to the new time zone was compared. The 
study took place in the Chronobiology and Sleep (CBS) Laboratory at the Division of Exercise 
Science and Sports Medicine, University of Cape Town (UCT) and was approved by UCT’s Faculty 
of Health Sciences Human Research Ethics Committee (HREC/REF: 360/2014). All participants 
gave written informed consent (Appendix 5D). The study was performed in accordance with the 
principles of the Declaration of Helsinki (Fortaleza, Brazil 2013), the International Conference on 
Harmonisation and South African Good Clinical Practice guidelines. 
 
5.2.2.1 Screening visit 
The purpose of the screening visit was to establish eligibility of volunteers for the study. The 
investigator explained the purpose of the study, as well as the associated procedures, risks and 
benefits to all volunteers. All volunteers completed a questionnaire (Appendix 5E) to obtain 
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descriptive characteristics and to establish their diurnal preference, and sleep quality. Volunteers 
completed the Ishihara colour-blind test to ensure that they were not colour-blind, and the 
investigator measured their height and weight. The volunteers swabbed the insides of their 
cheeks. Their DNA was extracted from the cheek cells and they were genotyped for the PER3 
VNTR polymorphism as described previously (sections 2.2.3.2 and 2.2.3.3). The first eight eligible 
individuals in each of the two genotype categories (PER35/5 and PER34/4) were invited to continue 
with the simulated jet-lag phase of the study.  
 
5.2.2.2 Simulated jet-lag trial  
During this 82h intervention trial, participants were housed at the CBS laboratory. This space, 
which is sound- and light-proof, comprises bedrooms, a lounge area, bathroom and kitchen. 
Participants reported to the CBS laboratory at 11h30 on Day 1 (D1) of the study. From 11h30 until 
the end of the trial, participants were not allowed contact with the outside world. That is, all time 
cues from sources such as environmental light, phones, computers, TV etc. were removed. All 
times given in the Methods section refer to local actual time (as opposed to phase-shifted 
environmental time). The first 30 min were used for administrative purposes and familiarisation. 
Figure 5.1 shows the protocol for the trial. 
 
The simulated jet-lag protocol began at 12h00 on D1. The aim of the first 36h of the protocol 
(constant routine (CR) 1) was to phase-advance the participants by 6h. Light was controlled to 
enforce the CR. Sleepiness was assessed every 3h using the Stanford Sleepiness Scale (SSS) and 
participants donated hourly saliva samples for melatonin and cortisol analysis as illustrated in 
Figure 5.1. CR1 ended at 16h00 on D2 when the participants were given their first 8h sleep 
opportunity.  
 
Participants were woken at midnight on D2 (06h00 phase-shifted environmental time). The 
investigator measured their resting metabolic rate (RMR) in a fasted state. Participants then ate 
a standardised breakfast, following which they underwent 3h of blue-enriched light therapy. For 
the remainder of the waking hours on D2/3, participants were kept under normal indoor light 
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conditions of 80 lux from incandescent bulbs. Participants were given a second sleep opportunity 
on D3 starting at 16h00. They were then kept awake for a second 24h CR period to assess their 
endogenous circadian phases of melatonin and cortisol. Participants were allowed to go home 
after collection of the last sample, in the company of family or friends.  
 
A maximum of three participants were tested at one time, and at least one investigator remained 
with them at all times. Participants who shared the laboratory were introduced to one another 
by first name only. During periods of wakefulness, participants interacted with one another in 




 Trial starts  28h Constant routine  3h light therapy  Sleep in darkness 
 Trial ends B Breakfast C Saliva sample for cortisol D Dinner 
E Ensure meal  L Lunch M Saliva sample for melatonin R Resting metabolic rate 
S Stanford sleepiness scale 
Figure 5.1: Raster plot of the simulated jet-lag protocol. 
 
5.2.3 Detailed testing procedures 
5.2.3.1 Questionnaire 
Participants completed a questionnaire detailing demographics, medical history, medication and 
supplement use, work, travel, sleep, exercise and dietary history (Appendix 5E). These questions 
were designed to determine the eligibility and obtain descriptive characteristics of volunteers for 
the intervention phase of the study. The questionnaire also contained the Horne-Östberg (HÖ) 
Morningness-Eveningness Personality Questionnaire to determine chronotype (Horne and 
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Questionnaire (Monk et al., 2003), and the Pittsburgh Sleep Quality Index Questionnaire to assess 
sleep quality (Buysse et al., 1989).  
 
Sleep Timing Questionnaire 
This is a published, validated tool used to establish normal sleep patterns (Monk et al., 2003). 
Specifically, it distinguishes between workday and non-workday sleep habits and outcome 
variables include workday and non-workday bedtime, wake-up time and sleep latency (Appendix 
5G). The outcome variables include estimated sleep latency, habitual sleep- and wake-times. 
 
Pittsburgh Sleep Quality Index Questionnaire 
This is a validated and widely used tool comprising 19 questions which are scored to give a global 
sleep quality score as well as scores for seven sub-components: subjective sleep quality, sleep 
latency, sleep duration, habitual sleep efficiency, sleep disturbance, use of sleep medication and 
day-time dysfunction (Appendix 5F) (Buysse et al., 1989). The outcome variable used for this 
study was the global sleep quality score. 
 
5.2.3.2 Ishihara test for colour blindness 
Participants were tested for colour blindness as this might have negatively influenced the efficacy 
of blue light therapy (Ruger et al., 2013, Lavric and Pompe, 2014). They completed the Ishihara 
test online and responded to 24 different plates. Based on their responses, the test indicated 
whether participants had (i) normal colour vision, (ii) red green colour blindness or (iii) total 
colour blindness. This test has been used in previous studies similar to this one studying the 
effects of blue light exposure on phase shifting (Smith et al., 2009, Smith and Eastman, 2009). 
None of the participants recruited for this study tested positive for red green colour blindness or 
total colour blindness. 
 
5.2.3.3 Buccal cell sample collection and PER3 VNTR genotyping 
These methods have been described in Chapter 2 (sections 2.2.3.2 and 2.2.3.3). Only participants 
who were genotyped as PER34/4 or PER35/5 were eligible for this study. 
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5.2.3.4 Pre-trial standardised “run-in” 
The aim of this standardised two-week “run-in” was to (i) ensure participants were not sleep 
deprived, (ii) verify supplement and medication use pre-trial, (iii) confirm reported physical 
activity levels, and (iv) obtain dietary intake information for each participant. All participants 
were asked to adhere to a regular sleep schedule at home that was in line with their normal sleep 
habits, with fixed bedtimes and wake times, for two full weeks prior to each trial. Specifically, 
they were required to go to sleep and wake-up within one hour of their normal weekday 
sleep/rise times. They were also asked to aim for a “time-in-bed” length that is one hour longer 
than their habitual weekday sleep length. For example, a person who normally sleeps 7.5h per 
night during the week was asked to aim to spend 8.5h in bed each night for this two-week period. 
Participants remained in bed in the dark even if they could not sleep; they were not allowed to 
listen to music, talk, read, or watch TV during “time-in-bed”. The reason for the additional hour 
was to try to lengthen sleep time marginally to overcome any recent sleep debt.  
 
To confirm that participants adhered to this and to document their normal sleep habits, 
participants kept a daily logbook (Appendix 5K) for the two weeks prior to the start of the trial 
and wore wrist actigraphy monitors (Actiwatch-2, Philips Respironics, Bend, OR, USA) 
continuously for the second week of the run-in period. The actigraphy data were used as an 
objective measure of bedtime, wake-up time, time-in-bed, sleep latency, efficiency and length. 
The logbook documented their wake-up and bed times; medications and supplement use; 
consumption of alcohol- and caffeine-containing products; meal timing; and any exercise 
sessions. Thus the actigraphy and logbook information were used together primarily to establish 
and verify their normal sleep habits prior to jet-lag simulation.  
 
5.2.3.5 Resting metabolic rate (RMR) test 
RMR was determined using the ventilated hood technique (Quark RMR, Cosmed, Rome, Italy). 
Participants were asked to recline quietly while oxygen uptake and carbon dioxide production 
were measured at 10 s intervals for 20 min, or until a steady state was achieved (<5% change in 
respiratory exchange ratio). To ensure accuracy, the gas analyser was calibrated before each trial 
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was undertaken with a 3 L syringe and standard gas mixtures of oxygen (26% O2 with the balance 
nitrogen) and carbon dioxide (4% CO2, 16% O2 and the balance nitrogen) (BOC Special Gas, Afrox, 
Cape Town, South Africa). RMR on the screening visit served as a familiarisation test, as well as 
to calculate participants’ RMR so that the caloric content of their meals during the trial could be 
determined. The purpose of taking these measurements during the intervention trial was to 
observe phase shifting in a physiological system. Baseline RMR measurements were taken 
between 07h00-08h00 one day prior to the start of each trial, with participants in a fasted state 
(10-12 hours).  
 
Participants were not permitted to consume alcohol and caffeine or to use non-steroidal anti-
inflammatories 24h prior to beginning the trial. Subsequent measurements were taken at 06h00 
on D2, D3 and D4, and 00h00 on D2 and D3 of the trial. The 06h00 (actual local time) 
measurements were taken 1h after the previous hourly snack and the 00h00 measurements were 
in the fasted state just before breakfast was served in the “new time zone”. Outcome variables 
from this test included total daily energy expenditure (kcal·d-1), respiratory exchange ratio (RER- 
a marker of predominant fuel utilisation), fat and carbohydrate oxidation (g∙day-1). 
 
5.2.3.6 Meals 
All meals were provided for participants in the CBS lab for the duration of each trial (Figure 5.1). 
For the two CR periods (12h00 D1 - 16h00 D2; 24h00 D3 - 22h00 D4) participants were given 
hourly snacks as opposed to regular meals. The reason for this was to ensure that the timing and 
composition of meals did not provide external time cues. The snacks were prepared using Ensure 
Powder (Abbott Nutrition, Johannesburg, South Africa) mixed with water, which is a complete 
meal replacement supplement designed to deliver approximately 55% carbohydrate, 30% fat and 
15% protein per serving. Each hourly snack was isocaloric, with the exact dosage calculated to be 
the necessary energy requirement for each participant based on his RMR, body weight and a 
metabolic equivalent of approximately 1.5 kcal·kg-1·h-1 (very light intensity activities such as 
watching television and writing or desk work) for the 28h period. Standard breakfast (35 g oats, 
rooibos tea, apple and/or banana), lunch (hot dog rolls with chicken vienna sausages, banana 
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and/or apple and fruit juice) and dinner (200 g beef lasagne, mixed salad, fruit juice and/or water) 
meals were scheduled six- or seven-hourly from 24h00 D2 - 24h00 D3 to coincide with 
appropriate meal times for the “new time zone”. Participants had ad lib access to water and 
rooibos tea (without sugar) during the simulated jet-lag trial. No caffeinated products were 
allowed.  
 
5.2.3.7 Constant routine (CR) protocol 
The CR protocol is a standard method used to unmask the endogenous circadian components of 
the physiological and behavioural rhythms by removing any rhythmic changes due to an 
individual’s lifestyle or environment (Duffy and Wright, 2005, Dallmann et al., 2012, Dijk and 
Archer, 2010). In this study, this was achieved by keeping participants under constant 
temperature (25oC), humidity (49%), and dim indoor light conditions (≤10 lux) with an hourly 
isocaloric nutritional supplement for 28 hours. Light levels at eye level were measured using a 
handheld digital light meter (Maplin LD 140 Light Meter, model 631, UK). During the CR protocol, 
participants were restricted to a regimen of semi-recumbent posture, low activity, and 
continuous wakefulness. They were allowed to engage in activities such as reading, listening to 
music (no radio), watching TV (not live, only pre-recorded), computer work (no internet), and 
playing board or card games. Both the TV and computer were fitted with screen filters to block 
light in the blue wavelength spectrum (LEE filters 767 Oklahoma Yellow, Camquip Trading CC, 
Johannesburg, South Africa). The clocks within the computers were deactivated so that 
participants could not obtain time cues from the devices. The investigator on duty enforced 
wakefulness during the CR.  
 
5.2.3.8 Stanford Sleepiness Scale (SSS) 
The investigator administered the SSS every 3h throughout the wake periods. The SSS is an 
introspective tool used to measure subjective sleepiness (Hoddes et al., 1972) by evaluating 
sleepiness at a particular moment in time. The scale consists of seven statements with 1 being 
“Feeling active and vital; alert; wide-awake” and 7 being “almost in reverie; sleep onset soon; 
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lost struggle to remain awake”. Participants choose the statement that best represents their level 
of perceived sleepiness. 
 
5.2.3.9 Induction of the 6h phase shift 
All participants experienced one night of total sleep deprivation (TSD) on D1 - D2, such that they 
were kept awake from their natural wake-up time on D1 until 16h00 on D2 (±33h). This coincided 
with the first CR protocol. Following TSD, participants were given their first 8h recovery sleep 
opportunity from 16h00 - 24h00 on D2. Upon waking at 24h00 on D2 room light levels were 
increased to 80 lux, and participants were told that it was 06h00 in their new “time zone”, thus 
shifting their environmental time cues by 6h. This simulated eastwards travel crossing six time 
zones. Participants were not told the degree to which their time zone environment had been 
shifted (i.e. 6h). The reason for this was to ensure that participants’ recovery would be monitored 
without them being able to second-guess the difference between their innate circadian rhythm 
and the new environmental time. A clock was provided showing the new time zone time, 
participants were provided with meals at breakfast, lunch, dinner, and snacks at times 
appropriate for the new zone times. Light levels at eye level were held at 80 lux during the day in 
the new time zone. 
 
5.2.3.10 Blue light therapy 
Following the first sleep opportunity on D2, participants underwent 3h of blue-enriched light 
therapy. Cool white fluorescent lights (6500K, model UP-PL3030-18W, China) were mounted on 
adjustable wooden stands, which delivered blue light (wavelength 450-495 nm) at a brightness 
of 100 lux measured at eye level. Participants were required to sit at a table for this period with 
the lights at a distance of 50 cm from their eyes. During this time, participants were allowed to 
play board or card games, eat breakfast and read novels. Following the 3h blue light therapy 
intervention, participants were kept in ordinary indoor light (80 lux from incandescent bulbs) for 
13h until bed-time on D3 (22h00 new time zone). Napping was not allowed during the light 
period.  
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5.2.3.11 Sample collection and analyses 
During the two CR periods, saliva was collected from participants for measurement of melatonin 
(for dim-light melatonin onset, DLMO) and cortisol levels (Duffy and Dijk, 2002).  
 
Saliva collection 
Whole saliva was collected by passive drool. The participants tilted their heads forward, allowing 
saliva to pool on the floor of the mouth and then passed the saliva through a short straw into a 
polypropylene vial. Samples were immediately placed in a covered icebox to minimise light 
exposure. All samples were centrifuged for 10 min at 3 000 g at 4°C and the supernatants 
removed and frozen at -20oC within 4h of collection until subsequent analysis. 
 
Saliva samples were collected hourly from each participant for subsequent melatonin and cortisol 
level analyses. Samples for melatonin were collected between 18h00 - 24h00 D1 (7 x 2ml 
samples) and 13h00 - 22h00 D4 (10 x 2ml samples). Those for cortisol were collected between 
05h00 D1 - 11h00 D2 (7 x 2ml samples) and 24h00 D2 - 07h00 D3 (8 x 2ml samples) (Figure 5.1). 
To measure DLMO a maximum sampling interval of 1h was required starting ±4h prior to and 
continuing to at least 4h after habitual sleep onset. Saliva for cortisol measurements were 
collected approximately 60 min after ingestion of any snack/meal and participants were asked to 
rinse their mouths out with water 10 min prior to sample collection. 
 
Salivary melatonin and cortisol assays  
Melatonin and cortisol were measured using appropriate enzyme immunoassay kits 
(Salimetrics™, LLC, Newmarket, Suffolk, UK). Specifically, the salivary melatonin and cortisol kits 
are competitive immunoassays designed and validated for the quantitative measurement of 
salivary melatonin and cortisol, respectively. A microtiter plate is coated with rabbit monoclonal 
antibodies to either melatonin or cortisol. Melatonin and cortisol in standards, controls and 
unknowns compete with components linked to horseradish peroxidase for the antibody binding 
sites on the microplate. Following incubation, unbound components were washed away. Bound 
melatonin or cortisol peroxidase was measured by the reaction of the horseradish peroxidase 
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enzyme with the substrate tetramethylbenzidine. This reaction produced a blue colour. A yellow 
colour was formed after stopping the reaction with 3 M acid solution. Optical density was read 
on a standard 96-well microplate reader (Multiscan 355, Thermo Scientific, Shanghai, China) at 
450 nm and corrected at 620 nm for melatonin and 630 nm for cortisol. The amount of melatonin- 
or cortisol-tagged peroxidase detected, as measured by the intensity of colour, was inversely 
proportional to the number of components present in the sample. Concentrations of unknown 
melatonin and cortisol samples were determined using a standard curve constructed as per the 
manufacturer’s instructions. All samples collected from one trial were assayed in the same batch 
to minimise inter-assay variability. DLMO was defined as the point where melatonin 
concentration reaches 4 pg·ml-1 as previously described (Pandi-Perumal et al., 2007, Keijzer et 
al., 2011). 
 
5.2.4 Data and statistical analyses 
Descriptive data are reported as mean ± standard deviation (SD, for normally distributed data) 
or median with interquartile range (IR, when data are not normally distributed). A Shapiro-Wilks 
test was used to test for normality of the data. Descriptive characteristics of the two PER3 VNTR 
genotype groups were compared using an independent t-test or the Mann-Whitney U test. 
Repeated data were compared using dependent t-test, Wilcoxon matched pairs, 2-way ANOVA 
with repeated measures or Friedman’s ANOVA tests. Phase shifting for melatonin was 
determined by subtracting each individual’s DLMO time in the first constant routine from that in 
the second constant routine. A positive difference in DLMO time meant participants had an 
advanced melatonin phase after the 6h phase shift. Phase shifting for cortisol was determined by 
calculating the area under the curve (AUC) for each individual during CR1 and subtracting that 
from the individual’s area under the curve for CR2 after the 6h phase shift. Post-hoc analyses 
were performed using Turkey’s HSD tests. Data were analysed using Statistica (version 11, 





5.3.1 Participant characteristics  
Descriptive characteristics of the two PER3 VNTR polymorphism groups are shown in Table 5.1. 
There were no differences between any of the variables. Eligibility for this study was based on an 
individual’s PER3 genotype. Since the PER3 VNTR polymorphism has been reported not to differ 
greatly with ethnicity (Ciarleglio et al., 2008), it was not essential to match the two groups for 
ethnicitiy. 
 
Table 5.1: Participant characteristics. 
 PER34/4 (n=8) PER35/5 (n=8) p-value 
Age (y) 23.0 (4.5) 24.5 (4.5) 0.983 
Height (cm) 177.6±5.6 178.6±6.7 0.749 
Weight (kg) 76.8±10.8 77.2±13.4 0.942 
Body mass index (kg∙m-2) 24.3±3.2 24.1±3.2 0.886 
Body fat (%) 18.5±4.2 19.6±4.9 0.669 
HÖ-score 45.6±12.3 52.1±9.3 0.253 
Pittsburgh sleep quality 4 (2.25) 4 (1.25) 0.804 
Training (days·week-1) 2.3±1.2  2.2±0.9 0.548 
Ethnicity (B:MA:W) 4:1:3 2:0:6 0.253 
Data are presented as mean ± SD, median with IR or counts. HÖ: Horne-Östberg, B: black African, MA: 
mixed ancestry, W: white. Significance was determined using an independent t-test, Mann-Whitney U test 
or Fisher’s exact test. 
 
A summary of the participants’ sleep data collected via actigraphy for seven days prior to the 
start of the trial is shown in Table 5.2. Actigraphy data files for two participants were not 
downloadable, while data from one participant was incomplete (participant removed actiwatch 
on retiring to bed). Total sleep time for all participants was longer for the night before the trial 
(8.7±1.3h) compared to the average sleep time for the seven days before the trial (6.9±1.0h, 
p<0.001). Furthermore, when analysed by genotype, the PER34/4 group slept for longer the night 
before the trial 8.9(1.2h) compared to the seven days prior to the trial 6.3(0.8h). However, no 
significant differences in total sleep time for the seven days prior to the trial 8.6(2.6h) and the 
night before the trial (7.2(0.7h), p=0.438) were noted in the PER35/5 group. 
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Table 5.2: Sleep characteristics of the PER34/4 and PER35/5 groups measured in the week prior 
to the start of the trial. 
 PER34/4 (n=8) PER35/5 (n=5) p-value 
Bed-time  24h15 (1h12) 23h26 (0h56) 0.057 
Wake-up time  08h35 (1h20) 07h32 (0h56) 0.280 
Total-time-in-bed (h) 7.3 (0.9) 7.9 (0.2) 0.263 
Total sleep time (h) 6.3 (0.8) 7.2 (0.7) 0.255 
Sleep onset latency (min) 7.4 (6.1) 1.2 (14.3) 0.881 
Sleep efficiency (%) 88.7 (2.5) 92.1 (6.1) 0.487 
WASO time (min) 28.3 (7.4) 28.7 (7.4) 0.311 
Data are presented as median with IR. WASO: wake after sleep onset. Significance was determined using 
a Mann-Whitney U test. 
 
5.3.2 Sleep characteristics of participants during the trial  
Sleep data for both groups measured using actigraphy during the trial are shown in Table 5.3. 
Data are presented for sleep opportunity (SO) 1 and SO2 as they took place after two different 
conditions. SO1 took place immediately after the first 28h CR period, starting at 16h00 and 
finishing at 24h00 (D2, local time). SO2 was also an 8h sleep opportunity, which took place after 
a full day (16h) in the new time zone, between 16h00 and 24h00 on D3. During SO1 the PER35/5 
group slept for longer (p=0.031) and had a better sleep efficiency (p=0.031) compared to the 
PER34/4 group. During SO2 the PER34/4 group had a longer sleep latency (p=0.050).  
 
Sleep data were also compared between SO1 and SO2 within each of the two groups. No 
significant differences were observed between SO1 and SO2 for all variables for the PER34/4 
group. However, the PER35/5 group slept for longer (p=0.012), had greater sleep efficiency 
(p=0.012) and less WASO time (p=0.025) during SO1 compared to SO2 (Table 5.3). 
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Table 5.3: Sleep characteristics of the PER34/4 (n=8) and PER35/5 (n=8) groups during the first 
(SO1) and second (SO2) sleep opportunities. 
 SO1 SO2 p-values 
 PER34/4 PER35/5 PER34/4 PER35/5 p1 p2 p3 p4 
Total sleep 
time (h) 
7.2 (0.2) 7.4 (0.6) 6.8 (1.2) 7.2 (0.4) 0.031 0.208 0.093 0.012 
Sleep onset 
latency (min) 
2.0 (1.1) 1.8 (3.3) 7.0 (2.6) 2.6 (3.5) 0.834 0.050 0.161 0.310 
Sleep 
efficiency (%) 
92.0 (9.6) 96.0 (3.2) 87.6 (6.7) 91.3 (15.4) 0.031 0.227 0.093 0.012 
WASO time 
(min) 
22.5±22.3 17.1±10.3 26.4 (22.2) 25.8 (10.7) 0.114 0.667 0.263 0.025 
Data are presented as median with IR. SO: Sleep opportunity, WASO: Wake after sleep onset. Significance 
was determined using the Mann-Whitney U and Wilcoxon matched pair’s tests. p1: SO1 PER34/4 v PER35/5, 
p2: SO2 PER34/4 v PER35/5; p3: PER34/4 SO1 v SO2, and p4: PER35/5 SO1 v SO2. 
 
5.3.3 Sleepiness of participants during the trial 
Subjective sleepiness data for both groups measured every 3h throughout the trial are presented 
in Figure 5.2. While there was a time effect in the level of sleepiness (p<0.001) during CR1 (Figure 
5.2A), there was no PER3 genotype effect (p=0.316) or time-by-genotype interaction (p=0.504) 
effect. In contrast, there were no time (p=0.516), genotype (p=0.394) or time-by-genotype 
interaction (p=0.332) effects during daytime in the new time zone (Figure 5.2B). Likewise, no 
significant differences were noted for time (p=0.532), genotype (p=0.468) or time-by-group 
interaction (p=0.944) effects during CR2 (Figure5.2C). No significant differences were noted in 
AUC between the PER34/4 and PER35/5 groups’ rate of perceived sleepiness during all conditions 
(CR1: Figure 5.2D, Daytime: Figure 5.2E and CR2: Figure 5.2F). 
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Figure 5.2: Change in perceived sleepiness levels as measured by the Stanford Sleepiness Scale in the 
PER35/5 and PER34/4 groups during CR1 (A), Daytime (B) and CR2 (C) phases of the trial. Area under the 
curve (AUC) data are also presented for the CR1 (D), daytime (E) and CR2 (F) phases. Data are presented 
as mean ± standard deviation. CR: Constant routine and Daytime: 16h day (waking hours) in new time 
zone. Significance was determined using a two-way ANOVA with repeated measures (A, B and C) and an 
independent t-test (D, E and F).  
 
5.3.4 Energy expenditure during the trial 
Energy expenditure data for the two groups are presented in Tables 5.4 and 5.5. Table 5.4 shows 
the metabolic data for the two groups at two time points taken at 48h intervals: 06h00 local time 
on- D2 and D4. The D2 and D4 measurements were during CR1 and CR2, respectively, and thus 
taken 1h after the previous hourly snack. These time points were chosen for comparison because 
they reflect time-standardised (i.e. morning) changes in RMR from baseline before (D2 06h00) 
and after (D4 06h00) blue light therapy.  
 
There were no significant differences in energy expenditure, fat and carbohydrate oxidation 
rates, and respiratory exchange ratio in the PER35/5 group between D2 and D4; and none of these 
variables were different from baseline at D2 or D4. In the PER34/4 group, none of the variables 
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were different between D2 and D4, nor did they change differently from baseline. There were no 
significant differences in RER (p=0.756), energy expenditure (p=0.881), carbohydrate (p=0.253) 
and fat (p=0.955) oxidation rates between groups at 06h00 on D2. Likewise, no significant 
differences were noted in RER (p=0.782), energy expenditure (p=0.679), carbohydrate (p=0.950) 
and fat (p=0.733) oxidation rates between groups at 06h00 on D4. 
 
Table 5.4: Resting metabolic rate measurements for the PER34/4 (n=8) and PER35/5 (n=8) 
groups taken at 48h intervals, measured at 06h00 D2 and 06h00 D4 during the trial, as well 
as within subject change from baseline. 
Data are presented as mean ± SD and median with IR. Change from baseline. CHO: carbohydrate oxidation 
rate, D2: day 2 of the trial, D4: day 4 of the trial, EE: energy expenditure, Fat: fat oxidation rate; RER: 
respiratory exchange ratio. p1: within group D2 v D4 comparison; p2: within group change from baseline 
comparison (Baseline, D2, D4). Significance was determined using dependent t-test or Wilcoxon matched 
pairs test p1 and an ANOVA with repeated measures or Friedman ANOVA test p2. 
 
Table 5.5 shows the waking, fasted metabolic data for the two groups taken at two time points: 
D2 and D3 upon waking from the two sleep opportunities during the trial (midnight local time, 
06h00 new time zone time). These time points were chosen for comparison as they enable 
comparison of fasted morning energy expenditure measurements between pre-trial (baseline, 
06h00), first morning in new time zone (D2, 06h00 new time zone time) and second morning in 
new time zone (D3, 06h00 new time zone time). The PER35/5 group oxidised less fat (p=0.017) 
and more carbohydrate (p=0.015) on D3 compared to D2. Accordingly, their RER was higher on 
D2 (p=0.003). In addition, within the PER35/5 group, the change in fat oxidation from baseline was 







-1)  1649.3±316.5 1777.6±414.3 1776.2±377.4 0.801 0.178 
Fat (g∙day-1) 166.3 (40.4) 101.8 (34.0) 99.9 (62.4) 0.297 0.419 
CHO (g∙day-1) 66.9±59.1 169.1±89.9 195.5±77.9 0.326 0.052 







-1)  1605.4±324.5 1749.0±252.2 1980.3±89.6 0.064 0.104 
Fat (g∙day-1) 122.1 (34.0) 97.9 (156.2) 96.7 (63.3) 0.945 0.531 
CHO (g∙day-1) 107.2±66.9 139.5±88.9 119.8±63.9 0.096 0.055 
RER 0.78 (0.05) 0.77 (0.06) 0.85 (0.07) 0.219 0.061 
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significantly higher at D2 (p=0.035) while that for carbohydrate oxidation was higher at D3 
(p=0.009). Accordingly, RER change from baseline was higher at D3 (p=0.005). In the PER34/4 
group, none of the variables were different at D3 compared to D2. There were no significant 
differences in RER (p=0.865), energy expenditure (p=0.622), carbohydrate (p=1.000) and fat 
(p=0.943) oxidation rates between groups at 24h00 on D2. Likewise, no significant differences 
were noted in RER (p=1.00), energy expenditure (p=0.486), carbohydrate (p=0.721) and fat 
(p=0.798) oxidation rates between groups at 24h00 on D3. 
Table 5.5: Morning, fasted resting metabolic rate measurements of the PER35/5 (n=8) PER34/4 
(n=8) groups measured at 24h00 D2 and 24h00 D3 during the trial, as well as their respective 
changes from baseline. 







-1) 1649.3±316.5 1691.0±305.3 1677.3±282.6 0.776 0.813 
Fat (g∙day-1) 146.5±46.5 152.8±46.8 112.5±54.7 0.017 0.035 
CHO (g∙day-1) 66.9±59.1 71.8±71.6 149.6±89.2 0.016 0.009 







-1) 1556.0 (562.0) 1702.0 (377.0) 1620.0 (336.0) 0.313 0.403 
Fat (g∙day-1) 122.1 (33.5) 167.6 (10.9) 81.3 (68.4) 0.125 0.290 
CHO (g∙day-1) 95.9 (119.7) 57.6 (33.4) 176.8 (117.0) 0.250 0.273 
RER 0.78 (0.05) 0.73 (0.06) 0.85 (0.09) 0.063 0.117 
Data are presented as mean ± SD and Median with IR. CHO: carbohydrate oxidation rate, D2: day 2 of the 
trial, D3: day 3 of the trial, EE: energy expenditure, Fat: fat oxidation rate; RER: respiratory exchange ratio. 
p1: within group D2 v D3 comparison and p2: within group change from baseline comparison. Significance 
was determined using dependent t-test and Wilcoxon matched pairs test p1 and an ANOVA with repeated 
measures p2.  
5.3.5 Changes in salivary melatonin concentration 
Hourly salivary melatonin concentrations for all participants measured during CR1 and CR2 are 
presented in Figure 5.3A. The dotted red lines represent the time of DLMO. When data from both 
groups were pooled there was a time-by-condition interaction effect for melatonin (p<0.001) 
such that there was an advanced increase in melatonin concentration during CR2 (Figure 5.3A). 
This corresponded with a significantly earlier mean DLMO onset time during CR2 (17h44±0h27) 
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compared to CR1 (19h28±0h16), indicating a mean phase advance of 1h44min (Figure 5.3B, 
p=0.026). Figures 5.3C and D show that DLMO phase advanced significantly for the PER34/4 
(p=0.012) and PER35/5 (p=0.011) groups, respectively. Prior to inducing jet-lag, DLMO was similar 
between the PER34/4 (19h34±0h12) and PER35/5 (19h23±0h19) groups during CR1 (p=0.224). 
During CR2, however, mean DLMO time for the PER35/5 group (17h31±0h21) occurred earlier 
than that of the PER34/4 group (17h58±0h24) during CR2 (p=0.032). Furthermore, the extent to 
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Figure 5.3: Hourly salivary melatonin concentrations in CR1 and CR2 (A) and dim -light 
melatonin onset (DLMO) times for CR1 and CR2 for all participants (B) the PER34/4 group (C) 
and the PER35/5 group (D). Data are presented as mean ± SD (A) and as each individual’s DLMO 
time before and after blue-light treatment (B, C and D). CR: constant routine. The red dotted 
line indicates DLMO for all participants combined. Significance was  determined using a two-
way ANOVA with repeated measures (A) and a Wilcoxon matched pairs test (B, C and D).  
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5.3.6 Salivary cortisol measurements 
Salivary cortisol data are presented in Figure 5.4. The pooled hourly cortisol data measured for 
all participants during CR1 and CR2 are presented in Figure 5.4A. Salivary cortisol peaked at 08h00 
during CR1. In contrast, cortisol measured in CR2 shows a small peak at 01h00 local time, where 
after levels dropped then rose again after 04h00 until the end of the sampling period (07h00). 
There was no time-by-group interaction effect for cortisol during the three overlapping sampling 
period. The area under the curve (AUC) for cortisol was determined for CR1 and CR2 for each 
participant. Figure 5.4B indicate that simulated eastward travel resulted in suppression of 
morning cortisol AUC in CR2 (0.71±0.24 µg∙dL-1), compared to CR1 (1.04±0.45 µg∙dL-1; p=0.022). 
Figures 5.4C and D compare the cortisol curves of the two genotype groups during CR1 and CR2, 
respectively. While there were no time-by-group interaction effects for CR1 (Figure 5.4C) and CR2 
(Figure 5.4D), there were significant group effects for both conditions such that cortisol levels 
were significantly higher in the PER35/5 group compared to the PER34/4 group during CR1 and 
during CR2. In confirmation of this, Figures 5.4E and F show the cortisol AUCs for the two 
genotype groups during CR1 and CR2, respectively. The PER34/4 group had lower values during 
both CR1 (p=0.328) and CR2 (p=0.028). 
 
Lastly, a single cortisol peak representing the cortisol awakening response peak is apparent for 
both genotype groups during CR1 (indicated by the arrow in Figure 5.4C). In comparison the 
PER35/5 group shows two peaks during CR2 (Figure 5.4D). The first arrow in Figure 5.4D indicates 
the original cortisol awakening response peak, while the second arrow indicates the cortisol 
awakening response peak in the new time zone.  
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Figure 5.4: Hourly salivary cortisol concentrations of all participants (A) and cortisol AUC for 
CR1 and CR2 for all participants (B) as well as genotype group comparisons measured during 
CR1 (C) and CR2 (D), and genotype group comparisons of cortisol AUC in CR1 (E) and CR2 (F). 
Data are presented as mean ± SD and median with IR. AUC: area under the curve, CR: constant 
routine, arrows indicate cortisol peaks.  Significance was determined using a Wilcoxon matched 





5.4 Discussion  
The aim of this study was to compare the extent to which individuals genotyped as PER34/4 or 
PER35/5 respond to appropriately-timed blue light exposure in order to resynchronise their 
circadian rhythm, following simulated eastward travel, based on changes in dim-light melatonin 
onset and cortisol circadian phases. The melatonin data indicate that while both groups were 
phase-shifted by the intervention, they entrained to the new time zone at different rates. The 
main finding was that there was a significant difference in DLMO phase shift between the PER35/5 
and PER34/4 genotype groups during CR2. Specifically, the DLMO of the PER35/5 group occurred 
27 min earlier than the PER34/4 group following the jet-lag induction protocol (Figure 5.3D). This 
implies that the PER35/5 individuals had phase-shifted more than the PER34/4 individuals, thus one 
may hypothesise that PER35/5 individuals may feel more tired or fall asleep earlier compared to 
the PER34/4 group in the new time zone.  
 
A recent study by Chellappa et al. (2012) reported that the PER35/5 genotype was more sensitive 
to blue light. This may explain why the PER35/5 group in this study had an earlier DLMO compared 
to the PER34/4 group following timed enriched-blue light treatment in CR2. Alternatively, the 
differences in DLMO between the two PER3 VNTR genotype groups under the same laboratory 
conditions may have arisen due to differences in the phase angle of entrainment as a result of 
differences between the timing of the circadian clock and external environmental time cues 
(Wright et al., 2013, Roenneberg et al., 2007, Duffy and Czeisler, 2009). For example, Wright et 
al. (2005) reported phase angle differences using DLMO as a circadian phase marker of the 
internal circadian period in healthy adults maintaining the same sleep schedules inside and 
outside the laboratory. Specifically, they reported that individuals who exhibited shorter 
circadian periods initiated sleep and awakened at an earlier biological time compared to those 
individuals with longer circadian periods.  
 
It is however unlikely to have been the case in this study because the two PER3 VNTR groups had 
similar starting DLMO during CR1. As such, it is likely that the blue light resynchronisation strategy 
used in this study may actually be more effective in resynchronising the PER35/5 genotype.  
   
157 
 
During CR1, there was an 11 min DLMO difference between the two genotype groups, however, 
this was not statistically significant. The small sample size and possibly the young age of 
participants- all still very “night owl” in nature, may have precluded the detection of any 
significant differences in DLMO between the two genotype groups in this study. This is 
conceivable given that the melatonin profile has been reported to be closely associated with the 
internal phase of the sleep-wake cycle which is different between the two genotype groups 
(Chellappa et al., 2012b). In support of this, Drake et al. (2015) demonstrated an earlier DLMO in 
PER35/5 compared to PER34/4 individuals in industrial shift workers who worked nighttime shifts 
only and complied with >5h nightly sleep for two weeks before the start of the controlled 
laboratory experiment.  
 
5.4.1 PER3 VNTR genotype and the cortisol circadian phase 
Cortisol was used as a second circadian phase marker to ascertain the extent to which re-
entrainment had occurred in the two PER3 VNTR groups. There was a 2h phase advance in the 
cortisol peak of the PER35/5 group, further indicating the effectiveness of the jet-lag induction 
protocol in phase shifting participants. Of interest was that, amplitude and AUC for cortisol were 
greater in the PER35/5 group compared to the PER34/4 group for both CRs, and it was significantly 
larger in CR2. This is congruent with findings from a recent study by Wirth et al. (2013), who 
reported higher amplitude and AUC for cortisol in the PER35/5 compared to the PER34/4 New York 
police officers who were involved in nighttime shift work. This result is also in line with studies 
that have demonstrated elevated cortisol levels among morning-types compared to evening-
types in general (Kudielka et al., 2007, Griefahn and Robens, 2008).  
 
The differences in amplitude and AUC for cortisol between the two PER3 VNTR groups during 
CR2 may be due to phase shifting of the circadian clock and dampening of output rhythms as 
observed in DLMO and sleepiness levels for the same output and activity. The lower cortisol 
awakening response during CR2 for both PER3 VNTR groups may be explained by the fact that 
these individuals were awoken before the time of their entrained biological awakening (Randler 
and Frech, 2006). It could also just be an indication of psychological stress arising from changes 
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in adrenal sensitivity around the process of awakening at this time-of-day (Shibuya et al., 2014, 
Clow et al., 2010).  
 
5.4.2 PER3 VNTR genotype and metabolism 
The RMR test was used to assess metabolic re-entrainment in the PER34/4 and PER35/5 groups. 
Fasting morning energy expenditure was similar after 24h in the new time zone compared to 
awakening on the first morning in each of the genotype groups (Table 5.5). Differences in the 
predominant type of fuel oxidised by the PER35/5 group were, however, evident. Specifically, the 
PER35/5 group oxidised less fat and more carbohydrate after 24h in the new time zone. This 
finding suggests that sleep deprivation, such as that induced by CR1, may have affected 
adipokines such as leptin (Spiegel et al., 2005, Knutson et al., 2007) in the PER35/5 individuals, but 
not in the PER34/4 individuals. Specifically, sleep deprivation lowers serum leptin concentration 
in the blood (Spiegel et al., 2005), which acts as a negative feedback on body fat stores to the 
appetite centers of the brain (Ahima and Flier, 2000, Tasali et al., 2008). 
 
A reduction in leptin concentration has been shown to promote fatty acid oxidation in the 
mitochondria (Ruderman and Saha, 2006), which may explain the elevated fat oxidation in the 
PER35/5 individuals following sleep deprivation in the jet-lag study. Other studies have reported 
a reduction in glucose uptake by peripheral tissues in favour of fat oxidation following sleep 
deprivation (Tasali et al., 2008, Knutson et al., 2007), which is consistent with what was observed 
in the PER35/5 group. The elevated carbohydrate oxidation in the PER35/5 group at 24h00 during 
D3 compared to D2 implies an up-regulation of hormones involved in gluconeogenesis after two 
nights of sleep recovery. This suggests that energy production may be affected differently in the 
two PER3 VNTR genotypes following circadian disruption.  
 
Alternatively, these variances may simply be due to differences in the function of the circadian 
clock (Markwald et al., 2013, Reilly and Edwards, 2007) between the 24h00 time points during 
D2 and D3 in the PER35/5 group. The neuroendocrine and metabolic systems may be co-regulated 
by the body clock resulting in differential production of RNAs that induce vital factors involved in 
   
159 
 
metabolism (Hastings et al., 2003, Laposky et al., 2008). The lack of significance in all RMR 
variables in the PER34/4 group further suggests that hormones and adipokines involved in fat and 
carbohydrate metabolism may be regulated differently in the two genotypes following circadian 
disruption.  
 
5.4.3 PER3 VNTR genotype and sleepiness  
Sleepiness is characterised by an overwhelming inclination to fall asleep or persistent 
uncontrollable urge to sleep and a lack of energy (Maire et al., 2014, Shen et al., 2006, Beebe et 
al., 2007). While there were no amplitude differences in the peaks of sleepiness levels between 
the two PER3 VNTR groups during CR1, the PER35/5 group reached their highest sleepiness levels 
earlier compared to their PER34/4 counterparts (Figure 5.2A). This could be explained by the fact 
that there are considerable differences in sensitivity to sleep loss in the PER34/4 and PER35/5 
genotypes as noted in previous sleep deprivation studies (Maire et al., 2014, Goel et al., 2009, 
Van Dongen et al., 2012, Archer et al., 2008). Specifically, the PER35/5 genotype has been shown 
to have a faster build-up of sleep pressure than the PER34/4 genotype, which may explain the 
earlier peak in sleepiness in this group of individuals. Thus, it is possible that the PER3 gene may 
be mediating vulnerability to sleep loss experienced by participants in response to the same 
laboratory conditions assessed using the Stanford Sleepiness Scale in this study.  
 
Alternatively, these differences may be related to circadian and homeostatic effects (Chellappa 
et al., 2012b, Van Dongen et al., 2012, Goel et al., 2009), since the body clock generates and 
maintains changes in physiological rhythms that control the sleep-wake cycle. Thus, interaction 
between these two regulatory processes may have induced the non-linear progression in 
sleepiness particularly during CR1. Sleepiness levels dampened considerably in both groups 
during daytime in the new time zone (Figure 5.2B) and CR2 (Figure 5.2C) possibly as a result of 
the recovery sleep, which appears to have been beneficial in restoring sleepiness levels to 
subjective rates at the beginning of the trial. The lack of a significant difference in sleepiness 
levels between the two genotypes during CR2 implies that neither of the PER3 VNTR groups 
recovered better than the other (Figures 5.2C and F). However, it is possible that the duration of 
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CR2 was not long enough to observe the disentanglement effects of jet-lag on the circadian 
system in the two PER3 VNTR groups. Therefore, time extension of the CR2 condition might have 
enabled observation of any differences between the PER34/4 and PER35/5 groups in sleepiness 
levels.  
 
5.4.4 PER3 VNTR genotype and sleep  
A minor observation from this study was that the two PER3 VNTR groups differed significantly in 
sleep characteristics immediately following the first 28h CR period. Total sleep time and 
efficiency were significantly greater in the PER35/5 group compared to the PER34/4 group during 
SO1 of the trial, suggesting that the PER35/5 group was affected to a larger degree by sleep 
deprivation and required more sleep than the PER34/4 group to recover. It was also noted that 
total sleep time and quality were greater during SO1 compared to SO2 in the PER35/5 group. This 
result demonstrates the differences in sleep debt (higher) accumulated prior to SO1, and the 
reduced sleep debt prior to SO2 combined with sleeping out of phase with circadian sleep time 
in the PER35/5 group. This is important because it suggests that the greater sleep debt of the 
PER35/5 group means that they sleep better on the first night in the new time zone, but then 
struggle with out of phase sleep for subsequent nights. This is indicated by the decrease in total 
sleep time and an increase in sleep onset latency and wake after sleep onset episodes in the 
PER35/5 group on the second night of recovery sleep during CR2.  
 
Perhaps the PER34/4 individuals who do not have such great sleep debt begin to realign their 
circadian sleep phase earlier compared to the PER35/5 individuals. This is conceivable since the 
PER34/4 group in this study appeared to have not fully offset the sleep debt in the first recovery 
sleep, thus they may have had sufficient sleep debt during the second recovery sleep to attain 
good sleep compared to their PER35/5 counterparts. This reflects active re-adjustment in the 
PER35/5 group whose homeostatic sleep pressure is tightly regulated and is dissipated faster 
during a sleep episode compared to that of the PER34/4 group (Dijk and Archer, 2010, Goel et al., 
2009, Maire et al., 2014, Chellappa et al., 2012b). This is consistent with other previous studies 
(Viola et al., 2007, Groeger et al., 2008, Lo et al., 2012), which reported a greater deterioration 
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in total sleep time and cognitive function in the PER35/5 genotype following sleep deprivation. 
The PER3 VNTR genotype may affect key markers of sleep homeostasis differently (Viola et al., 
2007, Dijk and Archer, 2010, Van Dongen et al., 2012), including sleep latency and efficiency in 
response to sleep deprivation as was the case in this study.  
 
A number of studies have suggested that the PER3 VNTR genotype may only play a marginal role 
in influencing circadian processes (Costa et al., 2011, Shearman et al., 2000). More specifically, 
that the effect of the PER3 VNTR genotype on sleep homeostasis may differ depending on the 
duration of sleep deprivation or the strategy used to adjust sleep loss (Goel et al., 2009, Gamble 
et al., 2011, Wirth et al., 2013), leading to different findings in various studies. For instance, Viola 
et al. (2007) reported that the PER35/5 individuals had poor cognitive performances and high 
sleep propensities than the PER34/4 individuals before and after total sleep deprivation (40h). 
Goel et al. (2009) reported no differences in cognitive performance and physiological alertness 
following partial sleep deprivation (4h per night) in PER34/4 and PER35/5 individuals across five 
nights of testing. Furthermore, Gamble et al. (2011) reported that, of the five strategies used by 
nurses to shift back their sleep patterns to nocturnal sleep times on days off, sleep deprivation 
was the least effective. Specifically, nurses who used this strategy were most poorly adapted 
compared to those who used napping, night-stay, incomplete and complete switching of daytime 
and nighttime shifts.  
 
5.4.5 PER3 VNTR genotype distribution in different ethnic groups 
Studies that have assessed the PER3 VNTR genotype distribution in various ethnic groups around 
the world have reported no significant differences in the distribution of this gene (Ciarleglio et 
al., 2008, Nadkarni et al., 2005, Chellappa et al., 2012b). For example, studies by Ciarleglio et al. 
(2008) reported no significant differences in the PER3 VNTR genotype distribution in the African 
American, European American and the Ghanaian populations. Specifically, they reported a high 
frequency of the PER3 4-repeat allele and a lower frequency of the PER3 5-repeat allele. 
Furthermore, a recent study in our research group (Nyambura Shawa, MSc thesis, 2014, Faculty 
of Science, University of Cape Town, Cape Town, South Africa) found no differences in the PER3 
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VNTR genotype frequencies in black African, mixed ancestry, Caucasian and Indian South African 
populations. Therefore, males of low physical activity from all ethnicities that were age matched 
to the Super Rugby population were recruited for this study. 
 
5.4.6 Study limitations 
This study had a few limitations. The cortisol peak of the PER34/4 group could not be determined 
during CR2 due to limited sampling points. This limited the scope of cortisol analyses that could 
be performed. Future research with increased sampling points during CR2 is warranted in order 
to determine the cortisol peak in the PER34/4 group. The sample size used in this study was also 
small. Therefore, the data must not be over-interpreted, as there is a risk of committing a type 1 
error.  
 
This study lacked a control condition. Ideally, a randomised crossover study would have been 
performed in which participants repeated the trial where the blue-light therapy would be 
replaced with light of a longer wavelength. This would have provided a full comparison of the 
effects of blue-enriched light in resynchronising the PER34/4 and PER35/5 genotypes to a new 
environment following trans-meridian travel. The effects of simulated jet-lag following westward 
travel were not investigated. 
 
5.5 Conclusion 
Results from this study suggest that the two PER3 VNTR groups differed significantly in the speed 
with which they resynchronised to the new environment when blue light therapy was included 
as a re-entrainment strategy after simulated eastward travel across six time zones. The DLMO of 
the PER35/5 group occurred significantly earlier during CR2 compared to that of the PER34/4 group 
indicating that they were in the process of re-entraining to the new time zone faster. One of the 
challenges facing individuals after eastward travel is being able to fall asleep early in the new 
time zone. Practically, having an earlier DLMO suggests that the PER35/5 group may be able to 
sleep earlier since nighttime sleepiness and sleep onset are related to DLMO timing (Keijzer et 
al., 2014, Martin and Eastman, 2002, Wright et al., 2013). 
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These results go some way to understanding the inter-individual differences in jet-lag recovery. 
The PER3 genotype of an individual, coupled with some yet unidentified factors, may be 
important in the rate of resynchronisation of circadian rhythms to a new time zone. Knowing the 
PER3 genotype of an individual may make predicting how rapidly or effectively they respond to 
resynchronisation interventions, and thus may have practical implications for team physicians in 
the way they manage players, in order to maintain proper circadian alignment with the external 
24h day. Future studies with larger sample sizes and more sampling points may be warranted to 
confirm these findings. This was a pilot study demonstrating proof of concept and the next steps 
would be to repeat the study with a larger cohort and include a crossover study for the simulated 
westward travel for comparison. This would either confirm or refute findings from this study as 




CHAPTER 6: SUMMARY AND CONCLUSIONS  
 
Trans-meridian travel is a common feature for many elite athletes and is often associated with 
jet-lag symptoms that influence an athlete’s health and physical performance. Understanding the 
degree to which individuals are affected by jet-lag symptoms is of interest to the sporting 
community, including the Super Rugby tournament. In this thesis, the role of the PER3 VNTR 
genotype as a source of inter-individual variation in response to jet-lag was examined in travelling 
rugby players and a control group in a laboratory environment.  
 
In this study, when activity rate was used as a marker for game involvement, no significant 
differences were evident with direction of travel and number of time zones crossed when 
athletes were considered together or grouped by genotype. Interesting though was the fact that 
while not significantly different from the other two groups; the PER35/5 group’s activity rate was 
always higher even after periods of international travel. The lack of significance in all activity rate 
variables may have arisen due to the fact that other factors such as behavioural and situational 
variables (Nippert and Smith, 2008, Taylor et al., 2008, Rampinini et al., 2007), which influence 
the extent of an individual’s involvement, were not taken into account. This would have allowed 
better analysis of game activity rate in general, but would have been logistically difficult to 
achieve given that situational and behavioural variables constantly change from one match to 
the next. However, it would be worthwhile attempting in future studies.  
 
Quality of play was reduced in the PER34/4 group compared to the PER34/5 and PER35/5 groups 
when more than ten time zones were crossed in a westward direction. This suggests that the 
effects of jet-lag were longer lasting in the PER34/4 players or that the PER34/4 players 
resynchronised more slowly in comparison to their PER34/5 and PER35/5 counterparts. This is 
plausible, given that while it was a different group and measured under different conditions, the 
PER35/5 group in the simulated jet-lag study (chapter 5) phase shifted to a greater extent than 
the PER34/4 group. Chellappa et al. (2012) showed that PER35/5 individuals were more sensitive 
to blue-light exposure than their PER34/4 counterparts, which may explain why the PER35/5 
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genotype phase advanced more rapidly in this study. It is therefore conceivable that the PER35/5 
individuals may be able to effectively use external time cues to phase delay their circadian 
rhythms and resynchronise into the new time zone faster than their PER34/4 counterparts 
following westward travel.  
 
Alternatively, it suggests differences in the underlying physiology between the two genotype 
groups, which may be explained in part by the variation in sleep homeostasis of the two groups 
(Goel et al., 2009, Dijk and Archer, 2010, Chellappa et al., 2012b, Maire et al., 2014). For example, 
Maire et al. (2014) reported higher sleep quality and nap efficiency across all naps in the PER35/5 
compared to the PER34/4 individuals following sleep deprivation, suggesting greater flexibility in 
sleep initiation by the PER35/5 genotype. The PER35/5 genotype has also been reported to have a 
quicker build-up and subsequent dissipation of the homeostatic sleep pressure than the PER34/4 
genotype following sleep deprivation studies (Chellappa et al., 2012b, Dijk and Archer, 2010). 
Thus, the PER35/5 individuals are more likely to re-establish normal sleep-wake cycles following 
trans-meridian travel prior to the matches, giving them an advantage over the other two PER3 
genotype groups.  
 
While the effects of jet-lag are so severe following travel across more than ten time zones 
(Leatherwood and Dragoo, 2013, Lee and Galvez, 2012, Reilly et al., 2005), it was expected that 
the quality of play will be better following westward compared to eastward travel across more 
than ten time zones. It could be argued that the day is lengthened following westward travel 
which makes it easier for circadian rhythms to extend in line with their natural free running 
period of nearly 25h (Golombek et al., 2013, Lehnkering and Siegmund, 2007, Duffy et al., 2011). 
In contrast, the day is shortened following eastward travel, which decreases the homeostatic 
sleep pressure during subjective night, since sleep (i.e. in Australia and New Zealand) occurs 
during the player’s biological day at least in the first 72h. In particular, failure to initiate and 
maintain sleep at this time-of-day may further increase circadian disruption worsening the 
effects of jet-lag. This is in line with studies which have shown that recovery time is longer and 
jet-lag symptoms worsen after eastward compared to westward travel (Reilly et al., 2007, Reilly 
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et al., 2005, Manfredini et al., 1998). Thus, it is conceivable that players may have been more jet-
lagged after eastward travel since players generally do not have enough time to resynchronise 
into the new time zone before a match. 
 
Injury incidence rates were lower when there was no time zone travel compared to crossing six 
or more time zone, especially in an eastward direction. Time zone travel affects both physical and 
psychological (e.g. mood, cognitive function) risk factors, for example, a dampened mood might 
ensue following time zone travel. Cumulative influences of both physical and psychological 
factors deplete perceptual and sensor motor reserves potentially exacerbating the risk of injury 
(Vandekerckhove and Cluydts, 2010, Evans et al., 2007). Athletes who undergo time zone travel 
are more likely to have a higher compound allostatic load (i.e. stressor) and an even more 
diminished threshold for mounting situational appropriate responses. Therefore, players were at 
an advantage when playing in their home country or when there was local travel with no time 
zone change. Furthermore, it suggests that travelling across time zones, especially eastward 
travel in this study may be detrimental to health. This is plausible since travel across time zones, 
especially after three or more time zones has been shown to shift physiological variables, leading 
to undesirable jet-lag symptoms (Chapman et al., 2012, Fowler et al., 2015a, Waterhouse et al., 
2005b, Forbes-Robertson et al., 2012). Specifically, players may have been more prone to injury 
when playing/training at the same intensity following eastward travel, by making mistakes as 
indicated by no change in GA rate, but lower quality of play. 
 
The PER34/4 individuals were more predisposed to injuries than the PER34/5 and PER35/5 
individuals after westward travel across six or more time zones, suggesting that they may have 
remained jet-lagged, particularly during matches. Specifically, a significant proportion of injuries 
in this study occurred during matches which concurs with previous Rugby Union studies (Fuller 
et al., 2015, King et al., 2015, Schwellnus et al., 2014). The fact that matches took place within 3-
5 days upon arrival in the new time zone, and more injuries were reported further implies slower 
resynchronisation in the PER34/4 group. This is plausible, since in the simulated jet-lag study, the 
PER34/4 individuals were unable to phase advance their internal 24h rhythms as rapidly as the 
   
167 
 
PER35/5 individuals using timed blue-light exposure and mealtime cues. As a result, sleep and 
circadian disruption, which influence cognitive and psychomotor functions key to performance, 
possibly take longer to get back to levels of prior to trans-meridian travel in the PER34/4 group. 
Thus, proper management of individuals homozygous for the PER3 4-repeat allele has the 
potential to improve performance, subsequently reducing the incidence of injuries, which may 
improve the longevity of players’ careers in the Super Rugby competition.  
 
The PER35/5 individuals may however be prone to injuries during training sessions in the first 72h 
upon arrival. This is conceivable given that while it is a separate group and measured under 
different circumstances, the PER35/5 group in the simulated jet-lag study slept for longer, had 
shorter sleep onset latency and reduced wake-after-sleep-onset during sleep opportunity 2, 
suggesting these individuals were jet-lagged. This is in line with studies which demonstrated 
deterioration in cognitive function, measured using a combination of multiple cognitive (Viola et 
al., 2007) and working memory tasks (Groeger et al., 2008) in the PER35/5 individuals under sleep 
deprivation. The effects of sleep loss on psychomotor vigilance may be worsened by time on task 
during training sessions (30-60 min). Specifically, time on task has been shown to result in 
reduced activation in over-lapping brain regions, suggesting neural and psychological causes 
(Asplund and Chee, 2013). Therefore, reducing training workload while using appropriate phase 
shifting protocols such as, morning-phased blue-enriched light exposure to facilitate 
resynchronisation to the new time zone is recommended in order to improve performance, and 
subsequently reduce injury risk.  
 
While the PER34/5 group’s ability to resynchronise into the new environment was not measured 
during the simulated jet-lag trial, it may be advantageous for actual travel to be heterozygous for 
the PER3 gene. This is conceivable given that those homozygous for the PER3 alleles were either 
more susceptible to illnesses or injuries while those heterozygous were neither susceptible to 
illnesses or injuries when direction of travel and number of time zones crossed were considered. 
Furthermore, the game activity rate of the PER34/5 group was in between that of the PER34/4 and 
PER35/5 groups across the entire tournament, even during periods of international travel. Thus, 
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carrying the PER35 allele may facilitate faster resynchronisation, thereby reducing the risk of 
injury, while carrying the PER34 allele may aid in reducing the risk for illnesses. The exact 
mechanism by which the PER3 gene may mediate a reduction in illnesses is however not clear 
warranting further research in this area.  
 
6.1 Limitations 
Numerous confounders, such as physical activity level, society/culture and the lack of flexibility 
in responses that one can give may influence the scoring on the HÖ-questionnaire (Horne and 
Ostberg, 1976, Taillard et al., 1999, Levandovski et al., 2013). As such, one might question the 
validity of assigning chronotype to athletes using the HÖ-questionnaire. In future, it may be 
useful to validate the HÖ-questionnaire in a sporting population. Alternatively, it may be useful 
to use a different questionnaire to the HÖ-questionnaire, possibly one that gives flexibility in the 
answers that an individual can give, although there may be reliability concerns with this.  
 
Interpretation of GA rate data was complicated by the fact that some players did not play in the 
same position throughout the duration of each tournament. Alternatively, other factors such as 
team strategy, game location, stage of play (e.g. finals) may have also influenced a player’s 
involvement on a given day. This highlights the difficulty in generalising GA rate data in this study, 
since game involvement is undoubtedly a combination of multiple factors, of which a single factor 
may be more important in a particular match than the other.  
 
This study had the special opportunity of using an actively competing Super Rugby population for 
the injury and illness study, and recognises that not having non-athlete travelling individuals 
control group was a limitation. However, the interest was on whether the PER3 VNTR genotype 
predisposed individuals within the same population differently to illnesses after trans-meridian 
travel. This was a first step study, and thus future studies can include travelling control 
individuals. Another limitation was that rugby players were not used for the simulated jet-lag 
study. However, the interest was on whether individuals homozygous for the two PER3 
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genotypes desynchronise and resynchronise differently following simulated jet-lag; hence, it 
wasn’t necessary to use actual rugby players for this part of the study.  
 
The fact that a typical Super Rugby team consist of 22 players naturally limited the number of 
travelling players, which led to smaller sample sizes during periods of international travel. This 
reduced the sample sizes when the injury and illness incidence rates were analysed by direction 
of travel and number of time zones crossed, and thus this data should be interpreted with 
caution. Specifically, it is difficult to determine if differences observed when both direction of 
travel and number of time zones crossed were accounted for are real or the presence of a 
significant difference is due to a type 1 statistical error.  
 
6.2 Practical applications and future work 
Disruption of habitual sleep patterns is likely to occur during and after trans-meridian travel 
(Lastella et al., 2014b, Fowler et al., 2015b), which may reduce physical performance (Forbes-
Robertson et al., 2012, Leatherwood and Dragoo, 2013). Sleep hygiene and re-entrainment 
recommendations that minimise this disruption in combination with appropriately-timed 
artificial or natural blue-enriched light exposure in order to phase shift players with various PER3 
VNTR genotypes may perhaps be the most effective way for resynchronising sports people into 
the new environment. Specifically, knowledge of how each PER3 VNTR group desynchronises and 
resynchronises into the new time zone may aid understanding of the inter-individual differences 
in illness and injury incidence rates as well as adaptation to new time zones. This may 
subsequently translate into improved physical performance if the risk of injuries and illnesses can 
be reduced as players can then derive the maximum possible benefit from training sessions.  
 
Observational studies will continue to be a vital source of performance, illness and injury 
surveillance with a focus on player welfare, especially following trans-meridian travel via 
individual specific intervention strategies. Ongoing surveillance studies either from individual 
teams or as combined data over multiple tournaments should be encouraged in the Super Rugby 
tournament embracing the covariates of trans-meridian travel. The effect of PER3 VNTR 
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genotype and trans-meridian travel on game involvement, quality of play, illness and injury 
incidence rates during a competition is new and adds a different dimension to knowledge in the 
current literature. Since the Super Rugby tournament provides an ideal platform to study this 
aspect further, SARU may want to ensure that such studies continue in the future.  
 
In order to better assess the impact of trans-meridian travel on the various PER3 VNTR genotypes 
with regards to illness and injury incidence rates as well as game involvement, future studies with 
more individuals in each PER3 VNTR group will need to examine additional team sports and 
across multiple seasons. Furthermore, studies with a higher resolution of assessment using 
different PER3 VNTR genotypes to assess sleep quality during adaptation in new time zones, 
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PARTICIPANT INFORMATION SHEET 
Background 
The UCT/MRC Research Unit for Exercise Science and Sports Medicine together with participating South African team 
physicians would like to study (i) the incidence and nature of medical illness and (ii) the influence of inter-individual 
variation in circadian rhythm on performance and incidence of illness and injury in rugby players during this 
tournament. This particular tournament is of interest since the strenuous schedule sees matches spanning 16 weeks 
(March to August 2012); during which 15 international rugby teams compete at different venues in South Africa, 
Australia and New Zealand. The competition is also unique in that the players are required to travel between venues 
in South Africa, Australia and New Zealand - often up to 9 hours across different time zones.  
 
Firstly, we are interested in determining how common injuries and a variety of medical conditions and illness are in 
rugby players during the tournament. For example, it is known that athletes, who train hard and then participate in 
strenuous competition, have increased respiratory tract symptoms (runny nose, sore throat, sinusitis, enlarged 
lymph glands in the neck, and even cough and chest pain with fever and headaches). However, these symptoms may 
not always be due to an infection but could be as a result of allergies or pollution. It has also been shown that apart 
from respiratory tract illness, other illnesses are very most common during competitions such as at the Olympic 
Games. These illnesses include gastro-intestinal symptoms, allergies, skin conditions, and other infections. These 
patterns of illness have not been studied in rugby players, particularly during competitions.  
 
Secondly, one of the unique aspects of the Super 15 tournament is that the players are required to travel across 
many time zones between matches. Such travel is known to disrupt circadian (24-hour) rhythm - experienced as jet 
lag. This in turn may impact performance. Your body’s 24-hour rhythm is also partially determined by your genetic 
makeup. For example, a variant in one of your “clock” genes may determine whether you are a morning or evening 
person (also known as diurnal preference). We are interested in whether rugby players tends to be morning or 





Aims of the research 
To document (i) the incidence of injuries and (ii) the incidence of medical illness in rugby players participating in the 
2012 Super 15 Rugby tournament. 
To relate the incidence of injuries and medical conditions/illness to 1) past medical history, 2) training history and 
load, and 3) environmental conditions (time zone changes, temperature, humidity, pollen counts, and atmospheric 
pollution) at the time of the 2012 Super 15 Rugby tournament. 
To describe the chronotype distribution of the rugby players participating in the 2012 Super 15 Rugby tournament. 
To describe the distribution of circadian rhythm gene polymorphisms (such as PER3 VNTR) of the rugby players 
participating in the 2011 & 2012 Super 15 rugby tournaments. 
To compare the differences in performance of the morning and evening-type rugby players travelling in both East-
West and West-East directions 
To compare the differences in the incidence of illness and injury of the morning and evening-type rugby players 
travelling in both East-West and West-East directions. 
 
Your possible involvement 
The UCT Research Office has provided your team doctor with all the information regarding the study, the details of 
which are explained in this document. As a participant in the 2012 Super 15 Rugby tournament, you are given the 
choice to participate in this research effort. Your participation is entirely voluntary. 
 
Should you agree to participate, you would be asked to do the following: 
Prior to the beginning of the tournament: 
Complete a medical questionnaire (this can be done together with your team doctor). This questionnaire, which 
deals with medical, training and circadian rhythm information, will be anonymous and only a coding system will be 
used to identify your team. 
Donate a 5 ml (1 teaspoon) blood sample from a vein in your arm. This will be used for the extraction and analysis 
of genetic material (DNA). The DNA will only be used for scientific research purposes relating to circadian rhythm. 
All data will be analysed anonymously and DNA samples will be destroyed on completion of the study 
During the competition: 
Every day your team doctor will ask you about possible medical conditions and injuries. This information will be 
recorded anonymously on a sheet (or in electronic format) that will be sent to the investigators. If you suffer from 
any injury or disease/condition, your team doctor will treat it in the usual fashion. 
Potential risks of this study  
The completion of a questionnaire is not associated with any risk. Questionnaire and other clinical data (paper and 
electronic) will be kept confidential and secure, and will not be made available to any party other than the research 
team without the consent of the individual participants. 
   
207 
 
The potential risks to participants of blood collection are minimal and are related to 1) blood sample collection 
technique, and 2) the volume of blood collected prior to a match and the potential risk of a decreased performance 
in a subsequent match. The potential risks associated with blood collection technique from the ante-cubital veins 
are: infection, delayed healing, haematoma, physical pain, mental discomfort and injury to a nerve or a vessel. These 
risks are small and will be minimized by the use of trained phlebotomists, use of sterile techniques and the use of 
disposable, single-use materials.  
Your personal genetic information will not be made known to you, your team mates, team medical team, coaches, 
trainers or management. The information will only be used for research purposes. 
All medical conditions and injuries will be treated by the team doctor.  
You may withdraw from this study at any time without question. 
 
Potential benefits of this study 
The research questions that will be addressed by this study have been identified to have a direct impact on improving 
medical care to rugby players in general, and specifically those who visit South Africa during future Super 15 Rugby 
competitions. The anticipated benefits of this study are that the results will further our understanding of the possible 
cause/s of medical conditions and injuries, and relationship between circadian rhythm and performance in rugby 
players who travel to participate in international competitions. 
 
Contact 
Please feel free to contact your team doctor, the UCT Research Office or members of the research team should you 
have any questions related to the study. Your team doctor has the contact details of the UCT Research Office and 
the research team. You can also call the following numbers of the principal investigators  
 
Lovemore Kunorozva (+27-76-956 4391),  
Dr Dale Rae (+27-72-141 3143) or Dr Laura Roden (+27-82-494 1765). 
Faculty of Health Sciences - Research Ethics Committee 
Room E52-24, Old Main Building, Groote Schuur Hospital, Observatory, 7925 
Tel: (021) 406 6338 
Fax: (021) 406 6441 
Email: nosi.tywabi@uct.ac.za 






ALL participants to read and sign 
 
I, the undersigned, have been fully informed about the University of Cape Town’s study entitled Diurnal preference 
and sports performance: a study of travelling sports teams to be conducted by researchers from the UCT/MRC 
Research Unit for Exercise Science and Sports Medicine within the Department of Human Biology and the Department 
of Molecular and Cell Biology.  
 
I agree to complete a questionnaire disclosing my personal details and information relating to my training and racing 
history. I understand that the following measurements / tests may be conducted on me during this study, as described 
in Participant Information document: 
 
Body composition assessment - height and weight measurements. 
Blood collection using the venepuncture or side cheek cell swab  
 
I have been fully informed about the risks inherent in participation in this trial. I understand that my DNA sample will 
only be used for the purposes explained to me, namely to determine my genotype for the VNTR polymorphism within 
the Per3 gene, and will be destroyed on completion of the Circadian rhythm and sports performance study. 
 
I understand that all the information collected during the study will be treated confidentially, will only be used for 
scientific research purposes and that my name and personal particulars will not be released under any circumstances. 
 
I have been informed that I will be free to withdraw from the study at any time if I so wish without explanation. I also 
understand that I may request that my samples are destroyed before the completion of the study. I will be free to ask 
any questions about the procedures and results of the study. I understand that I will receive, where applicable, 
feedback pertaining to my morning-evening personality type as well as general results of the study once the entire 
study has been completed.  
 
I agree to participate in the study. 
Participant’s name:  _________________________ 
Signature:   __________________________ 
Investigator’s name:  ___________________________ 
Signature:   ___________________________ 
Witness’s name:   ____________________________ 
Signature:   ____________________________  










Personal Details  
Name___________________________________________________________________________ 
Surname_________________________________________________________________________ 
Postal address______________________ Code ____________________________ 
Email adress____________________________________________________________ 
Phone  number_________________ Cell Phone ____________________ 
Date of birth _________________________Age  ____________________ 
Gender______________________________ Occupation _____________________ 
Ethnic group (only required and used for research purposes) 
Black African   White   Mixed  Ancestry (coloured)  
Indian   Asian   Other   
Ancestry (Tribal or National background - E.g. Xhosa, Dutch, Italian): _____________________ 
Dominant hand:  Left • Right  • 
Dominant leg  :   Left Right  • 
Medication and supplement use  
What medication, if any are you currently using ? 





What dietary supplements/vitamins, if any are you currently using? 
Type of supplement   Name     Years taken 






Do you currently participate in a sport/physical activity on 2 or more days per week? 




In the past two years have you ever participated in any team sport or physical activity on 2 or more days per week  
Yes  •  No  • 
If yes, type of activity or sport ___________ No" of years _______________ 






a) Please read each question very carefully before answering.
b) Answer ALL twenty questions.
c) Answer questions in numerical order.
d) Each question should be answered independently of others. DO NOT go back and check your answers.
e) For some questions, you are required to respond by placing a cross alongside your answer. In such cases, select ONE
answer only. 
f) Please answer each question as honestly as possible. Both your answers and results will be kept in strict confidence.
QUESTION 1 
Considering your own feelings about when you are “at your best”, at what time would you get up if you were entirely 
free to plan your day? 
Time:  
QUESTION 2 




If there is a specific time you have to get up in the morning, to what extent are you dependent on being woken up by 
an alarm clock? 





Assuming adequate environmental conditions, how easy do you find getting up in the morning? 





How alert do you feel during the first half hour after having woken in the morning? 





How is your appetite during the first half hour after having woken in the morning? 











When you have no commitments the next day, at what time do you go to bed compared to your usual bedtime? 
a. Seldom or never later
b. Less than one hour later
c. 1-2 hours later
d. More than 2 hours later
QUESTION 9 
You have decided to engage in some physical exercise. A friend suggests that you do this one hour twice a week and the 
best time for him/her is between 7.00-8.00 am. Bearing in mind nothing else but your own inclinations, how do you 
think you would perform? 
a. Would be on good form
b. Would be on reasonable form
c. Would find it difficult
d. Would find it very difficult
QUESTION 10 
At what time in the evening do you feel tired and in need of sleep? 
Time:  
QUESTION 11 
You wish to be at your peak for a test which you know is going to be mentally exhausting and last for two hours. You 
are entirely free to plan your day. When would you do this task? 
a. 8.00 am – 10.00 am
b. 11.00 am – 1.00 pm 
c. 3.00  pm – 5.00 pm
d. 7.00 pm – 9.00 pm
QUESTION 12 
If you went to bed at 11.00 pm at what level of tiredness would you be at that time? 
a. Not at all tired




For some reason you have gone to bed several hours later than usual, but there is no need to get up at any particular 
time the next morning. Will you: 
a. Wake up at the usual time and not go back to sleep
b. Wake up at the usual time and doze
c. Wake up at the usual time and go back to sleep
d. Wake up later than usual
QUESTION 14 
One morning you have to remain awake between 4.00 am and 6.00 am in order to carry out a watch duty. You have no 
commitments the next day. Which ONE of the following alternatives suits you best? 
a. Would NOT go to bed until 6.00 am
b. Nap before 4.00 am and sleep after 6.00 am
c. Sleep before 4.00 am and nap after 6.00 am
d. Only sleep before 4.00 am and remain awake after 6.00 am
QUESTION 15 
You have to do 2 hours of hard physical work. If you were completely free to plan your day, and considering only your 
“feeling best” rhythm, which hours would you prefer to do it between: 
a. 8.00 am – 10.00 am
b. 11.00 am – 1.00 pm 
c. 3.00 pm – 5.00 pm
d. 7.00 pm – 9.00 pm
QUESTION 16 
You have decided to engage in some physical exercise. A friend suggests that you do this between 
10.00 pm and 11.00 pm twice a week. How do you think you would perform? 
a. Would be on good form
b. Would be on reasonable form
c. Would find it difficult
d. Would find it very difficult
QUESTION 17 
Suppose that you can choose your own work hours, but had to work FIVE hours in the day. Assume that your job is 
interesting and paid by results. Which FIVE CONSECUTIVE HOURS would you choose? 
Hours:   
QUESTION 18 





One hears of “morning” and “evening” types. Which do you consider yourself to be? 
a. Morning type     
b. More morning than evening   
c. More evening than morning  
d. Evening type     
 
QUESTION 20 
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KEY PERFROMANCE INDICATORS TABLE 
Table 3.A: Definition of Key Performance Indicators used for game statistics analysis  
Variable Definition 
Breakdown The period immediately after a tackle, before and during the ensuing ruck, when teams compete 
for possession of the ball, initially with their hands and then using their feet in the ruck. 
Charge down When a player makes a defensive clearance kick, but it hits an opponent who has run towards him 
in an attempt to block it. 
Conversion An opportunity to “convert” for a further two points after a team scores a try by kicking the ball 
between the posts and above the crossbar. 
Drop goal Scored when a player kicks the ball from hand through the- ‘opposition’s goal post, but the ball 
must touch the ground between being dropped and kicked. 
Drop kick When a player kicks the ball from hand and the ball touches the ground between being dropped 
and kicked. 
Goal When a player kicks the ball through the plane bounded by the two uprights and above the 
crossbar. 
Handling error Errors incurred by the players, including knock-ons, forward passes, and balls dropped behind 
which do not result in a penalty. 
High tackle Also known as head-high tackle, is a form of tackle where the tackler grasps the ball carrier above 
the line of the shoulders.  
Line break When a player running with the ball breaks the line of defence. 
Line-out A maximum of seven and a minimum of two forwards line up parallel with each other between the 
five-metre and 15-metre lines. The hooker of the team in possession throws the ball in while his 
opposite number may stand in between the touchline and the five-metre line.  
Penalty Signal awarded for serious infringements like dangerous play, off-sides and handling the ball on the 
ground in a ruck. 
Penalty try Try awarded under the posts when the opposing team illegally prevents a try from being scored. 
Red card Signal shown to players who have been ordered off the field, which results in the player being 
removed from the game without being replaced. 
Successful pass Passes made that successfully went to the hand of a supporting player, including off-loads. 
Tackle Takes place when one or more opposition players grasp onto the ball carrier and succeed in bringing 
him to ground and holding him there. 
Tackle break When a tackle was made against the opponent, but was unsuccessful. 
Try Scored when a player places the ball on the ground with downward pressure in the in-goal area 
between and including the goal-line and up to, but not including dead ball line of the opposition's 
half. 
Turnover When a player turns over the ball to an offensive situation from a defensive tackle. 
Yellow card Signal shown to a player who has been cautioned “indicate temporary suspension" for repeated or 
deliberate infringements of the rules. 
Adapted from Fuller et al. (2007) 
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ILLNESS, INJURY AND CIRCADIAN RHYTHM IN ELITE RUGBY PLAYERS DURING THE 2012 
SUPER 15 TOURNAMENT 
PARTICIPANT INFORMATION SHEET 
Background 
The UCT/MRC Research Unit for Exercise Science and Sports Medicine together with colleagues from New 
Zealand and Australia (team physicians of participating teams) would like to study (i) the incidence and nature of 
medical illness and (ii) the influence of inter-individual variation in circadian rhythm on performance and 
incidence of illness and injury in rugby players during this tournament. This particular tournament is of interest 
since the strenuous schedule sees matches spanning 16 weeks (February to May 2012), during which 15 
international rugby teams compete at different venues in South Africa, Australia and New Zealand. The 
competition is also unique in that the players are required to travel between venues in South Africa, Australia 
and New Zealand - often up to 9 hours across different time zones.  
Firstly, we are interested in determining how common injuries and a variety of medical conditions and illness are 
in rugby players during the tournament. For example, it is known that athletes, who train hard and then 
participate in strenuous competition, have increased respiratory tract symptoms (runny nose, sore throat, 
sinusitis, enlarged lymph glands in the neck, and even cough and chest pain with fever and headaches). However, 
these symptoms may not always be due to an infection but could be as a result of allergies or pollution. It has 
also been shown that apart from respiratory tract illness, other illnesses are very most common during 
competitions such as at the Olympic Games. These illnesses include gastro-intestinal symptoms, allergies, skin 
conditions, and other infections. These patterns of illness have not been studied in rugby players, particularly 
during competitions.  
Secondly, one of the unique aspects of the Super 15 tournament is that the players are required to travel across 
many time zones between matches. Such travel is known to disrupt circadian (24-hour) rhythm – experienced as 
jet lag. This is turn may impact performance. Your body’s 24-hour rhythm is also partially determined by your 
genetic makeup. For example, a variant in one of your “clock” genes may determine whether you are a morning 
or evening person (also known as diurnal preference). We are interested in whether rugby players tend to be 
morning or evening types, and how travel across time zones might affect performance and/or incidence of injury 
and illness in rugby players. 
Aims of the research 
1. To document (i) the incidence of injuries and (ii) the incidence of medical illness in rugby players
participating in the 2012 Super 15 Rugby tournament.
2. To relate the incidence of injuries and medical conditions/illness to 1) past medical history, 2) training
history and load, and 3) environmental conditions (time zone changes, temperature, humidity, pollen
counts, and atmospheric pollution) at the time of the 2012 Super 15 Rugby tournament.
3. To describe the chronotype distribution of the rugby players participating in the 2012 Super 15 Rugby
tournament.
4. To describe the distribution of circadian rhythm gene polymorphisms (such as Per3 VNTR) of the rugby
players participating in the 2012 Super 15 rugby tournament.
5. To compare the differences in performance of the morning and evening-type rugby players travelling in
both East-West and West-East directions
6. To compare the differences in the incidence of illness and injury of the morning and evening-type rugby
players travelling in both East-West and West-East directions.
Your possible involvement 
The UCT Research Office has provided your team doctor with all the information regarding the study, the details 
of which are explained in this document. As a participant in the 2012 Super 15 Rugby tournament, you are given 
the choice to participate in this research effort. Your participation is entirely voluntary. 
Should you agree to participate, you would be asked to do the following: 
Prior to the beginning of the tournament: 
 Complete a medical questionnaire (this can be done together with your team doctor). This questionnaire,
which deals with medical, training and circadian rhythm information, will be anonymous and only a coding
system will be used to identify your team.
 Donate a 5ml (1 teaspoon) blood sample from a vein in your arm. This will be used for the extraction and
analysis of genetic material (DNA). The DNA will only be used for scientific research purposes relating to
circadian rhythm. All data will be analysed anonymously and DNA samples will be destroyed on completion
of the study
During the competition: 
 Every day your team doctor will ask you about possible medical conditions and injuries. This information
will be recorded anonymously on a sheet (or in electronic format) that will be sent to the investigators. If
you suffer from any injury or disease/condition, your team doctor will treat it in the usual fashion.
Potential risks of this study 
 The completion of a questionnaire is not associated with any risk. Questionnaire and other clinical data
(paper and electronic) will be kept confidential and secure, and will not be made available to any party other
than the research team without the consent of the individual participants.
 The potential risks to participants of blood collection are minimal and are related to 1) blood sample
collection technique, and 2) the volume of blood collected prior to a match and the potential risk of a
decreased performance in a subsequent match. The potential risks associated with blood collection
technique from the ante-cubital veins are: infection, delayed healing, haematoma, physical pain, mental
discomfort and injury to a nerve or a vessel. These risks are small and will be minimized by the use of trained
phlebotomists, use of sterile techniques and the use of disposable, single-use materials. The risk of
decreased performance as a result of blood collection will be reduced by not subjecting any participant to
the collection of a blood volume exceeding 15ml prior to a match.
 Your personal genetic information will not be made known to you, your team mates, team medical team,
coaches, trainers or management. The information will only be used for research purposes.
 All medical conditions and injuries will be treated by the team doctor.
 You may withdraw from this study at any time without question.
Potential benefits of this study 
The research questions that will be addressed by this study have been identified to have a direct impact on 
improving medical care to rugby players in general, and specifically those who visit South Africa during future 
Super 15 Rugby competitions. The anticipated benefits of this study are that the results will further our 
understanding of the possible cause/s of medical conditions and injuries, and relationship between circadian 
rhythm and performance in rugby players who travel to participate in international competitions. 
Contact 
Please feel free to contact your team doctor, the UCT Research Office or members of the research team should 
you have any questions related to the study. Your team doctor has the contact details of the UCT Research Office 
and the research team. You can also call the following numbers of the principal investigators Prof Martin 
Schwellnus (+27-83-4543783) or Dr Dale Rae (+27-72-1413143). 
Faculty of Health Sciences - Research Ethics Committee 
Room E52-24, Old Main Building, Groote Schuur Hospital, Observatory, 7925 
Tel: (021) 406 6338 
Fax: (021) 406 6441 
Email: nosi.tywabi@uct.ac.za 
University of Cape Town Research Ethics approval number: REC REF 008/2011 
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CONSENT FORM 
I understand that a study entitled “Illness, Injury and Circadian Rhythm in Elite Rugby Players During the 2012 
Super 15 Rugby tournament” will be conducted by the UCT/MRC Research Unit for Exercise Science and Sports 
Medicine (University of Cape Town). 
I understand that my participation in this research project has no direct benefits to me during the 2012 Super 15 
Rugby tournament. However, I understand that my participation will advance the medical and scientific 
knowledge related to rugby. Therefore, information gathered through my participation in this project could 
advance the future medical care, training advice and performance of rugby players. 
I have read the Participant Information Sheet and understand that the study involves the following components: 
Completion of a medical questionnaire before the tournament  
The completion of the questionnaire is not associated with any risk. All the questionnaire data and other clinical 
data (paper and electronic) will be kept confidential, secure and will not be made available to any party other 
than the research team without the consent of the individual concerned. 
I agree that the all the information, which will be collected by my team doctor before the tournament, may be 
used to answer scientific questions about (i) the medical conditions associated with the participation in and 
completion of a rugby tournament and (ii) inter-individual variation in circadian (24-hour) rhythms of rugby 
players. 
Blood sample collection for genetic studies before the tournament 
Prior to the tournament, I have agreed to donate 5mL (1 teaspoon) of venous blood. The sample will be used for 
the extraction and analysis of genetic material (DNA). 
The potential risks associated with the blood collection technique from the veins on my arm (ante-cubital veins) 
are: infection, delayed healing, blood clot (haematoma), physical pain, mental discomfort and injury to a nerve 
or a vessel. These risks are small and will be minimized by the use of staff that are trained to take blood samples 
(trained phlebotomists), use of sterile techniques and the use of disposable, single-use materials. The risk of 
decreased performance as a result of blood collection will be reduced by not subjecting any participant to the 
collection of a blood volume exceeding 15 ml prior to a match. 
The genetic material (DNA) that is extracted from my blood will only be used for scientific research purposes. I 
understand that the DNA will be analysed for variations within genes related to circadian rhythm. I also 
understand that all data will be analysed without revealing any of my personal details (anonymously) and my 
DNA sample will be destroyed on completion of the study. I realise that I have the right to request that my DNA 
sample be destroyed at any time.   
I understand that whilst there is no direct benefit to myself if a genetic predisposition for diurnal 
(morning/evening) preference in rugby players can be established, this research may lead to improved 
adaptation techniques available to travelling sports people to new time zones in the future. I understand 
that I will receive only the overall results of this part of the study. 
Daily information during the rugby tournament 
I agree that the all the information, which will be collected by my team doctor on a daily basis during the 
tournament, may be used to answer scientific questions about the medical conditions and injuries that are 
associated with the participation in and completion of a rugby tournament.  
I have read (or, where appropriate, have had read to me) and understood the information about this study 
provided in the preceding Participant Information Sheet. Any questions I have asked have been answered to my 
satisfaction. I agree that research data provided by me or with my permission during the study may be included 
in a thesis, presented at conferences and published in journals on the condition that neither my name nor any 
other identifying information is used. I understand that the medical staff and the research team have professional 
medical insurance.  
I understand that I may withdraw from this study at any time without further question.  
I hereby consent to participate in this study. 
Player accreditation number: __________ Name of the team doctor: __________ 
Signature of the player: _________ Signature of the team doctor: ____________ 
Date: ____________ Date: _______________________ 
Name of the investigator: _________ Signature of the Investigator: ______ Date: __________ 
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DAILY REPORT ON ILLNESS DURING THE 2012 SUPER 15 RUGBY TOURNAMENT 
Country __________________Physician’s name _________________Date of report _____/_____2011 
Location:  South Africa ______New Zealand ___Australia ___   City: _______________ 
Contact details Tel _______________ Fax ______________email ______________@_______________ 
Please report all new and recurrent illness in competition or training during the 2010 Super 14 Rugby tournament 
regardless of the consequences with respect to absence from competition or training. Illness is any medical 
condition for which the player consulted with the team physician. 
Illness Squad size:___ 
Player’s accreditation no. Affected system code Final diagnosis code Date of illness onset 
Main symptoms/signs code Cause of illness code Treatment (free text) Absence in days 
Player’s accreditation no. Affected system code Final diagnosis code Date of illness onset 
Main symptoms/signs code Cause of illness code Treatment (free text) Absence in days 
Player’s accreditation no. Affected system code Final diagnosis code Date of illness onset 
Main symptoms/signs code Cause of illness code Treatment (free text) Absence in days 
Player’s accreditation no. Affected system code Final diagnosis code Date of illness onset 
Main symptoms/signs code Cause of illness code Treatment (free text) Absence in days 
Player’s accreditation no. Affected system code Final diagnosis code Date of illness onset 
Main symptoms/signs code Cause of illness code Treatment (free text) Absence in days 
No illness in any player of our team today  
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Codes For Illness 
Affected system (codes A to N) 
A  Respiratory system H  Endocrine, nutritional or metabolic diseases 
B  Ears and mastoid  I  Mental and behavioural disorders 
C  Digestive system J  Nervous system 
D  Genitourinary system K  Skin & subcutaneous tissue 
E  Circulatory system L  Eye and adnexa 
F  Other infections and parasitic disease M  Specific medical conditions related to sports 
G  Hematological and immune system N  Other symptoms, signs, abnormal clinical and laboratory 
findings 
Final diagnosis code (according to affected system) 
Respiratory system – diagnostic codes: A 
A1 Acute upper respiratory 
infections 
A5  Allergic sinusitis A9  Exercise induced bronchospasm 
A2  Acute infective rhinitis A6 Influenza A10  Other acute lower respiratory tract 
infection 
A3  Acute infective sinusitis A7  Pneumonia A11  Other disease of the respiratory tract 
A4  Allergic rhinitis A8  Asthma 
Ears and mastoid – diagnostic codes: B 
B1  External ear infections B3  Middle ear infections B5  Inner ear disease 
B2  Other external ear disease B4  Other middle ear disease B6  Other ear disease 
Digestive system – diagnostic codes: C 
C1  Diarrhoea and gastroenteritis 
(infective) 
C4  Gastro-oesophageal reflux C7  Hernia 
C2  Diarrhoea and gastroenteritis (non-
infective) 
C5  Dyspepsia C8  Liver disease 
C3  Vomiting (no diarrhea – non specific) C6 Abdominal pain (non-
specific) 
C9  Other digestive system disease 
Genito-urinary system – diagnostic codes: D 
D1  Urethritis (infective) D4  Prostatitis D7  Proteinuria  
D2  Cystitis (infective) D5  Nephritis (infective) D8  Hematuria 
D3  Testicular disease (infective) D6  Other genitor-urinary infection D9  Other genito-urinary disease 
Circulatory system – diagnostic codes: E 
E1  Hypertension E4  Pulmonary embolism E7  Endocarditis 
E2  Arrhythmia E5  Pericarditis E8  Peripheral vascular disease 
E3  Ischaemic heart disease E6  Myocarditis E9  Other circulatory disease 
Other infections and parasitic disease – diagnostic codes: F 
F1  Other viral infections F3  Other fungal infections F5  Other infections 
F2  Other bacterial infections F4  Other parasitic infections 
Haematology and immune system – diagnostic codes: G 
G1  Anaemia (iron deficiency) G4  Bleeding disorder G7  Other immune system disease 
G2  Anaemia (other nutritional) G5  Other hematological disease 
G3  Anaemia (other) G6  Immune suppression 
Endocrine, nutritional and metabolic disease – diagnostic codes: H 
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H1  Thyroid gland disorder H3  Hypoglycemia H5  Other metabolic disease 
H2  Diabetes mellitus H4  Other endocrine disease 
Mental and behavioural disorders – diagnostic codes: I 
I1  Depression I3  Eating disorder I5  Chronic fatigue 
I2  Anxiety I4  Sleep disorder I6 Other mental or behavioral 
disorder 
Nervous system disease – diagnostic codes: J 
J1  Headache J2  Epilepsy J3  Other nervous system/muscle 
disease 
Skin and subcutaneous tissue – diagnostic codes: K 
K1  Viral skin infection K4  Other skin infection K7  Urticaria 
K2 Bacterial skin infection K5  Allergic dermatitis K8  Sunburn 
K3  Fungal skin infection  K6  Pruritis K9 Other skin/subcutaneous 
diseases 
Diseases of the eye and adnexa – diagnostic codes: L 
L1  Blepharitis (eyelid 
inflammation) 
L3  Conjunctivitis (allergic) L5  Other inflammatory eye disease 
L2  Conjunctivitis (infective) L4  Keratitis L6  Other eye disease 
Specific medical conditions related to sports participation – diagnostic codes: M 
M1 Hyperthermia (heat 
exhaustion) 
M4  Collapse (post- exercise) M7 Dehydration 
M2  Hyperthermia (heat stroke) M5  Collapse (during exercise) M8  Other medical condition with 
exercise 
M3  Hypothermia M6  Muscle cramping (EAMC) 
Team: 
_____________ 
Team Physician:  _____________ 
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DAILY REPORT ON INJURY DURING THE 2012 SUPER 15 RUGBY TOURNAMENT 
Country __________________Physician’s name _________________Date of report _____/_____ 2011 
Location:  South Africa ___New Zealand ___Australia ___   City: _______________ 
Contact details Tel _______________ Fax ______________email ______________@_______________ 
Please report: (1) All injuries (traumatic and overuse) newly incurred in match or training and 
(2) all illness regardless of the consequences with respect to absence from competition or training.
The information provided is for medical and research purposes and will be treated confidentially. 
(1) Injury:
Player no. match or training time / minute of match date of injury 
injured body part, side code type of injury code cause of injury code absence in days 
Player no. match or training time / minute of match date of injury 
injured body part code type of injury code cause of injury code absence in days 
Player no. match or training time / minute of match date of injury 
injured body part code type of injury code cause of injury code absence in days 
Player no. match or training time / minute of match date of injury 
injured body part code type of injury code cause of injury code absence in days 
Player no. match or training time / minute of match date of injury 
injured body part code type of injury code cause of injury code absence in days 
No injury in any player of our team today   
How many hours did your team train today? _________hours 
Absence from normal training or match play (in days) 
Please provide an estimate of the number of days that the player will not be able to undertake his normal 
training programme or will not be able to play. 
 0 =  0 days 7 = 1 week 28 = 4 weeks 
 1 =  1 day 14 = 2 weeks > 30 = more than 4 weeks
 2 =  2 days 21 = 3 weeks >180= 6 months or more 
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For injuries 
Injured body part - Location of injury 
Head and trunk Upper extremity Lower extremity 
1 face (incl. eye, ear, nose)  11 shoulder / clavicle 21 hip 
2 head  12 upper arm 22 groin 
3 neck / cervical spine 13 elbow 23 thigh 
4 thoracic spine / upper back 14 forearm 24 knee 
5 sternum / ribs  15 wrist 25 lower leg 
6 lumbar spine / lower back 16 hand 26 Achilles tendon 
7 abdomen 17 finger 27 ankle 
8 pelvis / sacrum / buttock 18 thumb 28 foot / toe 
Type of injury - Diagnosis 
1 concussion (regardless of loss of consciousness) 11 contusion / haematoma / bruise 
2 fracture (traumatic) 12 tendinosis / tendinopathy 
3 stress fracture (overuse) 13 arthritis / synovitis / bursitis 
4 other bone injuries 14 fasciitis / aponeurosis injury 
5 dislocation, subluxation 15 impingement 
6 tendon rupture  16 laceration / abrasion / skin lesion 
7 ligamentous rupture  17 dental injury / broken tooth 
8 sprain (injury of joint and/or ligaments) 18 nerve injury / spinal cord injury 
9 lesion of meniscus or cartilage 19  muscle cramps or spasm 
10 strain / muscle rupture / tear 20  other 
Cause of injury 
1 overuse (gradual onset) 3 non-contact trauma 5 contact with another player 
2 overuse (sudden onset) 4 recurrence of previous injury 6 foul play (overt & hidden fouls) 
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RECRUITMENT POSTER 
PARTICIPANTS WANTED FOR UCT RESEARCH 
HOW CAN WE SPEED UP RECOVERY FROM JET-LAG? 
The aims of this study are (i) to determine to what extent an aspect of your genetic makeup governs the speed 
and timing of recovery from jet-lag, and (ii) to determine whether exposure to blue and yellow light in the 
morning can enhance recovery from jet-lag. 
We are looking for males with low levels of physical activity. 
If you: 
 Are between 18 and 40 years of age
 Sleep between 6 and 10 hours per night
 Do no more than two days of physical activity per week
You can volunteer for this study 
What is involved? 
 Part A: Complete a questionnaire and donate a cheek cell sample to determine your genetic variant
for a gene linked to sleep behaviour and preference for mornings or evenings (i.e. lark v owl 
behaviour) 
 Part B: Eligible participants will then be asked to stay in our Chronobiology and Sleep lab for one four-
period so that we can simulate jet-lag and then measure your recovery.
What are the benefits? 
 Personal feedback (e.g. personal preference for either mornings or evenings, sleep quality, colour
blind test, resting energy expenditure levels, response to jet-lag) as well as the general results of the
study
If you are interested in taking part in the study and would like additional information, please contact: 
Lovemore Kunorozva 
KNRLOV001@myuct.ac.za 
076 956 4391 
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MEDIA RELEASE 
SPORTS SCIENCE INSTITUTE OF SOUTH AFRICA 
FOR IMMEDIATE RELEASE 
MALES REQUIRED FOR UCT STUDY ON RECOVERY FROM JET-LAG 
Anyone who has travelled east or west on an airplane may have experienced jet-lag. We are interested in how 
fast individuals recover from jet lag – that is, how quickly can your internal body clock realign with your new time 
zone? Are these differences determined by your genetic make-up? And can blue and yellow light exposure in the 
morning speed up your recovery? The aims of this study are (i) to determine to what extent an aspect of your 
genetic makeup governs the speed and timing of recovery from jet lag, and (ii) to determine whether exposure 
to blue light in the morning can enhance recovery from jet lag. Volunteers will be asked to complete a 
questionnaire and donate a cheek cell sample to determine their personal variant for a gene linked to sleep 
behavior. Eligible participants will then be asked to stay in our Chronobiology and Sleep lab for a four-period so 
that we can simulate jet lag and then measure your recovery.  
Those interested in volunteering for this research should 
 Be males between the ages of 18 and 40 years
 Normally sleep 6 – 10 hours per night
 Not normally be too physically active
Benefits of participating in the study include 
 Personal feedback (e.g. personal preference for either mornings or evenings, sleep quality, colour blind
test, resting energy expenditure levels, response to jet lag) as well as the general results of the study.
To apply or for more information, please contact: 
Lovemore Kunorozva: KNRLOV001@myuct.ac.za 076 956 4391 
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PARTICIPANT INFORMATION SHEET 
RESETTING OUR BODY CLOCKS AFTER SIMULATED JET LAG 
PARTICIPANT INFORMATION SHEET 
Dear Volunteer, 
Thank you for considering participating in this study to be conducted by researchers from the MRC/UCT Research 
Unit for Exercise Science and Sports Medicine within the Department of Human Biology and the Department of 
Molecular and Cell Biology, at the University of Cape Town. 
Why are we doing this study? 
Jet lag is something that anyone who has travelled east or west in an aeroplane may have experienced – 
especially if more than three time zones have been crossed. Jet lag occurs when you arrive in a new time zone 
and your body’s internal clock is out of synch with your new environment. While one primarily experiences 
fatigue and disturbed sleep, other symptoms may include gut disturbances, reduced mental function and 
reduced physical capacity. 
A speedy recovery from jetlag is key, not only to the general population, but also to sports teams travelling during 
tournaments and business people travelling for work. The purpose of jetlag recovery strategies is to realign your 
body clock with the new environmental time as fast as possible. Current strategies designed to enhance recovery 
from east-west travel include timed light exposure, manipulation of sleep schedules and the use of sedative or 
stimulant medication. In this study we are going to compare the effectiveness of enriched blue light exposure on 
resetting your internal clock following simulated jet lag. 
While the general rule is that for every time zone crossed, 24h of recovery time is required, it appears that this 
recovery time varies significantly between individuals. We believe that this may in part be attributed to our 
genetic make-up (i.e. differences in our DNA). For example, small differences within our “clock” genes (those 
genes involved with regulating our bodies’ internal clock) have been associated with our tendency to be owls 
(night people) or larks (morning people). Specifically, we want to know whether 3 hours of blue light therapy 
following simulated jet lag is more effective in resynchronising the body clock of individuals who carry the PER35 
gene variant – which is more common in morning people (larks) compared to evening people (owls), who are 
more likely to have the PER34 variant. 
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What is the aim of the study? 
To compare the extent to which individuals genotyped as PER34/4 and PER35/5 respond to blue light exposure to 
resynchronise their circadian rhythm following simulated eastward trans-meridian travel, based on changes in 
dim-light melatonin onset and cortisol circadian phases. 
Who can participate in this study? 
Twenty-four apparently healthy males who: 
 Are between 18 – 40 years of age 
 Normally sleep 6 – 10 hours per night 
 Are not normally very physically active 
 Are genotyped as PER35/5 or PER34/4 
 
Exclusion criteria - If any of the following criteria apply to you, you will not be eligible for the study: 
 Diagnosed chronic medical condition requiring medication  
 Any sleep disorder 
 Chronic medication known to affect sleep, cortisol, melatonin and/or circadian rhythms (past six 
months) 
 Night time or rotating shift work in past three months 
 East-west travel of three time zones or more (past 2 months) 
 Smoking 
 Normal caffeine consumption greater than 300mg per day (±10 cups instant coffee, or ±3 cups brewed 
coffee, or ±5 espressos) 
 Red-green colour blind condition 
 Body mass index >30kgm-2 (divide your body weight in kg by the square of your height in m) 
 
How long will this study last? 
This study will span about 3 weeks. Following a screening visit to establish your eligibility for the trial, you will 
then be required to have a two-week “run-in” period where you regulate your sleep patterns at home. This will 
be followed by a 98-hour (4 days and 2 hours) in-laboratory intervention trial.  
 
What do we want you to do? 
Screening visit (±1 hour) 
First, to determine whether you would like to participate and whether you are eligible for the study, we ask you 
to visit us for screening. The researcher will explain the study in detail to you, including the risks and benefits 
associated with participating. You will be free to ask any questions you may have relating to the study. Should 
you agree to participate, you will sign a consent form and be asked to complete a questionnaire detailing your 
personal information; medical history; work, travel, sleep and physical activity habits. The questionnaire will also 
include sections on your sleep quantity and duration, as well as your daytime sleepiness levels and your “diurnal 
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preference” – that is whether you are more of a morning person (lark) or an evening person (owl). This should 
take about 30 minutes to complete.  
 
The investigator will measure your height and weight, following which you will complete a test to determine 
whether or not you are colour blind. Next, we will measure your resting metabolic rate – that is how much energy 
you use when lying down. To do this, you will be asked to lie down and relax with your head and shoulders 
beneath a ventilated hood so that the oxygen and carbon dioxide levels in your expired air can be measured. 
From this, the researchers are able to calculate your energy expenditure (metabolic rate). Lastly, the investigator 
will use a cotton wool swab to gently obtain a sample of your cheek cells. This is painless and non-invasive. We 
will extract your DNA from these cells to test for a variant within the PER3 gene - one of your clock genes. Based 
on this genetic analysis, 12 volunteers genotyped as PER35/5 (genetic variant associated with “morningness”) and 
12 with the PER34/4 genotype (associated with “eveningness”) will be invited to participate in the intervention 
phase of this study. 
 
Prior to the intervention visit 
We want to ensure that you are well rested and not sleep deprived before you begin the intervention trials in 
this study. Therefore we ask that for two full weeks prior to the trials you maintain a regular sleep/wake 
schedule. This will be based on your normal wake-up and bed times during the week, such that you go to sleep 
and wake-up within an hour of these normal times. The catch is, though, that we will ask you to try to spend one 
extra hour in bed each night. To monitor this, we will ask you to wear a simple device on your wrist for the second 
week of this period that tracks your movement. It is pretty good at determining when you are awake (more 
active) and asleep (less active). During this week we also ask that you complete a daily logbook documenting 
your wake-up and bed times and your daytime sleepiness levels. Seven, four and one day prior to the trial, you 
will also record all that you eat and drink for these three 24h periods using an online tool to do so. We do this so 
that we can plan for your meals during the interventions! Lastly, we ask that you please refrain from consuming 
alcohol and caffeine and using non-steroidal anti-inflammatories 24h before the trial begins. 
Intervention trial 
For this part of the study we require you to stay at our Chronobiology and Sleep (CBS) Lab for a 98-h period (4 
days and 2 hours). The CBS lab is a specially designed space, which is sound- and light-proof, and comprises a 
bedroom, lounge area, bathroom and kitchen. During these four days you will not be allowed contact with the 
outside world – that is all time cues from sources such as outdoor light, phones, computers, TV etc. will be 
removed. You will however be in the company of the study investigators at all times, and may share the 
laboratory with other participants. During periods of wakefulness, participants will be able to interact with each 
other in a common seating area. You will retire to individual or partitioned bedrooms for sleep opportunities. 
Ablutions will be carried out in a shared bathroom to which you will have individual access and the option to lock 
the door. Please note that you have the right to withdraw from the study at any time, including during the 
intervention trial period. There are two reasons for this isolation. First, we want to measure the natural timing 
of your body’s internal clock. Second, we want to simulate jet lag by putting you in a new “time zone” so that we 
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can then measure your recovery. We do this by using what is called a “constant routine” protocol combined with 
sleep deprivation. Essentially, we keep you awake for 28 hours in dim light conditions. During this time you will 
be required to remain awake, but be relatively inactive. You will be able to read, play board games, work on your 
computer (but no internet and the clocks will be disabled), watch TV (pre-recorded, not live TV) and we will give 
you hourly snacks. The investigator will ensure that you are awake during scheduled waking periods, and will 
engage with you regularly to prevent you from sleeping at these times. 
After this constant routine period, you will be given an 8h sleep opportunity. When you wake up, you will have 
a 3h light therapy session. This will be with blue-enriched light (a special lamp which emits blue wavelength 
light). The light therapy session is important, as blue light can speed up your recovery from the imposed jet lag. 
You will have breakfast during the light therapy session, and for the rest of the day you will remain relatively 
inactive (as for the previous day) in dim light, and will be served lunch and dinner. At the end of the day you will 
be given a second 8-hour sleep opportunity, followed by a second 28-h constant routine period (identical to the 
first one). Prior to leaving the lab, you will have third 8-h recovery sleep opportunity. 
Near the beginning of the trial a trained staff member is going to insert a small tube into a vein in your arm (called 
a cannula, much like a drip) so that we can obtain regular hourly blood samples (less than one teaspoon at a 
time) from you for a 7h period on day one and a 10h period on days 3 into 4. In addition, we will also ask you to 
give us hourly saliva samples for two 7h periods on days 2 and 3 into 4. We will analyse these samples for a 
hormones called melatonin and cortisol – which are both very good markers of the timing of your internal body 
clock. Based on the levels of these markers that we observe, we will be able to determine how well and/or fast 
your body’s internal clock has recovered following simulated jet lag. Periodically throughout the trial we will also 
measure your resting metabolic rate so that we can have an indication of whether your body is adjusting to the 
new time zone on a physiological (i.e. systems) level. 
What are the risks of participating? 
The completion of a questionnaire is not associated with any risk. Questionnaire and other clinical data (paper 
and electronic) will be kept confidential, will be kept secured, and will not be made available to any party other 
than the research team without your consent. Electronic files will also be kept confidential. There are no risks 
related to donating either cheek cell or saliva samples. The potential risks relating to blood collection from 
forearm veins include: infection, delayed healing, bruising, physical pain, mental discomfort and injury to a nerve 
or a vessel. These risks are small and will be minimized by the use of trained phlebotomists (individuals qualified 
to draw blood samples), sterile techniques and disposable, single-use materials. The blue light in this protocol is 
actually blue-enriched white light from cool fluorescent light bulbs used for indoor lighting. The spectrum of 
these bulbs is closer to natural sunlight than other indoor lighting, and thus there are no adverse effects 
anticipated from exposure to light from this source. There are also no risks associated with measuring your 
metabolic rate using the ventilated hood technique or with either of the light therapies to be used in this trial. 
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The combination of undergoing simulated jet lag and one night of total sleep deprivation may cause discomfort 
(mental and physical). The risk associated with simulating jet lag is that when the trial ends you may be tired and 
have difficulty sleeping for a few days afterwards. Acute sleep deprivation, such as you will experience during 
this protocol, is associated with reduced mental performance and impaired coordination, similar to those 
induced by alcohol consumption. During this time you will be in the care of the study investigators, and will only 
be able to go home following a recovery sleep – which reverses the effects of sleep deprivation.  
What if something goes wrong? 
Any medical emergency will be managed based on the basic life support protocol implemented at both ESSM 
and the Sports Science Institute of South Africa (SSISA) during the four-day intervention trial period. Should a 
medical emergency arise, the investigator on duty will trigger the emergency alarm in the CBS laboratory, which 
is connected to the Medical Practice located at SSISA during working hours, and to the SSISA Main Reception 
front desk after hours. During working hours, a medical doctor within SSISA will immediately respond to the 
emergency. During after hours, the receptionist on duty at SSISA will contact one of the following: Metro, 
Netcare, Life healthcare emergency or the Claremont 24h emergency unit to dispatch an ambulance The 
investigator on duty can also dial the 112 Emergency call from his/her cell phone. There is also an automated 
external defribillator (AED) and a crash cart with resuscitation equipment on first floor of the SSISA building, 
which is in close proximity to the CBS lab. The investigators in this study have been trained in basic life support 
and cardiopulmonary resuscitation. At any given time during a trial, one of them will always be on site and thus 
able to initiate the emergency plan. 
The University of Cape Town (UCT) undertakes that in the event of you suffering any significant deterioration in 
health or well-being that is caused by your participation in the study, it will provide immediate medical care. UCT 
has appropriate insurance cover to provide prompt payment of compensation for any trial-related injury 
according to the guidelines outlined by the Association of the British Pharmaceutical Industry, ABPI 1991. 
Broadly-speaking, the ABPI guidelines recommend that the insured company (UCT), without legal commitment, 
should compensate you without you having to prove that UCT is at fault. An injury is considered trial-related if, 
and to the extent that, it is caused by study activities. You must notify the study doctor immediately of any side 
effects and/or injuries during the trial, whether they are research-related or other related complications 
UCT reserves the right not to provide compensation if, and to the extent that, your injury came about because 
you chose not to follow the instructions that you were given while you were taking part in the study. Your right 
in law to claim compensation for injury where you prove negligence is not affected. Copies of these guidelines 
are available on request 
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What are the benefits of participating? 
On completion of the study you will receive personal feedback (e.g. preference for either mornings or evenings, 
sleep quality, resting metabolic rate) as well as the general results of the study when completed. 
Is there any reward for taking part in this study? 
On completion of the intervention phase of the trial you will receive R800.00 as partial compensation for your 
time and travel. 
What are the ethical considerations? 
This study will be performed in accordance with the principles of the Declaration of Helsinki (October 2013, 
Fortaleza, Brazil), International Conference on Harmonisation and the South African Good Clinical Practice 
guidelines, and the laws of South Africa. This trial will be covered by the University of Cape Town’s No Fault 
Compensation Insurance cover for clinical trials and/or human volunteer studies (Policy 713/SPRGL1400443). 
You will not be included in the study unless you have signed a consent form, after the investigator has provided 
substantial verbal and written explanation of the study, including risk factors. Participation in the study is entirely 
voluntary and you have the right to withdraw from the study at any time without stating a reason. The 
investigator may also withdraw you from the study at any time. All the information collected during the trial will 
be stored in a computer database in a secure facility, will be kept confidential and will only be used for scientific 
purposes. Your anonymity will be ensured should the data be published. The DNA collected for this study will 
only be used for the purposes described above. The DNA samples will be destroyed at the end of the study. 
Alternatively, you may request that your DNA sample be destroyed prior to the end of the study should you so 
desire.  
Contact 
Please do not hesitate to contact us should you require any additional information. You may contact the HREC if 
you have any questions or concerns about your rights or welfare as research participants. It is advisable that you 
inform family/friends that you are taking part in this trial and give them these contact details should they need 
to contact you in an emergency. Our contact information is listed below. 
Faculty of Health Sciences – Human Research Ethics Committee (HREC) 
Room E52-24, Old Main Building, Groote Schuur Hospital, Observatory, 7925 
Tel: (021) 406 6338  Fax: (021) 406 6441  Email: nosi.tywabi@uct.ac.za 
Investigators 
Principal investigator: Dr. Laura Roden 021 650 5322 Laura.Roden@uct.ac.za 
Principal investigator: Dr. Dale Rae 021 650 4577 Dale.Rae@uct.ac.za 
Student investigator: Lovemore Kunorozva 021 650 4691 KNRLOV001@myuct.ac.za 
Collaborator: Dr  Jacolene Kroff 021 650 5126 Jacolene.Kroff@uct.ac.za 
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INFORMED CONSENT 
I, the undersigned, have read and understood the above information and have been fully informed verbally about 
the study entitled “Resetting our body clocks after simulated jet lag” to be conducted by researchers from the 
MRC/UCT Research Unit for Exercise Science and Sports Medicine (ESSM) within the Department of Human Biology 
and the Department of Molecular and Cell Biology at the University of Cape Town. 
I agree to visit the Chronobiology and Sleep (CSB) laboratory on two occasions. The first (screening visit) is to 
determine my eligibility for the study. I agree to donate a cheek cell sample to determine my genotype for a variant 
within the PERIOD3 gene as described in the participant information section above. Should I be eligible for the 
intervention phase of the study, I agree to spend one four-day period in the CBS lab. I understand that I will be 
isolated from the outside world for this four-day period and that I will undergo jet lag simulation and two nights of 
total sleep deprivation, as well as light therapy to enhance my recovery from jet lag. I also understand that regular 
blood and saliva samples will be collected from me to assess my recovery from jet lag. 
I have been fully informed about the risks inherent in participation in this trial. I understand that all the information 
collected during the study will be treated confidentially, will only be used for scientific research purposes and that 
my name and personal particulars will not be released under any circumstances. 
I have been informed that I will be free to withdraw from the study at any time if I so wish without explanation. I 
will be free to ask any questions about the procedures and results of the study. I understand that I will receive, 
where applicable, personal feedback and the general results of the study once the entire study has been completed. 
I agree to participate in the study. 
Participant: 
Full name Signature Date 
Investigator: 
Full name Signature Date 
Date: Code: 
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QUESTIONNAIRE 
RESETTING OUR BODY CLOCKS AFTER SIMULATED JET LAG 
GENERAL QUESTIONNAIRE 
PERSONAL DETAILS 
Date of birth: Age : 
Gender: Ethnicity : 
OCCUPATION AND TRAVEL 
Do you currently work shifts? Yes  No  
If no, Have you ever worked shifts? Yes  No  
If yes, When did you stop working shifts?  (month, year) 
Did you work night  shifts? Yes  No  
Did you work rotating night/day shifts? Yes  No  
What are your current work hours?  (start time)  (end time) 
Have you recently travelled abroad via plane? Yes  No  
If yes, What was your final destination?   (City, Country) 
When did you arrive back in South Africa?   (Date home) 
MEDICAL HISTORY, MEDICATION AND SUPPLEMENT USE 
Do you currently suffer from any sleep disorder? Yes  No  
If yes, please list the disorder(s): 
Name of condition Person who diagnosed Date diagnosed 
Do you currently suffer from any chronic medical condition?  Yes  No  
If yes, please list the condition(s): 
Name of condition Person who diagnosed Date diagnosed 
What medication, if any, are you currently using? 
Name of medication Purpose Years taken 
What medication, if any, have you taken during the past six months, but are no longer using? 
Name of medication Purpose Years taken 
What dietary supplements / vitamins, if any, are you currently using? 
Name of supplement/Active ingredient Purpose Years taken 
Do you consider yourself to be in good health? Yes  No  
Do you currently smoke? Yes  No  
Have you ever  smoked? Yes  No  
If yes, when did you stop smoking?  (month, year) 
Are you colour   blind? Yes  No  
CAFFEINE CONSUMPTION 
How many of the following do you usually have per day? 
Instant coffee  (cups per day) 
Filter coffee  (cups per day) 
Espresso  (cups per day) 
Decaffeinated coffee  (cups per day) 
Ceylon tea  (cups per day) 
Rooibos tea  (cups per day) 
Energy drinks  (drinks per day)  (brand) 
Caffeinated soft drinks  (drinks per day)  (brand) 
Any other caffeine-containing products? 
  
 
PHYSICAL ACTIVITY HISTORY 
Over the past three months, how would you describe your level of physical activity? 
 Inactive         
 Occasionally active (At least 1 – 4 sessions per month)   
 Somewhat active  (At least 1 – 2 sessions per week)   
 Reasonably active  (At least 3 – 4 sessions per week)   
 Very active   (More than 4 sessions per week)   
 
Do you currently participate in any sports / physical activities?  Yes   No  
If yes, please describe 
Sport / Physical activity Days per week Years 
   
   
   
Has your participation included recreational competition / matches / games etc.? 
 Yes   No  
Over the past three months, what has been the average duration of your exercise sessions and / or recreational 
activity? 
 0-15min   16 – 30min    31 – 60min  
 1 – 2h    >2h    
 
What is your average total exercise time for the week? 
 <60min   60 – 90min    90 – 12min  
 2 – 3h    3–4h     >4h    
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PITTSBURGH SLEEP QUALITY INDEX QUESTIONNAIRE 
INSTRUCTIONS 
The following questions relate to your usual sleep habits during the past month only. Your answers should indicate 
the most accurate reply for the majority of days and nights in the past month. Please answer all questions by either 
giving the precise time or ticking the appropriate box. 
1. During the past month, when have you usually gone to bed at night?
Usual bed time: 
2. During the past month, how long, in minutes has it usually taken you to fall asleep each night?
Number of minutes: 
3. During the past month, when have you usually gotten up in the morning?
Usual getting up time: 
4. During the past month, how many hours of actual sleep did you get each night? (This may be different than the
number of hours you spend in bed) 
Hours of sleep per night:   
For each of the remaining questions, check the one best response. Please answer all questions. 
5. During the past month, how often have you had trouble sleeping because you…
(a) Cannot get to sleep within 30 minutes
Not during the past month  Less than once per week  
Once or twice a week   Three or more times a week 
(b) Wake up in the middle of the night or early morning
Not during the past month  Less than once per week  
Once or twice a week   Three or more times a week 
(c) Have to get up to use the bathroom
Not during the past month  Less than once per week  
Once or twice a week   Three or more times a week 
(d) Cannot breath comfortably
Not during the past month  Less than once per week  
Once or twice a week   Three or more times a week 
(e) Cough or snore loudly
Not during the past month  Less than once per week  
Once or twice a week   Three or more times a week 
(f) Feel too cold
Not during the past month  Less than once per week  
Once or twice a week   Three or more times a week 
(g) Feel too hot
Not during the past month  Less than once per week  
Once or twice a week   Three or more times a week 
(h) Had bad dreams
Not during the past month  Less than once per week  
Once or twice a week   Three or more times a week 
(i) Have pain
Not during the past month  Less than once per week  
Once or twice a week   Three or more times a week 
(j) Other reason(s), please describe
How often during the past month have you had trouble sleeping because of this? 
Not during the past month   Less than once per week 
Once or twice a week    Three or more times a week 
6. During the past month, how would you rate your sleep quality overall?
Very good  Fairly good 
Fairly bad  Very bad 
7. During the past month, how often have you taken medicine (prescribed or “over the counter”) to help you sleep?
Not during the past month  Less than once per week  
Once or twice a week   Three or more times a week 
8. During the past month, how often have you had trouble staying awake while driving, eating meals, or engaging
in social activity? 
Not during the past month  Less than once per week  
Once or twice a week   Three or more times a week 
9. During the past month, how much of a problem has it been for you to keep up enough enthusiasm to get things
done? 
No problem at all   Only a very slight problem 
Somewhat of a problem  A very big problem 
  
 
10. Do you have a bed partner or roommate? 
 No bed partner or roommate     
Partner/roommate in other room    
Partner in same room, but not same bed   
Partner in same bed     
If you have a roommate or bed partner, ask him/her how often in the past month you have had… 
(a) Loud snoring 
Not during the past month    Less than once per week   
Once or twice a week     Three or more times a week   
(b) Long pauses between breaths while asleep 
Not during the past month    Less than once per week   
Once or twice a week     Three or more times a week   
(c) Legs twitching or jerking while you sleep 
Not during the past month    Less than once per week   
Once or twice a week     Three or more times a week   
(d) Episodes of disorientation or confusion during sleep 
Not during the past month    Less than once per week   
Once or twice a week     Three or more times a week   
(e) Other restlessness while you sleep: please describe        
             
Not during the past month    Less than once per week  
Once or twice a week     Three or more times a week   
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SLEEP TIMING QUESTIONNAIRE 
INSTRUCTIONS 
This questionnaire asks about when you normally sleep. We are interested in getting as accurate a picture as we 
can of the times when you normally go to bed and get up. Please think carefully before giving your answers and be 
as accurate and as specific as you can be. Please answer in terms of a recent “normal average week,” not one in 
which you travelled, vacationed or had family crises. Thanks. 
Please think of “GOOD NIGHT” TIME as the time at which you are finally in bed and trying to fall asleep. 
1. On the night before a work day or school day:
a. What is your earliest GOOD NIGHT TIME?  PM/AM 
b. What is your latest GOOD NIGHT TIME?  PM/AM 
c. What is your usual GOOD NIGHT TIME?  PM/AM 
d. How stable (i.e., similar each night) are your GOOD NIGHT TIMES? (please tick one)
0-15min  16-30min  31-45min 
46-60min  61-75min  76-90min 
91-105min  106-120min  2-3h 
3-4h  Over 4h 
2. On a night before a day off (e.g. a weekend):
a. What is your earliest GOOD NIGHT TIME?  PM/AM 
b. What is your latest GOOD NIGHT TIME?  PM/AM 
c. What is your usual GOOD NIGHT TIME? PM/AM 
d. How stable (i.e., similar each night) are your GOOD NIGHT TIMES? (please tick one)
0-15min    16-30min   31-45min  
46-60min    61-75min    76-90min   
91-105min    106-120min   2-3h    
3-4h    Over 4h    
Please think of “GOOD MORNING” TIME as the time at which you finally get out of bed and start your day. 
3. Before a work day or school day:
a. What is your earliest GOOD MORNING TIME?  AM/PM 
b. What is your latest GOOD MORNING TIME?  AM/PM 
c. What is your usual GOOD MORNING TIME?  AM/PM 
d. How stable (i.e. similar each night) are your GOOD MORNING TIMES? (please tick one)
0-15min  16-30min  31-45min 
46-60min  61-75min  76-90min 
91-105min  106-120min  2-3h 
3-4h  Over 4h 
4. Before a day off (e.g. a weekend):
a. What is your earliest GOOD MORNING TIME?  AM/PM 
b. What is your latest GOOD MORNING TIME?  AM/PM 
c. What is your usual GOOD MORNING TIME?  AM/PM 
d. How stable (i.e., similar each night) are your GOOD MORNING TIMES? (please tick one)
0-15min    16-30min  31-45min 
46-60min    61-75min   76-90min 
91-105min    106-120min  2-3h 
3-4h    Over 4h    
These questions are about how much sleep you lose to unwanted wakefulness: 
5. On most nights, how long, on average does it take you to fall asleep after you start trying?
min 
6. On most nights, how much sleep do you lose, on average, from waking up during the night (e.g. to go to the
bathroom)?  min
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THE EPWORTH SLEEPINESS SCALE 
INSTRUCTIONS 
How likely are you to doze off or fall asleep in the following situations, in contrast to feeling just tired? This refers 
to your usual way of life in recent times. Even if you have not done some of these things recently, try to work out 
how they would have affected you. Use the following scale to choose the most appropriate number for each 
situation: 
0 = would never doze 
1 = slight chance of dozing 
2 = moderate chance of dozing 
3 = high chance of dozing 
Situation Score (0 – 3) 
Sitting and reading 
Watching television 
Sitting inactive in a public place (e.g. theatre or meeting) 
As a passenger in a car for an hour without a break 
Lying down to rest in the afternoon when circumstances permit 
Sitting and talking to someone 
Sitting quietly after a lunch without alcohol 
In a car, while stopped for a few minutes in the traffic 
TOTAL score 
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HORNE-ÖSTBERG MORNING-EVENING PERSONALITY QUESTIONNAIRE 
INSTRUCTIONS 
a) Please read each question very carefully before answering.
b) Answer ALL 19 questions.
c) Answer questions in numerical order.
d) Each question should be answered independently of others. DO NOT go back and check your answers.
e) For some questions, you are required to respond by placing a cross alongside your answer. In such cases, select
ONE answer only. 
f) Please answer each question as honestly as possible. Both your answers and results will be kept in strict
confidence. 
1. Considering your own feelings about when you are “at your best”, at what time would you get up if you were
entirely free to plan your day? 
Time:  AM/PM 
2. Considering only your own “feeling best” rhythm, at what time would you go to bed if you were entirely free
to plan your day? 
Time:  AM/PM 
3. If there is a specific time you have to get up in the morning, to what extent are you dependent on being woken
up by an alarm clock? 
a. Not at all dependent  b. Slightly dependent 
c. Fairly dependent   d. Very dependent 
4. Assuming adequate environmental conditions, how easy do you find getting up in the morning?
a. Not at all easy  b. Slightly easy 
c. Fairly easy  d. Very easy 
5. How alert do you feel during the first half hour after having woken in the morning?
a. Not at all alert  b. Slightly alert 
c. Fairly alert  d. Very alert  
6. How is your appetite during the first half hour after having woken in the morning?
a. Not at all good  b. Slightly good 
c. Fairly good  d. Very good 
7. During the first half hour after having woken in the morning, how tired do you feel?
a. Very tired  b. Slightly tired 
c. Fairly refreshed  d. Very refreshed 
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8. When you have no commitments the next day, at what time do you go to bed compared to your usual 
bedtime? 
a. Seldom or never later      b. Less than one hour later   
c. 1-2 hours later       d. More than 2 hours later  
  
9. You have decided to engage in some physical exercise. A friend suggests that you do this one hour twice a 
week and the best time for him/her is between 7.00-8.00 am. Bearing in mind nothing else but your own 
inclinations, how do you think you would perform? 
a. Would be on good form   b. Would be on reasonable form   
c. Would find it difficult   d. Would find it very difficult   
10. At what time in the evening do you feel tired and in need of sleep? 
Time:     AM/PM 
11. You wish to be at your peak for a test, which you know is going to be mentally exhausting and last for two 
hours. You are entirely free to plan your day. When would you do this task? 
a. 8.00 am – 10.00 am     b. 11.00 am – 1.00 pm   
c. 3.00 pm – 5.00 pm      d. 7.00 pm – 9.00 pm   
12. If you went to bed at 11.00 pm at what level of tiredness would you be at that time? 
a. Not at all tired      b. A little tired    
c. Fairly tired      d. Very tired    
13. For some reason you have gone to bed several hours later than usual, but there is no need to get up at any 
particular time the next morning. Will you: 
a. Wake up at the usual time and not go back to sleep    
b. Wake up at the usual time and doze     
c. Wake up at the usual time and go back to sleep    
d. Wake up later than usual      
14. One morning you have to remain awake between 4.00 am and 6.00 am in order to carry out a watch duty. 
You have no commitments the next day. Which ONE of the following alternatives suits you best? 
a. Would NOT go to bed until 6.00 am      
b. Nap before 4.00 am and sleep after 6.00 am     
c. Sleep before 4.00 am and nap after 6.00 am     
d. Only sleep before 4.00 am and remain awake after 6.00 am    
15. You have to do 2 hours of hard physical work. If you were completely free to plan your day, and considering 
only your “feeling best” rhythm, which hours would you prefer to do it between: 
a. 8.00 am – 10.00 am     b. 11.00 am – 1.00 pm   
c. 3.00 pm – 5.00 pm     d. 7.00 pm – 9.00 pm  
  
16. You have decided to engage in some physical exercise. A friend suggests that you do this between 10.00 pm 
and 11.00 pm twice a week. How do you think you would perform? 
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a. Would be on good form  b. Would be on reasonable form 
c. Would find it difficult  d. Would find it very difficult 
17. Suppose that you can choose your own work hours, but had to work FIVE hours in the day. Assume that your
job is interesting and paid by results. Which FIVE CONSECUTIVE HOURS would you choose? 
Hours: 
18. At what time of day do you feel at your best?
Time:  AM/PM 
19. One hears of “morning” and “evening” types. Which do you consider yourself to be?
a. Morning type 
b. More morning than evening 
c. More evening than morning 
d. Evening type 
 Appendix 5J  
 
Version 1 · Approved · 9 Jult 2014 
EMERGENCY CONTACT DETAILS 
 
CONTACT INFORMATION 
Date:          Code:     
PERSONAL DETAILS 
First name:            
Surname:            
Postal address:            
       Code:    
Email address:            
Phone number (h):      Cell phone:    
 
EMERGENCY CONTACT 
Please give us the contact details of two people we may call in case of an emergency. 
Name:         Relation:      
Cell phone:       Landline:      
Name:         Relation:      
Cell phone:       Landline:      
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1. Write the date, day of the week, and type of day (Work, School, Day Off, or Weekend). 
2. Put a “” in the actiwatch column if you wore it and the letter “x” if you did not. 
3. Write the letter “W” to show when you woke up, “B” to show when you went to bed and “N” when you napped. 
4. Write the letter “C” in the box when you have coffee or any products with caffeine in them; “M” when you take any medicine; “A” when you drink alcohol and “E” 
when you exercise.  
5. SAMPLE ENTRY BELOW: On a Monday when I worked, I wore my Actiwatch, woke up at about 06h00, had medicine at 07h00 and coffee at 09h00 and 13h00. I went 
for a walk at 18h00, had a glass of wine at 20h00 and went to bed at 22h00. 
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Notes: 
Please indicate the type of medication you took, as well as the type of exercise done. 
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Date Day Medication (type and dose) Exercise (type and time) 
02/06/14 Monday DS-24, 1 capsule 30min walk with dog 
